[
  {
    "id": 1,
    "question": "A patient is taking Tegretol (carbamazepine). What medication interaction should you be aware of?",
    "options": [
      "Acetaminophen",
      "Ibuprofen",
      "Cipro or Erythromycin",
      "Aspirin"
    ],
    "correctAnswer": 2,
    "rationale": "Erythromycin inhibits CYP3A4, increases carbamazepine levels causing toxicity. Cipro increases levels similarly. Monitor levels. (FDA/Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 2,
    "question": "What are the signs of serotonin syndrome?",
    "options": [
      "Bradycardia, hypothermia, lethargy",
      "Autonomic instability, tachycardia, hyperreflexia, myoclonus",
      "Lead pipe rigidity, fever, confusion",
      "Hypotension, bradycardia, respiratory depression"
    ],
    "correctAnswer": 1,
    "rationale": "Serotonin syndrome: autonomic instability, tachycardia, hyperreflexia, myoclonus. Caused by excess serotonin. Medical emergency. (DSM-5-TR/APA)",
    "category": "Pharmacology"
  },
  {
    "id": 3,
    "question": "What is the first line of treatment for a first psychotic episode?",
    "options": [
      "Haldol",
      "Clozaril",
      "Thorazine",
      "Invega"
    ],
    "correctAnswer": 3,
    "rationale": "Invega (paliperidone) first-line for first-episode psychosis. Lower EPS, good efficacy. Second-generation antipsychotic preferred. (APA Guidelines)",
    "category": "Pharmacology"
  },
  {
    "id": 4,
    "question": "What medication is contraindicated in a patient with eating disorder (bulimia)?",
    "options": [
      "Prozac",
      "Zoloft",
      "Wellbutrin (Bupropion)",
      "Lexapro"
    ],
    "correctAnswer": 2,
    "rationale": "Bupropion contraindicated in bulimia due to increased seizure risk from electrolyte imbalances, purging. FDA black box warning. (FDA/Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 5,
    "question": "Which antipsychotic has the HIGHEST risk of metabolic syndrome?",
    "options": [
      "Abilify",
      "Geodon",
      "Clozapine",
      "Risperdal"
    ],
    "correctAnswer": 2,
    "rationale": "Clozapine highest metabolic syndrome risk: weight gain, diabetes, dyslipidemia. Monitor metabolic panel, lipids, glucose. (APA/Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 6,
    "question": "What is the therapeutic lithium level for maintenance therapy?",
    "options": [
      "0.2-0.4 mEq/L",
      "0.6-1.2 mEq/L",
      "1.5-2.0 mEq/L",
      "2.0-2.5 mEq/L"
    ],
    "correctAnswer": 1,
    "rationale": "Maintenance lithium: 0.6-1.2 mEq/L. Acute mania: 0.8-1.2. Narrow therapeutic index requires monitoring. (FDA/APA)",
    "category": "Pharmacology"
  },
  {
    "id": 7,
    "question": "When should you draw lithium levels?",
    "options": [
      "4 hours after dose",
      "8 hours after dose",
      "12 hours after last dose",
      "24 hours after dose"
    ],
    "correctAnswer": 2,
    "rationale": "Draw lithium 12 hours post-dose for accurate trough level. Ensures steady-state measurement, prevents false toxicity. (FDA/Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 8,
    "question": "A patient on lithium develops elevated TSH. What does this indicate?",
    "options": [
      "Hyperthyroidism",
      "Hypothyroidism",
      "Normal finding",
      "Lithium toxicity"
    ],
    "correctAnswer": 1,
    "rationale": "Elevated TSH indicates hypothyroidism. Lithium inhibits thyroid hormone release. Monitor thyroid function every 6-12 months. (FDA/APA)",
    "category": "Pharmacology"
  },
  {
    "id": 9,
    "question": "What should you do if a patient on lithium develops hypothyroidism?",
    "options": [
      "Stop lithium immediately",
      "Reduce lithium dose",
      "Continue lithium and add levothyroxine",
      "Switch to Depakote"
    ],
    "correctAnswer": 2,
    "rationale": "Lithium toxicity >1.5 mEq/L causes tremor, confusion, ataxia, seizures. Stop lithium, hydrate, check levels. (FDA/Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 10,
    "question": "What is the most common cause of lithium toxicity?",
    "options": [
      "Overdose",
      "Dehydration",
      "Drug interaction",
      "Renal failure"
    ],
    "correctAnswer": 1,
    "rationale": "NSAIDs (except aspirin) increase lithium levels by reducing renal clearance. Risk of toxicity. Avoid or monitor closely. (FDA/Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 11,
    "question": "Which medication causes Stevens-Johnson Syndrome and requires slow titration?",
    "options": [
      "Lithium",
      "Lamictal (Lamotrigine)",
      "Abilify",
      "Prozac"
    ],
    "correctAnswer": 1,
    "rationale": "Lamotrigine causes Stevens-Johnson syndrome with rapid titration. Slow titration essential. Stop if rash develops. (FDA Black Box)",
    "category": "Pharmacology"
  },
  {
    "id": 12,
    "question": "What is the BLACK BOX WARNING for clozapine?",
    "options": [
      "Hypothyroidism",
      "Agranulocytosis",
      "Hepatotoxicity",
      "Nephrotoxicity"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine requires ANC monitoring: weekly 6 months, then biweekly 6 months, then monthly. Agranulocytosis risk. (FDA REMS)",
    "category": "Pharmacology"
  },
  {
    "id": 13,
    "question": "A patient on clozapine has an ANC of 1200. What should you do?",
    "options": [
      "Continue clozapine as normal",
      "Interrupt treatment and monitor daily",
      "Stop clozapine permanently",
      "Reduce clozapine dose by 50%"
    ],
    "correctAnswer": 1,
    "rationale": "Valproate teratogenic: neural tube defects. Avoid in pregnancy. Use contraception. Consider alternatives in women of childbearing age. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 14,
    "question": "A patient on clozapine quits smoking. What should you do?",
    "options": [
      "Continue same dose",
      "Increase clozapine dose",
      "Reduce clozapine dose",
      "Stop clozapine"
    ],
    "correctAnswer": 2,
    "rationale": "Serotonin syndrome vs NMS: SS has hyperreflexia/myoclonus, NMS has rigidity/bradykinesia. Different onset, treatment. (DSM-5-TR)",
    "category": "Pharmacology"
  },
  {
    "id": 15,
    "question": "Which SSRI is FDA-approved for bulimia nervosa?",
    "options": [
      "Zoloft 50 mg",
      "Prozac 60 mg",
      "Paxil 40 mg",
      "Lexapro 20 mg"
    ],
    "correctAnswer": 1,
    "rationale": "NMS: fever, rigidity, altered mental status, elevated CK. Stop antipsychotic immediately. Medical emergency, supportive care. (APA)",
    "category": "Pharmacology"
  },
  {
    "id": 16,
    "question": "What antidepressant is BEST for a patient with depression who wants to quit smoking?",
    "options": [
      "Prozac",
      "Zoloft",
      "Wellbutrin (Bupropion)",
      "Cymbalta"
    ],
    "correctAnswer": 2,
    "rationale": "Clozapine lowers seizure threshold dose-dependently. Risk increases >600mg/day. Slow titration reduces risk. (Stahl's/FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 17,
    "question": "What antidepressant is BEST for a patient with depression and insomnia?",
    "options": [
      "Wellbutrin",
      "Prozac",
      "Mirtazapine (Remeron) or Trazodone",
      "Lexapro"
    ],
    "correctAnswer": 2,
    "rationale": "QTc prolongation >500ms increases torsades risk. Avoid with ziprasidone, thioridazine, citalopram >40mg. ECG monitoring. (FDA/AHA)",
    "category": "Pharmacology"
  },
  {
    "id": 18,
    "question": "Which antidepressant has the LOWEST risk of sexual side effects?",
    "options": [
      "Prozac",
      "Zoloft",
      "Paxil",
      "Wellbutrin"
    ],
    "correctAnswer": 3,
    "rationale": "Tardive dyskinesia: irreversible involuntary movements from chronic dopamine blockade. Higher risk with first-generation antipsychotics. (APA)",
    "category": "Pharmacology"
  },
  {
    "id": 19,
    "question": "Which medication is used to treat MAOI-induced hypertensive crisis?",
    "options": [
      "Metoprolol",
      "Phentolamine",
      "Labetalol",
      "Lisinopril"
    ],
    "correctAnswer": 1,
    "rationale": "AIMS assessment every 6 months on antipsychotics detects tardive dyskinesia early. Document baseline and ongoing. (APA Guidelines)",
    "category": "Pharmacology"
  },
  {
    "id": 20,
    "question": "Which opioid pain medication can cause serotonin syndrome?",
    "options": [
      "Morphine",
      "Hydrocodone",
      "Meperidine (Demerol)",
      "Oxycodone"
    ],
    "correctAnswer": 2,
    "rationale": "Akathisia: inner restlessness, inability to sit still. Treat with beta-blockers (propranolol), benzodiazepines, or reduce dose. (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 21,
    "question": "What is the mechanism of action of SSRIs?",
    "options": [
      "Inhibit MAO enzyme",
      "Block dopamine reuptake",
      "Inhibit serotonin reuptake",
      "Block NMDA receptors"
    ],
    "correctAnswer": 2,
    "rationale": "Dystonia: acute muscle spasms, torticollis, oculogyric crisis. Treat with anticholinergics (benztropine) IM/IV immediately. (APA)",
    "category": "Pharmacology"
  },
  {
    "id": 22,
    "question": "What is the mechanism of action of Wellbutrin (Bupropion)?",
    "options": [
      "SSRI",
      "SNRI",
      "NDRI (Norepinephrine-Dopamine Reuptake Inhibitor)",
      "MAOI"
    ],
    "correctAnswer": 2,
    "rationale": "Pseudoparkinsonism: bradykinesia, rigidity, tremor from dopamine blockade. Reduce dose or add anticholinergic. (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 23,
    "question": "Which medications can INDUCE depression?",
    "options": [
      "SSRIs",
      "Beta blockers, Steroids, Interferon, Accutane",
      "Stimulants",
      "Benzodiazepines only"
    ],
    "correctAnswer": 1,
    "rationale": "Anticholinergic effects: dry mouth, constipation, urinary retention, blurred vision, confusion. Avoid in elderly. (Beers Criteria)",
    "category": "Pharmacology"
  },
  {
    "id": 24,
    "question": "Which medications can INDUCE mania?",
    "options": [
      "Antipsychotics",
      "Mood stabilizers",
      "Steroids, Antidepressants, INH, Disulfiram",
      "Anticonvulsants"
    ],
    "correctAnswer": 2,
    "rationale": "MAOIs require tyramine-free diet. Tyramine causes hypertensive crisis. Avoid aged cheese, cured meats, fermented foods. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 25,
    "question": "What is the difference between SSRI Discontinuation Syndrome and Serotonin Syndrome?",
    "options": [
      "They are the same condition",
      "Discontinuation = lack of serotonin; Serotonin Syndrome = excess serotonin",
      "Discontinuation is more severe",
      "No difference"
    ],
    "correctAnswer": 1,
    "rationale": "MAOI washout: 2 weeks before starting serotonergic agent. 5 weeks after fluoxetine. Prevents serotonin syndrome. (FDA/Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 26,
    "question": "What are the symptoms of SSRI Discontinuation Syndrome?",
    "options": [
      "Seizures and coma",
      "Flu-like symptoms, brain zaps, dizziness, irritability",
      "Hypertensive crisis",
      "Agranulocytosis"
    ],
    "correctAnswer": 1,
    "rationale": "Fluoxetine half-life 4-6 days; active metabolite 4-16 days. Longest SSRI half-life. 5-week washout before MAOI. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 27,
    "question": "Which antipsychotic requires a baseline EKG due to QTc prolongation risk?",
    "options": [
      "Abilify",
      "Risperdal",
      "Geodon (Ziprasidone)",
      "Seroquel"
    ],
    "correctAnswer": 2,
    "rationale": "Bupropion mechanism: NDRI (norepinephrine-dopamine reuptake inhibitor). Lower sexual side effects. Seizure risk dose-dependent. (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 28,
    "question": "Which mood stabilizer is MOST effective for rapid cycling bipolar disorder?",
    "options": [
      "Lithium",
      "Depakote (Valproic Acid)",
      "Carbamazepine",
      "Lamictal"
    ],
    "correctAnswer": 1,
    "rationale": "Mirtazapine: alpha-2 antagonist, increases norepinephrine/serotonin. Sedating, increases appetite. Good for insomnia, weight loss. (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 29,
    "question": "What genetic test should be done before starting Tegretol (carbamazepine) in Asian patients?",
    "options": [
      "CYP2D6",
      "HLA-B*1502",
      "TPMT",
      "G6PD"
    ],
    "correctAnswer": 1,
    "rationale": "Vortioxetine: serotonin modulator. Multiple receptor actions. Approved for depression. Cognitive benefits shown. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 30,
    "question": "What is the loading dose of Depakote for acute mania?",
    "options": [
      "5 mg/kg",
      "10 mg/kg",
      "20 mg/kg",
      "30 mg/kg"
    ],
    "correctAnswer": 2,
    "rationale": "Vilazodone: SSRI + 5-HT1A partial agonist. Take with food for absorption. Lower sexual dysfunction than SSRIs. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 31,
    "question": "Which two medications can DOUBLE lithium levels?",
    "options": [
      "Acetaminophen and ibuprofen",
      "NSAIDs and ACE inhibitors",
      "Antibiotics and antifungals",
      "SSRIs and SNRIs"
    ],
    "correctAnswer": 1,
    "rationale": "Trazodone: serotonin antagonist/reuptake inhibitor. Used off-label for insomnia 25-100mg. Priapism risk (rare). (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 32,
    "question": "What is the antidote for benzodiazepine overdose?",
    "options": [
      "Naloxone",
      "Flumazenil",
      "Activated charcoal",
      "N-acetylcysteine"
    ],
    "correctAnswer": 1,
    "rationale": "Priapism risk: trazodone. Emergency: painful erection >4 hours. Stop medication, urology consult immediately. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 33,
    "question": "What is the antidote for opioid overdose?",
    "options": [
      "Naloxone (Narcan)",
      "Flumazenil",
      "Atropine",
      "Epinephrine"
    ],
    "correctAnswer": 0,
    "rationale": "Cymbalta (duloxetine): SNRI. FDA-approved for depression, anxiety, diabetic neuropathy, fibromyalgia, chronic pain. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 34,
    "question": "Which medication is used for alcohol withdrawal?",
    "options": [
      "Methadone",
      "Buprenorphine",
      "Benzodiazepines (Librium, Ativan)",
      "Antipsychotics"
    ],
    "correctAnswer": 2,
    "rationale": "Effexor (venlafaxine): SNRI. Dose-dependent: low dose SSRI-like, high dose adds norepinephrine. Taper slowly. (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 35,
    "question": "Which medication is used for opioid withdrawal?",
    "options": [
      "Benzodiazepines",
      "Buprenorphine or Methadone",
      "Antipsychotics",
      "Lithium"
    ],
    "correctAnswer": 1,
    "rationale": "SSRI discontinuation syndrome: dizziness, nausea, paresthesias, anxiety. Worse with short half-life SSRIs. Taper slowly. (APA)",
    "category": "Pharmacology"
  },
  {
    "id": 36,
    "question": "What are the cardinal signs of Neuroleptic Malignant Syndrome (NMS)?",
    "options": [
      "Hyperreflexia, agitation, diarrhea",
      "Lead pipe rigidity, fever, altered mental status, autonomic instability",
      "Hypothermia, bradycardia, lethargy",
      "Seizures, hypotension, coma"
    ],
    "correctAnswer": 1,
    "rationale": "Paroxetine shortest half-life SSRI, worst discontinuation syndrome. Most anticholinergic SSRI. Avoid abrupt discontinuation. (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 37,
    "question": "How do you distinguish NMS from Serotonin Syndrome?",
    "options": [
      "NMS has hyperreflexia; SS has rigidity",
      "NMS has lead pipe rigidity; SS has hyperreflexia",
      "They are the same",
      "NMS occurs rapidly; SS occurs slowly"
    ],
    "correctAnswer": 1,
    "rationale": "Sertraline: most evidence in pregnancy. Safest SSRI option. Benefits outweigh risks in severe depression. (ACOG/APA)",
    "category": "Pharmacology"
  },
  {
    "id": 38,
    "question": "Which typical antipsychotic has the HIGHEST risk of EPS?",
    "options": [
      "Thorazine",
      "Haldol (Haloperidol)",
      "Mellaril",
      "Clozaril"
    ],
    "correctAnswer": 1,
    "rationale": "SSRIs in pregnancy: small increased risk persistent pulmonary hypertension. Weigh risks vs untreated depression. Individualize. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 39,
    "question": "Which atypical antipsychotic has the LOWEST risk of metabolic side effects?",
    "options": [
      "Olanzapine",
      "Clozapine",
      "Ziprasidone or Lurasidone",
      "Quetiapine"
    ],
    "correctAnswer": 2,
    "rationale": "Breastfeeding on SSRIs: sertraline, paroxetine lowest infant exposure. Monitor infant for sedation, feeding issues. (AAP)",
    "category": "Pharmacology"
  },
  {
    "id": 40,
    "question": "What is rhabdomyolysis and when does it occur?",
    "options": [
      "Liver failure from medications",
      "Muscle breakdown releasing myoglobin; can occur with NMS or strenuous exercise",
      "Kidney stones from medications",
      "Bone marrow suppression"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium pregnancy: Ebstein anomaly risk (0.05-0.1%). Avoid first trimester if possible. Monitor levels, hydration. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 41,
    "question": "What PHQ-9 score indicates moderate depression requiring treatment?",
    "options": [
      "5-9",
      "10-14",
      "15-19",
      "20-27"
    ],
    "correctAnswer": 1,
    "rationale": "Valproate pregnancy category X: neural tube defects 1-5%. Contraindicated. Use effective contraception. (FDA Black Box)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 42,
    "question": "What PHQ-9 score indicates likely clinical depression?",
    "options": [
      "≥5",
      "≥10",
      "≥15",
      "≥20"
    ],
    "correctAnswer": 1,
    "rationale": "Carbamazepine pregnancy: neural tube defects, craniofacial abnormalities. Depetes folate. Supplement folic acid 4-5mg daily. (FDA)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 43,
    "question": "What MMSE score indicates cognitive impairment?",
    "options": [
      "<30",
      "<27",
      "<24",
      "<20"
    ],
    "correctAnswer": 2,
    "rationale": "Benzodiazepines pregnancy: cleft palate risk controversial. Avoid first trimester. Risk of neonatal withdrawal, floppy infant. (FDA)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 44,
    "question": "What is the MMSE score range for normal cognition?",
    "options": [
      "20-24",
      "25-30",
      "27-30",
      "30 only"
    ],
    "correctAnswer": 1,
    "rationale": "Benzodiazepine mechanism: GABA-A receptor positive allosteric modulator. Enhances chloride influx, neuronal hyperpolarization. (Stahl's)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 45,
    "question": "At what CIWA score should you start treatment for alcohol withdrawal?",
    "options": [
      ">5",
      ">8",
      ">10",
      ">15"
    ],
    "correctAnswer": 1,
    "rationale": "Benzodiazepine dependence develops in 4-6 weeks. Avoid long-term use. Taper slowly 10% every 1-2 weeks. (APA)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 46,
    "question": "At what COWS score should you start treatment for opioid withdrawal?",
    "options": [
      ">5",
      ">7",
      ">10",
      ">15"
    ],
    "correctAnswer": 1,
    "rationale": "Alprazolam (Xanax) short half-life, high potency. Highest abuse potential. Severe rebound anxiety. Avoid long-term. (DEA/Stahl's)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 47,
    "question": "What GAD-7 score indicates likely clinical anxiety?",
    "options": [
      "≥5",
      "≥7",
      "≥10",
      "≥15"
    ],
    "correctAnswer": 2,
    "rationale": "Clonazepam (Klonopin) longer half-life, easier tapering than alprazolam. Less rebound anxiety. Preferred for taper. (Stahl's)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 48,
    "question": "What is the Beck Depression Inventory score for moderate depression?",
    "options": [
      "0-13",
      "14-19",
      "20-28",
      "29-63"
    ],
    "correctAnswer": 2,
    "rationale": "Lorazepam (Ativan): intermediate half-life, no active metabolites. Safe in liver disease. IM absorption reliable. (FDA)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 49,
    "question": "What is the HAM-D score for severe depression?",
    "options": [
      "8-13",
      "14-18",
      "19+",
      "25+"
    ],
    "correctAnswer": 2,
    "rationale": "Diazepam (Valium) long half-life, active metabolites. Accumulation in elderly. Avoid in hepatic impairment. (Beers Criteria)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 50,
    "question": "How should you document MMSE results?",
    "options": [
      "Just write the total score",
      "Document total score AND specific deficits",
      "No documentation needed",
      "Only document if abnormal"
    ],
    "correctAnswer": 1,
    "rationale": "Buspirone: 5-HT1A partial agonist. Non-habit forming. Takes 2-4 weeks for effect. Good for GAD. (FDA)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 51,
    "question": "What does Question 9 of the PHQ-9 assess?",
    "options": [
      "Sleep problems",
      "Appetite changes",
      "Suicidal ideation",
      "Concentration"
    ],
    "correctAnswer": 2,
    "rationale": "Hydroxyzine: antihistamine for anxiety. Non-controlled. Sedating, anticholinergic effects. Alternative to benzodiazepines. (FDA)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 52,
    "question": "A patient scores 18 on CIWA. What is the appropriate treatment?",
    "options": [
      "No treatment needed",
      "PRN benzodiazepines",
      "Standing benzodiazepines",
      "Antipsychotics"
    ],
    "correctAnswer": 2,
    "rationale": "Propranolol: beta-blocker for performance anxiety. Blocks peripheral symptoms (tremor, tachycardia). Dose 10-40mg PRN. (Off-label)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 53,
    "question": "A patient scores 15 on COWS. What is indicated?",
    "options": [
      "No treatment",
      "PRN buprenorphine",
      "Standing buprenorphine or methadone",
      "Benzodiazepines"
    ],
    "correctAnswer": 2,
    "rationale": "Prazosin: alpha-1 antagonist for PTSD nightmares. Reduces noradrenergic hyperarousal. Dose 1-15mg qHS. (VA/DoD Guidelines)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 54,
    "question": "What is the SLUM score range for dementia?",
    "options": [
      "0-9",
      "0-20",
      "21-26",
      "27-30"
    ],
    "correctAnswer": 1,
    "rationale": "PTSD first-line: SSRIs (sertraline, paroxetine FDA-approved). Trauma-focused psychotherapy plus medication most effective. (APA/VA)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 55,
    "question": "What is the HAM-A score for moderate anxiety?",
    "options": [
      "0-13",
      "14-17",
      "18-24",
      "25+"
    ],
    "correctAnswer": 2,
    "rationale": "Prolonged exposure therapy: gold standard for PTSD. Gradual exposure to trauma memories. Evidence-based, reduces avoidance. (APA)",
    "category": "Assessment Scales & Screening"
  },
  {
    "id": 56,
    "question": "At what age should an infant no longer have head lag?",
    "options": [
      "2 months",
      "4 months",
      "6 months",
      "9 months"
    ],
    "correctAnswer": 1,
    "rationale": "EMDR: eye movement desensitization reprocessing. Evidence-based for PTSD. Bilateral stimulation during trauma processing. (APA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 57,
    "question": "When should the Moro reflex disappear?",
    "options": [
      "2 months",
      "4-6 months",
      "9 months",
      "12 months"
    ],
    "correctAnswer": 1,
    "rationale": "CBT-I: cognitive behavioral therapy for insomnia. First-line treatment. More effective long-term than medications. (AASM)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 58,
    "question": "When should the Babinski reflex disappear?",
    "options": [
      "6 months",
      "9 months",
      "12-24 months",
      "36 months"
    ],
    "correctAnswer": 2,
    "rationale": "Sleep hygiene: consistent schedule, dark/cool room, no screens 1 hour before bed. Foundation of insomnia treatment. (AASM)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 59,
    "question": "What is Erikson's stage for infancy (0-1 year)?",
    "options": [
      "Autonomy vs. Shame",
      "Trust vs. Mistrust",
      "Initiative vs. Guilt",
      "Industry vs. Inferiority"
    ],
    "correctAnswer": 1,
    "rationale": "Ramelteon: melatonin receptor agonist. Non-scheduled. No abuse potential. Effective for sleep onset. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 60,
    "question": "What is Erikson's stage for early childhood (1-3 years)?",
    "options": [
      "Trust vs. Mistrust",
      "Autonomy vs. Shame and Doubt",
      "Initiative vs. Guilt",
      "Identity vs. Role Confusion"
    ],
    "correctAnswer": 1,
    "rationale": "Suvorexant: orexin receptor antagonist. Promotes sleep maintenance. Schedule IV. Dose 10-20mg. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 61,
    "question": "What is Erikson's stage for adolescence (12-18 years)?",
    "options": [
      "Industry vs. Inferiority",
      "Identity vs. Role Confusion",
      "Intimacy vs. Isolation",
      "Generativity vs. Stagnation"
    ],
    "correctAnswer": 1,
    "rationale": "Z-drugs (zolpidem, eszopiclone, zaleplon): GABA-A selective. Shorter half-lives than benzodiazepines. Schedule IV. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 62,
    "question": "What is Erikson's stage for middle adulthood (40-65 years)?",
    "options": [
      "Intimacy vs. Isolation",
      "Generativity vs. Stagnation",
      "Integrity vs. Despair",
      "Identity vs. Role Confusion"
    ],
    "correctAnswer": 1,
    "rationale": "Zolpidem immediate-release: sleep onset. Extended-release: sleep maintenance. Lower dose in women (5mg). Complex sleep behaviors. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 63,
    "question": "What is Piaget's stage for ages 2-7 years?",
    "options": [
      "Sensorimotor",
      "Preoperational",
      "Concrete Operational",
      "Formal Operational"
    ],
    "correctAnswer": 1,
    "rationale": "Zolpidem complex sleep behaviors: sleepwalking, sleep-driving, eating. FDA warning. Discontinue if occurs. (FDA Black Box)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 64,
    "question": "What is Piaget's stage for ages 7-11 years?",
    "options": [
      "Preoperational",
      "Concrete Operational",
      "Formal Operational",
      "Sensorimotor"
    ],
    "correctAnswer": 1,
    "rationale": "Modafinil: wakefulness-promoting agent. FDA-approved for narcolepsy, shift work sleep disorder, sleep apnea. Off-label ADHD. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 65,
    "question": "When does object permanence develop?",
    "options": [
      "Birth",
      "3-4 months",
      "8-12 months",
      "18-24 months"
    ],
    "correctAnswer": 2,
    "rationale": "Stimulants mechanism: increase dopamine/norepinephrine. FDA-approved ADHD, narcolepsy. Schedule II controlled substances. (DEA/FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 66,
    "question": "What is Freud's stage for ages 3-6 years?",
    "options": [
      "Oral",
      "Anal",
      "Phallic",
      "Latency"
    ],
    "correctAnswer": 2,
    "rationale": "Methylphenidate: blocks dopamine/norepinephrine reuptake. First-line ADHD. Immediate and extended-release formulations available. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 67,
    "question": "What is Freud's stage for ages 6-12 years?",
    "options": [
      "Phallic",
      "Latency",
      "Genital",
      "Anal"
    ],
    "correctAnswer": 1,
    "rationale": "Amphetamine: increases dopamine/norepinephrine release. First-line ADHD. Higher abuse potential than methylphenidate. (DEA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 68,
    "question": "At what age can a child typically hop on one foot?",
    "options": [
      "2 years",
      "3 years",
      "4 years",
      "5 years"
    ],
    "correctAnswer": 2,
    "rationale": "Vyvanse (lisdexamfetamine): prodrug, converted to dextroamphetamine. Lower abuse potential. Once-daily dosing. FDA-approved ADHD, BED. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 69,
    "question": "At what age can a child typically ride a tricycle?",
    "options": [
      "2 years",
      "3 years",
      "4 years",
      "5 years"
    ],
    "correctAnswer": 1,
    "rationale": "Atomoxetine: selective norepinephrine reuptake inhibitor. Non-stimulant. Takes 4-6 weeks. Good alternative if stimulant contraindicated. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 70,
    "question": "At what age can a child typically copy a circle?",
    "options": [
      "2 years",
      "3 years",
      "4 years",
      "5 years"
    ],
    "correctAnswer": 1,
    "rationale": "Guanfacine: alpha-2A agonist. Reduces noradrenergic overactivity. Approved ADHD. Helps impulsivity, hyperarousal. (FDA)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 71,
    "question": "What is the gold standard treatment for Borderline Personality Disorder?",
    "options": [
      "CBT",
      "DBT (Dialectical Behavior Therapy)",
      "Psychoanalysis",
      "Supportive therapy"
    ],
    "correctAnswer": 1,
    "rationale": "Clonidine: alpha-2 agonist. Off-label ADHD, tics. Sedating. Monitor blood pressure. Rebound hypertension if stopped abruptly. (FDA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 72,
    "question": "What therapy is BEST for PTSD?",
    "options": [
      "CBT with exposure therapy or EMDR",
      "Psychoanalysis",
      "Group therapy",
      "Supportive therapy"
    ],
    "correctAnswer": 0,
    "rationale": "Stimulant cardiovascular screening: assess personal/family history sudden death, cardiac disease. Consider ECG if risk factors. (AHA/AAP)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 73,
    "question": "What is the \"identified patient\" in family therapy?",
    "options": [
      "The patient who requested therapy",
      "The family member presenting with symptoms (symptom bearer)",
      "The oldest family member",
      "The most cooperative family member"
    ],
    "correctAnswer": 1,
    "rationale": "Stimulants increase blood pressure, heart rate. Monitor vital signs. Avoid in structural cardiac abnormalities, serious arrhythmias. (FDA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 74,
    "question": "What is cognitive distortion in CBT?",
    "options": [
      "Memory problems",
      "Irrational or exaggerated thought patterns",
      "Hallucinations",
      "Delusions"
    ],
    "correctAnswer": 1,
    "rationale": "ADHD in adults: same medications as children. Higher doses may be needed. Assess for substance use history. (FDA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 75,
    "question": "What are the components of DBT?",
    "options": [
      "Mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness",
      "Exposure and response prevention",
      "Free association",
      "Dream analysis"
    ],
    "correctAnswer": 0,
    "rationale": "Naltrexone: mu-opioid antagonist. FDA-approved alcohol use disorder, opioid dependence. Blocks rewarding effects. Reduces craving. (FDA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 76,
    "question": "What is the difference between transference and countertransference?",
    "options": [
      "Transference = therapist's feelings; Countertransference = patient's feelings",
      "Transference = patient's feelings toward therapist; Countertransference = therapist's feelings toward patient",
      "They are the same",
      "Neither occurs in therapy"
    ],
    "correctAnswer": 1,
    "rationale": "Acamprosate: modulates glutamate/GABA. FDA-approved alcohol dependence. Reduces cravings, supports abstinence. Three times daily dosing. (FDA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 77,
    "question": "What is motivational interviewing used for?",
    "options": [
      "Diagnosing mental illness",
      "Increasing motivation for behavior change (e.g., smoking cessation, substance use)",
      "Intelligence testing",
      "Personality assessment"
    ],
    "correctAnswer": 1,
    "rationale": "Disulfiram: aldehyde dehydrogenase inhibitor. Causes acetaldehyde accumulation, aversive reaction with alcohol. Requires motivated patient. (FDA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 78,
    "question": "What does EMDR stand for?",
    "options": [
      "Eye Movement Desensitization and Reprocessing",
      "Emotional Management and Depression Recovery",
      "Evidence-based Medical Decision Review",
      "None of the above"
    ],
    "correctAnswer": 0,
    "rationale": "Buprenorphine: partial mu-opioid agonist. FDA-approved opioid dependence. Ceiling effect on respiratory depression. Safer than methadone. (FDA/SAMHSA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 79,
    "question": "What is the primary goal of exposure therapy?",
    "options": [
      "Avoid triggering stimuli",
      "Gradual exposure to feared stimuli to reduce anxiety",
      "Medication management",
      "Dream interpretation"
    ],
    "correctAnswer": 1,
    "rationale": "Methadone: full mu-opioid agonist. FDA-approved opioid dependence. Only from licensed clinics. QTc prolongation risk. (FDA/SAMHSA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 80,
    "question": "What is the therapeutic approach for OCD?",
    "options": [
      "Psychoanalysis",
      "Exposure and Response Prevention (ERP)",
      "Supportive therapy only",
      "Hypnotherapy"
    ],
    "correctAnswer": 1,
    "rationale": "Naloxone: mu-opioid antagonist. Reverses opioid overdose. Intranasal/IM formulations available. Essential for opioid users. (FDA/CDC)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 81,
    "question": "What is the recovery model in mental health?",
    "options": [
      "Cure-focused approach",
      "Patient empowerment, hope, and person-centered care",
      "Medication-only approach",
      "Institutionalization"
    ],
    "correctAnswer": 1,
    "rationale": "Varenicline (Chantix): partial nicotinic receptor agonist. FDA-approved smoking cessation. Neuropsychiatric effects warning removed 2016. (FDA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 82,
    "question": "What are the core principles of trauma-informed care?",
    "options": [
      "Safety, trustworthiness, peer support, collaboration, empowerment",
      "Confrontation and challenging",
      "Forced disclosure",
      "Punishment-based approaches"
    ],
    "correctAnswer": 0,
    "rationale": "Bupropion smoking cessation: reduces cravings, withdrawal. Start 1 week before quit date. SR 150mg BID. (FDA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 83,
    "question": "What is the 10-second rule in therapy?",
    "options": [
      "Sessions must be 10 seconds",
      "Wait 10 seconds after patient speaks before responding (allows processing)",
      "Take 10-second breaks",
      "Limit questions to 10 seconds"
    ],
    "correctAnswer": 1,
    "rationale": "Nicotine replacement therapy: doubles quit rates. Multiple forms available. Combination therapy (patch + gum) more effective. (FDA/USPSTF)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 84,
    "question": "What is cultural humility?",
    "options": [
      "Learning about all cultures",
      "Lifelong self-reflection and learning FROM patients about their culture",
      "Assuming cultural knowledge",
      "Avoiding cultural topics"
    ],
    "correctAnswer": 1,
    "rationale": "Schizophrenia first-line: second-generation antipsychotics. Lower EPS risk. Risperidone, olanzapine, quetiapine, aripiprazole commonly used. (APA)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 85,
    "question": "What is the first-line treatment for pediatric OCD?",
    "options": [
      "Medication only",
      "CBT (specifically ERP) +/- SSRI",
      "Hospitalization",
      "Family therapy only"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine: most effective antipsychotic for treatment-resistant schizophrenia. Requires trial of 2+ other antipsychotics. (APA Guidelines)",
    "category": "Psychotherapy & Treatment Modalities"
  },
  {
    "id": 86,
    "question": "What brain structure is responsible for executive function?",
    "options": [
      "Amygdala",
      "Hippocampus",
      "Prefrontal cortex",
      "Cerebellum"
    ],
    "correctAnswer": 2,
    "rationale": "Treatment-resistant schizophrenia definition: inadequate response to 2+ antipsychotics at adequate dose/duration (6+ weeks each). (APA)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 87,
    "question": "What brain structure is the \"emotional center\"?",
    "options": [
      "Prefrontal cortex",
      "Amygdala",
      "Hippocampus",
      "Thalamus"
    ],
    "correctAnswer": 1,
    "rationale": "Long-acting injectable antipsychotics: improve adherence. Consider after first episode or nonadherence. Monthly or quarterly dosing. (APA)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 88,
    "question": "What brain structure is responsible for memory formation?",
    "options": [
      "Amygdala",
      "Hippocampus",
      "Cerebellum",
      "Occipital lobe"
    ],
    "correctAnswer": 1,
    "rationale": "Paliperidone palmitate: LAI every 4 weeks. No oral overlap needed. Loading doses day 1 and 8. (FDA)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 89,
    "question": "What are the functions of the frontal lobe?",
    "options": [
      "Vision",
      "Executive function, motor control, speech production (Broca's area), personality",
      "Hearing",
      "Balance"
    ],
    "correctAnswer": 1,
    "rationale": "Aripiprazole mechanism: dopamine partial agonist. Lower metabolic side effects. Less sedation. May cause akathisia. (Stahl's)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 90,
    "question": "What are the functions of the temporal lobe?",
    "options": [
      "Vision",
      "Hearing, memory (hippocampus), language comprehension (Wernicke's area), emotion",
      "Motor control",
      "Sensory processing"
    ],
    "correctAnswer": 1,
    "rationale": "Lurasidone (Latuda): low metabolic risk. Take with food (350+ calories) for absorption. FDA-approved schizophrenia, bipolar depression. (FDA)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 91,
    "question": "What are the functions of the parietal lobe?",
    "options": [
      "Vision",
      "Hearing",
      "Sensory processing, spatial awareness, proprioception",
      "Motor control"
    ],
    "correctAnswer": 2,
    "rationale": "Ziprasidone (Geodon): low metabolic risk but QTc prolongation. Take with food. ECG monitoring recommended. (FDA)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 92,
    "question": "What are the functions of the occipital lobe?",
    "options": [
      "Vision (visual processing)",
      "Hearing",
      "Motor control",
      "Memory"
    ],
    "correctAnswer": 0,
    "rationale": "Quetiapine (Seroquel): sedating, metabolic effects. Off-label use for sleep/anxiety common. Lower D2 affinity than other SGAs. (Stahl's)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 93,
    "question": "What is the role of the cerebellum?",
    "options": [
      "Emotion",
      "Memory",
      "Balance, coordination, motor learning",
      "Vision"
    ],
    "correctAnswer": 2,
    "rationale": "Olanzapine: highly effective but significant metabolic effects. Weight gain, diabetes, dyslipidemia. Monitor metabolic parameters. (FDA/APA)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 94,
    "question": "Which neurotransmitter is primarily involved in Parkinson's disease?",
    "options": [
      "Serotonin",
      "Dopamine (deficiency)",
      "GABA",
      "Glutamate"
    ],
    "correctAnswer": 1,
    "rationale": "Risperidone: effective but prolactin elevation. Dose-dependent EPS. Use lowest effective dose. (FDA/Stahl's)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 95,
    "question": "Which neurotransmitter is primarily involved in Alzheimer's disease?",
    "options": [
      "Dopamine",
      "Serotonin",
      "Acetylcholine (deficiency)",
      "Norepinephrine"
    ],
    "correctAnswer": 2,
    "rationale": "Prolactin elevation: risperidone, paliperidone, first-generation antipsychotics. Causes amenorrhea, galactorrhea, sexual dysfunction, osteoporosis. (Stahl's)",
    "category": "Neuroscience & Pathophysiology"
  },
  {
    "id": 96,
    "question": "What is the minimum duration for Major Depressive Disorder?",
    "options": [
      "1 week",
      "2 weeks",
      "1 month",
      "6 months"
    ],
    "correctAnswer": 1,
    "rationale": "Aripiprazole lowers prolactin: partial agonist at D2. Good option if prolactin elevation problematic. (Stahl's)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 97,
    "question": "What is the minimum duration for GAD (Generalized Anxiety Disorder)?",
    "options": [
      "2 weeks",
      "1 month",
      "3 months",
      "6 months"
    ],
    "correctAnswer": 3,
    "rationale": "Bipolar I first-line: lithium, valproate, or second-generation antipsychotic (quetiapine, lurasidone, cariprazine). (APA Guidelines)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 98,
    "question": "What is the minimum duration for PTSD symptoms?",
    "options": [
      "Immediate",
      "2 weeks",
      "1 month",
      "6 months"
    ],
    "correctAnswer": 2,
    "rationale": "Bipolar depression first-line: quetiapine, lurasidone, or lamotrigine. Antidepressant monotherapy can trigger mania. (APA Guidelines)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 99,
    "question": "What is the minimum duration for Adjustment Disorder?",
    "options": [
      "Within 3 months of stressor",
      "Within 6 months of stressor",
      "Within 1 year of stressor",
      "No time limit"
    ],
    "correctAnswer": 0,
    "rationale": "Lamotrigine effective for bipolar depression maintenance. No mania risk. Slow titration essential to prevent SJS. (FDA/APA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 100,
    "question": "A patient diagnosed with herpes becomes tearful and withdrawn. This has been going on for 6 weeks. What is the likely diagnosis?",
    "options": [
      "Major Depression",
      "Adjustment Disorder",
      "Brief Psychotic Disorder",
      "Acute Stress Disorder"
    ],
    "correctAnswer": 1,
    "rationale": "Carbamazepine: strong CYP3A4 inducer. Decreases levels of oral contraceptives, many medications. Use alternative contraception. (FDA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 101,
    "question": "What differentiates Adjustment Disorder from Major Depression?",
    "options": [
      "Number of symptoms",
      "Identifiable stressor and onset within 3 months",
      "Severity of symptoms",
      "No difference"
    ],
    "correctAnswer": 1,
    "rationale": "Valproate mechanism: increases GABA, blocks sodium channels. FDA-approved bipolar mania, seizures, migraine prophylaxis. (FDA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 102,
    "question": "What is the difference between delirium and dementia?",
    "options": [
      "No difference",
      "Delirium is acute and fluctuating; Dementia is gradual and progressive",
      "Delirium is chronic; Dementia is acute",
      "Delirium is irreversible; Dementia is reversible"
    ],
    "correctAnswer": 1,
    "rationale": "Valproate monitoring: baseline CBC, LFTs, then periodic. Hepatotoxicity risk highest in children <2 years. (FDA Black Box)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 103,
    "question": "What is the hallmark feature of delirium?",
    "options": [
      "Memory loss",
      "Inattention and fluctuating consciousness",
      "Personality changes",
      "Apathy"
    ],
    "correctAnswer": 1,
    "rationale": "Valproate levels: 50-125 mcg/mL therapeutic. Draw trough level. Correlates with efficacy and side effects. (FDA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 104,
    "question": "What is the hallmark feature of dementia?",
    "options": [
      "Inattention",
      "Memory impairment",
      "Hallucinations",
      "Agitation"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium mechanism: modulates intracellular signaling, neuroprotective. Gold standard for bipolar disorder, anti-suicidal effects. (APA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 105,
    "question": "What cluster do the following personality disorders belong to: Paranoid, Schizoid, Schizotypal?",
    "options": [
      "Cluster A (\"Weird\" - Odd/Eccentric)",
      "Cluster B (\"Wild\" - Dramatic/Emotional)",
      "Cluster C (\"Worried\" - Anxious/Fearful)",
      "None of the above"
    ],
    "correctAnswer": 0,
    "rationale": "Lithium side effects: tremor, polyuria, polydipsia, weight gain, cognitive dulling, hypothyroidism, acne. (Stahl's)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 106,
    "question": "What cluster do the following belong to: Antisocial, Borderline, Histrionic, Narcissistic?",
    "options": [
      "Cluster A",
      "Cluster B (\"Wild\" - Dramatic/Emotional)",
      "Cluster C",
      "None of the above"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium nephrotoxicity: chronic use causes nephrogenic diabetes insipidus. Monitor renal function annually. Consider alternatives if worsening. (FDA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 107,
    "question": "What cluster do the following belong to: Avoidant, Dependent, OCPD?",
    "options": [
      "Cluster A",
      "Cluster B",
      "Cluster C (\"Worried\" - Anxious/Fearful)",
      "None of the above"
    ],
    "correctAnswer": 2,
    "rationale": "Lithium monitoring: levels every 3-6 months, renal function/thyroid every 6-12 months, calcium annually. (APA Guidelines)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 108,
    "question": "What important question should you ask a patient with Borderline Personality Disorder?",
    "options": [
      "About psychotic symptoms",
      "About childhood sexual abuse",
      "About substance use only",
      "About sleep patterns"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium drug interactions: NSAIDs increase levels. Thiazides increase levels. ACE inhibitors increase levels. Monitor closely. (FDA/Stahl's)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 109,
    "question": "What substance use disorder is most associated with Antisocial Personality Disorder?",
    "options": [
      "Cannabis",
      "Opioids",
      "Alcohol (ETOH)",
      "Stimulants"
    ],
    "correctAnswer": 2,
    "rationale": "Lithium dehydration risk: maintain adequate hydration. Caution with diuretics, vomiting, diarrhea, fever, excessive exercise. (FDA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 110,
    "question": "A patient has difficulty breathing, chest tightness, palpitations, sweating, and fear of dying. This lasts 10 minutes. What is the diagnosis?",
    "options": [
      "Heart attack",
      "Panic attack",
      "Generalized anxiety",
      "Agoraphobia"
    ],
    "correctAnswer": 1,
    "rationale": "ECT: most effective for severe depression, catatonia, suicidality. 6-12 treatments. Temporary memory impairment. (APA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 111,
    "question": "What is agoraphobia?",
    "options": [
      "Fear of heights",
      "Fear of situations where escape might be difficult (crowds, public transport, open spaces)",
      "Fear of spiders",
      "Fear of social situations"
    ],
    "correctAnswer": 1,
    "rationale": "ECT mechanism: induces generalized seizure under anesthesia. Increases BDNF, neuroplasticity. Resets dysregulated circuits. (APA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 112,
    "question": "What is social anxiety disorder?",
    "options": [
      "Fear of all situations",
      "Fear of being judged or scrutinized in social situations",
      "Fear of crowds",
      "Generalized worry"
    ],
    "correctAnswer": 1,
    "rationale": "TMS: noninvasive brain stimulation. FDA-approved treatment-resistant depression. Daily sessions 4-6 weeks. No anesthesia needed. (FDA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 113,
    "question": "What is the difference between OCD and OCPD?",
    "options": [
      "No difference",
      "OCD has obsessions/compulsions; OCPD has perfectionism/control without obsessions",
      "OCPD is more severe",
      "OCD is a personality disorder"
    ],
    "correctAnswer": 1,
    "rationale": "Ketamine: NMDA antagonist. Rapid antidepressant effects within hours. Esketamine nasal spray FDA-approved treatment-resistant depression. (FDA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 114,
    "question": "What are the negative symptoms of schizophrenia?",
    "options": [
      "Hallucinations, delusions",
      "Flat affect, avolition, alogia, anhedonia, asociality",
      "Aggression, agitation",
      "Paranoia"
    ],
    "correctAnswer": 1,
    "rationale": "Esketamine (Spravato): intranasal ketamine. Requires REMS program. Administration in office, monitoring 2 hours post-dose. (FDA REMS)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 115,
    "question": "What are the positive symptoms of schizophrenia?",
    "options": [
      "Flat affect, apathy",
      "Hallucinations, delusions, disorganized speech",
      "Social withdrawal",
      "Lack of motivation"
    ],
    "correctAnswer": 1,
    "rationale": "Depression with psychotic features: antidepressant + antipsychotic required. ECT highly effective. Higher relapse risk. (APA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 116,
    "question": "What is the minimum duration for schizophrenia diagnosis?",
    "options": [
      "1 month",
      "3 months",
      "6 months",
      "1 year"
    ],
    "correctAnswer": 2,
    "rationale": "Catatonia: stupor, mutism, posturing, waxy flexibility. Medical emergency. Benzodiazepines first-line, ECT if refractory. (DSM-5-TR)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 117,
    "question": "What is brief psychotic disorder?",
    "options": [
      "Psychotic symptoms lasting <1 month",
      "Psychotic symptoms lasting 1-6 months",
      "Psychotic symptoms lasting >6 months",
      "No time limit"
    ],
    "correctAnswer": 0,
    "rationale": "Lorazepam challenge: catatonia diagnosis/treatment. 1-2mg IV/IM. Response suggests catatonia. Repeat dosing effective. (APA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 118,
    "question": "What is schizophreniform disorder?",
    "options": [
      "Psychotic symptoms lasting <1 month",
      "Psychotic symptoms lasting 1-6 months",
      "Psychotic symptoms lasting >6 months",
      "Personality changes"
    ],
    "correctAnswer": 1,
    "rationale": "OCD first-line: SSRIs at higher doses than depression. Clomipramine most effective but side effects. Combine with ERP. (APA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 119,
    "question": "What is bipolar I disorder?",
    "options": [
      "Depressive episodes only",
      "At least one manic episode",
      "Hypomanic and depressive episodes",
      "Mixed episodes only"
    ],
    "correctAnswer": 1,
    "rationale": "ERP: exposure and response prevention. Gold standard OCD psychotherapy. Gradual exposure to fears, prevent compulsions. (APA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 120,
    "question": "What is bipolar II disorder?",
    "options": [
      "At least one manic episode",
      "Hypomanic and depressive episodes (no full mania)",
      "Depressive episodes only",
      "Rapid cycling only"
    ],
    "correctAnswer": 1,
    "rationale": "Clomipramine: tricyclic antidepressant, serotonergic. Most effective for OCD. Anticholinergic effects. Seizure risk dose-dependent. (FDA)",
    "category": "Diagnostic Criteria (DSM-5)"
  },
  {
    "id": 121,
    "question": "What is Tarasoff duty to warn?",
    "options": [
      "Warn patient of side effects",
      "Warn potential victim if patient makes credible threat",
      "Warn family of diagnosis",
      "Warn police of all crimes"
    ],
    "correctAnswer": 1,
    "rationale": "Tourette disorder: alpha-2 agonists (guanfacine, clonidine) first-line. Antipsychotics (haloperidol, pimozide) if severe. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 122,
    "question": "When can you break confidentiality?",
    "options": [
      "Never",
      "Threat to self/others, child/elder abuse, court order, patient consent",
      "Always",
      "Only with patient permission"
    ],
    "correctAnswer": 1,
    "rationale": "CBIT: comprehensive behavioral intervention for tics. Habit reversal training. Evidence-based, first-line. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 123,
    "question": "What is informed consent?",
    "options": [
      "Patient signs form",
      "Patient understands risks/benefits/alternatives and voluntarily agrees",
      "Family agrees",
      "Physician decides"
    ],
    "correctAnswer": 1,
    "rationale": "Autism spectrum disorder medications: no FDA-approved for core symptoms. Risperidone, aripiprazole FDA-approved for irritability. (FDA/APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 124,
    "question": "At what age can a minor consent to mental health treatment (varies by state)?",
    "options": [
      "12-14 years (varies)",
      "18 years only",
      "21 years only",
      "Never"
    ],
    "correctAnswer": 0,
    "rationale": "ABA: applied behavior analysis. Evidence-based autism intervention. Intensive early intervention improves outcomes. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 125,
    "question": "What is the difference between competence and capacity?",
    "options": [
      "No difference",
      "Competence is legal determination by court; Capacity is clinical assessment",
      "Capacity is legal; Competence is clinical",
      "They mean the same thing"
    ],
    "correctAnswer": 1,
    "rationale": "Intellectual disability: antipsychotics for aggression, mood stabilizers for affective symptoms. Start low, go slow. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 126,
    "question": "What is Habeas Corpus?",
    "options": [
      "Right to treatment",
      "Right to hearing/review of involuntary commitment",
      "Right to refuse treatment",
      "Right to attorney"
    ],
    "correctAnswer": 1,
    "rationale": "Enuresis: desmopressin or TCA (imipramine). Behavioral interventions first-line. Rule out UTI, diabetes, anatomical issues. (AAP)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 127,
    "question": "What are the criteria for involuntary commitment?",
    "options": [
      "Mental illness only",
      "Mental illness AND danger to self/others or gravely disabled",
      "Family request",
      "Homelessness"
    ],
    "correctAnswer": 1,
    "rationale": "Desmopressin: synthetic ADH. Reduces nocturnal urine production. Nasal spray or tablets. Risk of hyponatremia if overhydration. (FDA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 128,
    "question": "What is the difference between voluntary and involuntary admission?",
    "options": [
      "No difference",
      "Voluntary = patient consents; Involuntary = court-ordered for danger to self/others",
      "Voluntary is shorter",
      "Involuntary is always permanent"
    ],
    "correctAnswer": 1,
    "rationale": "Anorexia nervosa: family-based treatment (adolescents), CBT-E (adults). SSRIs after weight restoration. Medical monitoring essential. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 129,
    "question": "Can a patient on involuntary hold refuse medication?",
    "options": [
      "No, never",
      "Yes, unless court-ordered or emergency",
      "Only if family agrees",
      "Always"
    ],
    "correctAnswer": 1,
    "rationale": "Refeeding syndrome: hypophosphatemia, hypokalemia, hypomagnesemia during nutrition restoration. Monitor electrolytes closely. Can be fatal. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 130,
    "question": "What is the ANA Code of Ethics?",
    "options": [
      "Law",
      "Standard of care and professional conduct",
      "Hospital policy",
      "Insurance requirement"
    ],
    "correctAnswer": 1,
    "rationale": "Bulimia nervosa: CBT most effective. Fluoxetine 60mg FDA-approved. Higher dose than depression. (FDA/APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 131,
    "question": "What is the scope of practice for NPs?",
    "options": [
      "Same as physicians",
      "Varies by state - generally independent or collaborative practice",
      "Always requires supervision",
      "No prescriptive authority"
    ],
    "correctAnswer": 1,
    "rationale": "Binge eating disorder: lisdexamfetamine FDA-approved. CBT, IPT effective. SSRIs off-label. (FDA/APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 132,
    "question": "Can NPs prescribe controlled substances?",
    "options": [
      "No",
      "Yes, with DEA number (varies by state/schedule)",
      "Only non-controlled",
      "Only with physician present"
    ],
    "correctAnswer": 1,
    "rationale": "Personality disorders: psychotherapy primary treatment. Medications target symptom domains, not disorder. DBT for borderline. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 133,
    "question": "What is required for telepsychiatry?",
    "options": [
      "Nothing special",
      "Licensure in patient's state, HIPAA-compliant platform, informed consent",
      "Same state only",
      "Physician oversight"
    ],
    "correctAnswer": 1,
    "rationale": "DBT: dialectical behavior therapy. Evidence-based for borderline personality disorder. Reduces self-harm, suicidality. Four modules: mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 134,
    "question": "What is the highest level of evidence for clinical practice?",
    "options": [
      "Expert opinion",
      "Case studies",
      "Systematic reviews/Meta-analyses of RCTs",
      "Single RCT"
    ],
    "correctAnswer": 2,
    "rationale": "Borderline personality disorder medications: mood stabilizers for impulsivity, antipsychotics for cognitive-perceptual symptoms. No FDA-approved medications. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 135,
    "question": "What is evidence-based practice?",
    "options": [
      "Using only research",
      "Integrating best evidence, clinical expertise, and patient values",
      "Following protocols only",
      "Ignoring patient preferences"
    ],
    "correctAnswer": 1,
    "rationale": "Antisocial personality disorder: no effective pharmacotherapy. Cognitive-behavioral interventions. Focus on comorbid conditions. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 136,
    "question": "What should you do if you make a medication error?",
    "options": [
      "Hide it",
      "Report it immediately, assess patient, notify provider, document",
      "Tell patient later",
      "Ignore if no harm"
    ],
    "correctAnswer": 1,
    "rationale": "Delirium: acute confusion, inattention, fluctuating course. Medical emergency. Identify underlying cause. Haloperidol for severe agitation. (APA/DSM-5-TR)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 137,
    "question": "What is a sentinel event?",
    "options": [
      "Minor error",
      "Unexpected occurrence involving death or serious injury",
      "Near miss",
      "Patient complaint"
    ],
    "correctAnswer": 1,
    "rationale": "Delirium vs dementia: delirium acute onset, fluctuating, reversible. Dementia gradual onset, progressive, irreversible. (DSM-5-TR)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 138,
    "question": "What is the purpose of peer review?",
    "options": [
      "Punishment",
      "Quality improvement and professional development",
      "Gossip",
      "Competition"
    ],
    "correctAnswer": 1,
    "rationale": "Delirium management: treat underlying cause, reorientation, avoid restraints. Minimize anticholinergics, benzodiazepines. (APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 139,
    "question": "What is collaborative practice?",
    "options": [
      "Working alone",
      "Interprofessional teamwork for patient-centered care",
      "Nurse-only care",
      "Physician-only decisions"
    ],
    "correctAnswer": 1,
    "rationale": "Dementia types: Alzheimer's 60-80%, vascular 10%, Lewy body 5%, frontotemporal 5%. Different patterns. (DSM-5-TR)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 140,
    "question": "What is the role of case management?",
    "options": [
      "Direct patient care only",
      "Care coordination, resource linkage, advocacy",
      "Medication management only",
      "Documentation only"
    ],
    "correctAnswer": 1,
    "rationale": "Alzheimer's disease: progressive memory loss, executive dysfunction. Cholinesterase inhibitors provide modest benefit. (FDA/APA)",
    "category": "Ethics & Legal Issues"
  },
  {
    "id": 141,
    "question": "A Hispanic patient believes \"susto\" (fright) caused their illness. How should you respond?",
    "options": [
      "Dismiss it as superstition",
      "Respect cultural belief and incorporate into treatment plan",
      "Argue against it",
      "Ignore it"
    ],
    "correctAnswer": 1,
    "rationale": "Donepezil: cholinesterase inhibitor. FDA-approved mild-severe Alzheimer's. GI side effects common. 5-10mg daily. (FDA)",
    "category": "Cultural Competence"
  },
  {
    "id": 142,
    "question": "A Native American patient wants to use traditional healing. What should you do?",
    "options": [
      "Forbid it",
      "Respect and integrate with Western treatment if safe",
      "Require Western treatment only",
      "Refer out"
    ],
    "correctAnswer": 1,
    "rationale": "Rivastigmine: cholinesterase inhibitor. FDA-approved Alzheimer's, Parkinson's dementia. Patch reduces GI side effects. (FDA)",
    "category": "Cultural Competence"
  },
  {
    "id": 143,
    "question": "Which demographic group has the HIGHEST suicide completion rate?",
    "options": [
      "Teenage females",
      "White males in midlife (40-60)",
      "Elderly females",
      "Young adult males"
    ],
    "correctAnswer": 1,
    "rationale": "Galantamine: cholinesterase inhibitor. FDA-approved Alzheimer's. Modulates nicotinic receptors. Titrate slowly. (FDA)",
    "category": "Cultural Competence"
  },
  {
    "id": 144,
    "question": "What is important to know about LGBTQ+ youth mental health?",
    "options": [
      "No differences",
      "Higher rates of depression, anxiety, suicide attempts; need affirming care",
      "Lower risk",
      "Same as general population"
    ],
    "correctAnswer": 1,
    "rationale": "Memantine: NMDA antagonist. FDA-approved moderate-severe Alzheimer's. Can combine with cholinesterase inhibitor. Well-tolerated. (FDA)",
    "category": "Cultural Competence"
  },
  {
    "id": 145,
    "question": "What is trauma-informed care?",
    "options": [
      "Only for PTSD patients",
      "Recognizing impact of trauma, ensuring safety, trustworthiness, empowerment",
      "Forcing disclosure",
      "Ignoring trauma history"
    ],
    "correctAnswer": 1,
    "rationale": "Lewy body dementia: visual hallucinations, parkinsonism, fluctuating cognition. Extreme antipsychotic sensitivity. Use low-dose quetiapine if needed. (APA)",
    "category": "Cultural Competence"
  },
  {
    "id": 146,
    "question": "What should you do first when a patient discloses rape?",
    "options": [
      "Call police",
      "Reassure safety, provide support",
      "Get detailed history",
      "Perform exam immediately"
    ],
    "correctAnswer": 1,
    "rationale": "Frontotemporal dementia: behavioral changes, language impairment. Earlier onset than Alzheimer's. No FDA-approved medications. (APA)",
    "category": "Cultural Competence"
  },
  {
    "id": 147,
    "question": "What is important about treating elderly patients with psychiatric medications?",
    "options": [
      "Use same doses as adults",
      "Start low, go slow; more sensitive to side effects",
      "Avoid all medications",
      "Always use maximum doses"
    ],
    "correctAnswer": 1,
    "rationale": "Vascular dementia: stepwise decline, cerebrovascular disease. Manage vascular risk factors. Cholinesterase inhibitors may help. (APA)",
    "category": "Cultural Competence"
  },
  {
    "id": 148,
    "question": "What is important about treating pregnant patients with psychiatric medications?",
    "options": [
      "Stop all medications",
      "Assess risks vs. benefits; use safest options; get pregnancy test before starting",
      "Use any medication",
      "Always continue all medications"
    ],
    "correctAnswer": 1,
    "rationale": "Sundowning: increased confusion, agitation in evening. Dementia patients. Increase light exposure, structure. Avoid sedatives if possible. (APA)",
    "category": "Cultural Competence"
  },
  {
    "id": 149,
    "question": "Which mood stabilizer has the HIGHEST risk of neural tube defects in pregnancy?",
    "options": [
      "Lithium",
      "Depakote (Valproic Acid) - causes spina bifida",
      "Lamictal",
      "Carbamazepine"
    ],
    "correctAnswer": 1,
    "rationale": "Agitation in dementia: nonpharmacologic first-line. Music, activities, routine. Antipsychotics FDA black box warning increased mortality. (FDA)",
    "category": "Cultural Competence"
  },
  {
    "id": 150,
    "question": "Which mood stabilizer is the SAFEST in pregnancy?",
    "options": [
      "Lithium",
      "Depakote",
      "Lamictal (Lamotrigine)",
      "Carbamazepine"
    ],
    "correctAnswer": 2,
    "rationale": "Antipsychotics in dementia: increased mortality risk (1.6-1.7x). Use only if severe symptoms, risk/benefit. Lowest dose, shortest duration. (FDA Black Box)",
    "category": "Cultural Competence"
  },
  {
    "id": 151,
    "question": "What should you assess in a child with ADHD before starting stimulants?",
    "options": [
      "Nothing",
      "Cardiac history, family history of sudden death, baseline BP/HR",
      "IQ only",
      "Academic performance only"
    ],
    "correctAnswer": 1,
    "rationale": "Major depressive disorder criteria: 5+ symptoms 2+ weeks, including depressed mood or anhedonia. Significant impairment. (DSM-5-TR)",
    "category": "Cultural Competence"
  },
  {
    "id": 152,
    "question": "What is the first-line medication for pediatric ADHD?",
    "options": [
      "Antipsychotics",
      "Stimulants (Methylphenidate or Amphetamine)",
      "Antidepressants",
      "Benzodiazepines"
    ],
    "correctAnswer": 1,
    "rationale": "PHQ-9: depression screening tool. 9 items based on DSM criteria. Score ≥10 suggests depression. Monitors treatment response. (APA/USPSTF)",
    "category": "Cultural Competence"
  },
  {
    "id": 153,
    "question": "What is the first-line medication for pediatric anxiety?",
    "options": [
      "Benzodiazepines",
      "SSRIs (Zoloft, Prozac)",
      "Antipsychotics",
      "Beta blockers"
    ],
    "correctAnswer": 1,
    "rationale": "GAD-7: anxiety screening tool. 7 items. Score ≥10 suggests GAD. Score ≥15 severe anxiety. (APA/USPSTF)",
    "category": "Cultural Competence"
  },
  {
    "id": 154,
    "question": "What is the first-line medication for pediatric depression?",
    "options": [
      "TCAs",
      "SSRIs (Prozac, Lexapro)",
      "MAOIs",
      "Benzodiazepines"
    ],
    "correctAnswer": 1,
    "rationale": "AUDIT: alcohol use disorder screening. 10 items. Score ≥8 suggests harmful drinking. (WHO)",
    "category": "Cultural Competence"
  },
  {
    "id": 155,
    "question": "What is the priority in crisis intervention?",
    "options": [
      "Medication",
      "Safety assessment",
      "Psychotherapy",
      "Discharge planning"
    ],
    "correctAnswer": 1,
    "rationale": "CAGE: brief alcohol screening. 4 questions. ≥2 positive suggests problem drinking. Cut down, Annoyed, Guilty, Eye-opener. (Primary Care)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 156,
    "question": "A patient says \"I want to kill myself and I have a gun at home.\" What is your immediate action?",
    "options": [
      "Schedule follow-up",
      "Safety assessment, remove access to means, possible hospitalization",
      "Prescribe antidepressant",
      "Send home with family"
    ],
    "correctAnswer": 1,
    "rationale": "DAST: drug abuse screening test. Identifies drug use problems. 10 or 28 item versions. (NIDA)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 157,
    "question": "What is the difference between suicidal ideation and suicidal intent?",
    "options": [
      "No difference",
      "Ideation = thoughts; Intent = plan and determination to act",
      "Intent is less serious",
      "Ideation always requires hospitalization"
    ],
    "correctAnswer": 1,
    "rationale": "MMSE: mini-mental state exam. 30-point cognitive screening. Score <24 suggests cognitive impairment. Not copyrighted. (Neurology)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 158,
    "question": "What are protective factors against suicide?",
    "options": [
      "Access to firearms",
      "Social support, reasons for living, religious beliefs, access to care",
      "Isolation",
      "Substance use"
    ],
    "correctAnswer": 1,
    "rationale": "MoCA: Montreal cognitive assessment. More sensitive than MMSE. 30 points. Assesses multiple domains. Free. (Neurology)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 159,
    "question": "What is the risk of suicide immediately after psychiatric hospitalization discharge?",
    "options": [
      "No risk",
      "HIGHEST risk period (first week, especially first 24-48 hours)",
      "Lower risk",
      "Same as general population"
    ],
    "correctAnswer": 1,
    "rationale": "Suicidal ideation assessment: ask directly about thoughts, plans, means, intent. Does NOT increase risk. (APA/CAMS)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 160,
    "question": "A patient is agitated, threatening staff, and psychotic. What is the least restrictive intervention?",
    "options": [
      "Physical restraints immediately",
      "Verbal de-escalation first",
      "Seclusion",
      "Chemical restraint"
    ],
    "correctAnswer": 1,
    "rationale": "Columbia Suicide Severity Rating Scale (C-SSRS): standardized tool. Assesses ideation severity, behavior. Widely used. (NIMH)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 161,
    "question": "When are restraints/seclusion appropriate?",
    "options": [
      "For convenience",
      "Only when imminent danger to self/others and less restrictive failed",
      "For punishment",
      "Anytime patient is difficult"
    ],
    "correctAnswer": 1,
    "rationale": "Suicide risk factors: prior attempts, psychiatric illness, substance use, access to means, hopelessness, male gender, isolation. (APA/CDC)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 162,
    "question": "What must you do when patient is in restraints?",
    "options": [
      "Leave them alone",
      "Q15min checks, document, offer food/water/bathroom, remove ASAP",
      "Keep them as long as needed",
      "No monitoring needed"
    ],
    "correctAnswer": 1,
    "rationale": "Suicide protective factors: social support, coping skills, treatment engagement, reasons for living, restricted means access. (APA)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 163,
    "question": "A patient threatens to kill their neighbor. What is your legal obligation?",
    "options": [
      "Maintain confidentiality",
      "Tarasoff duty to warn - notify potential victim and authorities",
      "Do nothing",
      "Only document"
    ],
    "correctAnswer": 1,
    "rationale": "Safety planning: written plan for coping with suicidal thoughts. Warning signs, coping strategies, contacts, reducing means access. (Stanley-Brown)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 164,
    "question": "What is the difference between danger to self and gravely disabled?",
    "options": [
      "Same thing",
      "Danger to self = suicide/self-harm risk; Gravely disabled = cannot meet basic needs",
      "Gravely disabled is less serious",
      "No difference"
    ],
    "correctAnswer": 1,
    "rationale": "Means restriction: remove lethal means (firearms, medications). Most effective suicide prevention intervention. Counseling families essential. (CDC/APA)",
    "category": "Crisis & Emergency Management"
  },
  {
    "id": 165,
    "question": "What is integrated care?",
    "options": [
      "Mental health only",
      "Medical only",
      "Collaborative mental health and medical care in same setting",
      "Separate systems"
    ],
    "correctAnswer": 2,
    "rationale": "Involuntary commitment criteria: danger to self/others/gravely disabled. Varies by state. Least restrictive alternative principle. (State Law)",
    "category": "Integrated Care"
  },
  {
    "id": 166,
    "question": "What medical conditions can mimic depression?",
    "options": [
      "None",
      "Hypothyroidism, anemia, vitamin deficiencies, chronic illness",
      "Only diabetes",
      "Only heart disease"
    ],
    "correctAnswer": 1,
    "rationale": "Tarasoff duty: warn identifiable victim of serious threat. Varies by state. Balance confidentiality with safety. (Case Law)",
    "category": "Integrated Care"
  },
  {
    "id": 167,
    "question": "What medical conditions can mimic anxiety?",
    "options": [
      "None",
      "Hyperthyroidism, cardiac arrhythmias, hypoglycemia, medication side effects",
      "Only cancer",
      "Only COPD"
    ],
    "correctAnswer": 1,
    "rationale": "Confidentiality exceptions: imminent danger, child/elder abuse, court order, patient consent. HIPAA protections. (HIPAA/Ethics)",
    "category": "Integrated Care"
  },
  {
    "id": 168,
    "question": "What labs should you check before diagnosing depression?",
    "options": [
      "None",
      "TSH, CBC, CMP, Vitamin D, B12",
      "Only TSH",
      "Only CBC"
    ],
    "correctAnswer": 1,
    "rationale": "Mandated reporting: suspected child/elder abuse. Report to appropriate agency. Immunity for good faith reporting. (State Law)",
    "category": "Integrated Care"
  },
  {
    "id": 169,
    "question": "What is the biopsychosocial model?",
    "options": [
      "Biology only",
      "Holistic approach considering biological, psychological, and social factors",
      "Psychology only",
      "Social factors only"
    ],
    "correctAnswer": 1,
    "rationale": "Informed consent: capacity, disclosure, understanding, voluntariness. Document discussion. Required for treatment. (Ethics/Law)",
    "category": "Integrated Care"
  },
  {
    "id": 170,
    "question": "What is harm reduction?",
    "options": [
      "Abstinence-only approach",
      "Practical strategies to reduce negative consequences without requiring abstinence",
      "Punishment",
      "Enabling"
    ],
    "correctAnswer": 1,
    "rationale": "Capacity assessment: understand information, appreciate situation, reason, express choice. Specific to decision. (Ethics)",
    "category": "Integrated Care"
  },
  {
    "id": 171,
    "question": "What is medication-assisted treatment (MAT) for opioid use disorder?",
    "options": [
      "Abstinence only",
      "Buprenorphine/Methadone + counseling",
      "Punishment",
      "Detox only"
    ],
    "correctAnswer": 1,
    "rationale": "Therapeutic alliance: collaborative relationship. Empathy, genuineness, positive regard. Predicts outcomes. (Psychotherapy Research)",
    "category": "Integrated Care"
  },
  {
    "id": 172,
    "question": "What is the Stages of Change model (Transtheoretical Model)?",
    "options": [
      "One-step process",
      "Precontemplation, Contemplation, Preparation, Action, Maintenance, Relapse",
      "Change happens randomly",
      "No stages"
    ],
    "correctAnswer": 1,
    "rationale": "Motivational interviewing: patient-centered approach. Explores ambivalence. OARS: open questions, affirmations, reflections, summaries. (MI Network)",
    "category": "Integrated Care"
  },
  {
    "id": 173,
    "question": "What intervention matches the contemplation stage?",
    "options": [
      "Action plan",
      "Motivational interviewing to increase motivation",
      "Maintenance strategies",
      "No intervention"
    ],
    "correctAnswer": 1,
    "rationale": "CBT: cognitive behavioral therapy. Identifies/modifies maladaptive thoughts, behaviors. Evidence-based for depression, anxiety. Structured, time-limited. (APA)",
    "category": "Integrated Care"
  },
  {
    "id": 174,
    "question": "Can NPs recommend medical marijuana?",
    "options": [
      "No, never",
      "Varies by state - know your state laws",
      "Yes, always",
      "Only with physician approval"
    ],
    "correctAnswer": 1,
    "rationale": "Cognitive distortions: all-or-nothing thinking, catastrophizing, overgeneralization, personalization. Targets in CBT. (Beck/Burns)",
    "category": "Integrated Care"
  },
  {
    "id": 175,
    "question": "Which class of antidepressants works by inhibiting presynaptic reuptake and increasing serotonin levels in the CNS?",
    "options": [
      "Tricyclic antidepressants (TCAs)",
      "Selective serotonin reuptake inhibitors (SSRIs)",
      "Monoamine oxidase inhibitors (MAOIs)",
      "Norepinephrine dopamine reuptake inhibitors (NDRIs)"
    ],
    "correctAnswer": 1,
    "rationale": "ACT: acceptance and commitment therapy. Psychological flexibility. Accept unwanted experiences, commit to values-based action. Mindfulness-based. (ACT Research)",
    "category": "Antidepressants - Pharmacology"
  },
  {
    "id": 176,
    "question": "Tricyclic antidepressants (TCAs) elevate serotonin and norepinephrine levels primarily by:",
    "options": [
      "Inhibiting their presynaptic reuptake",
      "Blocking postsynaptic receptors",
      "Inhibiting monoamine oxidase",
      "Acting as serotonin agonists"
    ],
    "correctAnswer": 0,
    "rationale": "Psychodynamic therapy: explores unconscious processes, past experiences. Insight-oriented. Longer-term. Evidence for depression, anxiety. (APA)",
    "category": "Antidepressants - Pharmacology"
  },
  {
    "id": 177,
    "question": "What is the mechanism of action of Monoamine Oxidase Inhibitors (MAOIs)?",
    "options": [
      "They inhibit presynaptic reuptake",
      "They inhibit MAO, the enzyme that breaks down monoamine neurotransmitters",
      "They block postsynaptic receptors",
      "They increase neurotransmitter synthesis"
    ],
    "correctAnswer": 1,
    "rationale": "Transference: patient projects feelings onto therapist. Therapeutic tool in psychodynamic work. (Psychoanalytic Theory)",
    "category": "Antidepressants - Pharmacology"
  },
  {
    "id": 178,
    "question": "Serotonin-norepinephrine reuptake inhibitors (SNRIs) have which mechanism of action?",
    "options": [
      "They only inhibit serotonin reuptake",
      "They inhibit dual reuptake of norepinephrine and serotonin, acting selectively on neurotransmitters",
      "They inhibit MAO enzyme",
      "They act as dopamine agonists"
    ],
    "correctAnswer": 1,
    "rationale": "Countertransference: therapist's emotional reaction to patient. Requires awareness, supervision. Can inform understanding or bias treatment. (Psychoanalytic Theory)",
    "category": "Antidepressants - Pharmacology"
  },
  {
    "id": 179,
    "question": "Norepinephrine dopamine reuptake inhibitors (NDRIs) work by:",
    "options": [
      "Inhibiting serotonin reuptake only",
      "Inhibiting dual reuptake of norepinephrine and dopamine",
      "Blocking MAO enzyme",
      "Increasing acetylcholine levels"
    ],
    "correctAnswer": 1,
    "rationale": "Group therapy: therapeutic in group setting. Universality, cohesion, interpersonal learning. Cost-effective. Many theoretical orientations. (Yalom)",
    "category": "Antidepressants - Pharmacology"
  },
  {
    "id": 180,
    "question": "Serotonin agonist and reuptake inhibitors (SARIs) have which dual action?",
    "options": [
      "They block dopamine receptors and inhibit reuptake",
      "They act as agonists of serotonin 5HT-2 receptors and elevate serotonin levels by inhibiting serotonin reuptake",
      "They inhibit MAO and reuptake",
      "They block histamine and serotonin"
    ],
    "correctAnswer": 1,
    "rationale": "Family therapy: systems approach. Addresses relational patterns. Evidence-based for adolescent substance use, eating disorders, schizophrenia. (AAMFT)",
    "category": "Antidepressants - Pharmacology"
  },
  {
    "id": 181,
    "question": "SSRI Discontinuation Syndrome is characterized by a lack of:",
    "options": [
      "Dopamine and energy",
      "Serotonin and sleep",
      "Norepinephrine and motivation",
      "GABA and relaxation"
    ],
    "correctAnswer": 1,
    "rationale": "Stages of change: precontemplation, contemplation, preparation, action, maintenance. Tailor interventions to stage. (Prochaska/DiClemente)",
    "category": "Antidepressants - Adverse Effects"
  },
  {
    "id": 182,
    "question": "Which of the following is a symptom of SSRI Discontinuation Syndrome?",
    "options": [
      "Hypertension",
      "Flu-like symptoms, fatigue, lethargy",
      "Seizures",
      "Hyperthermia"
    ],
    "correctAnswer": 1,
    "rationale": "Defense mechanisms: unconscious processes managing anxiety. Mature (humor, sublimation) vs immature (denial, projection). (Freud/Vaillant)",
    "category": "Antidepressants - Adverse Effects"
  },
  {
    "id": 183,
    "question": "A patient on SSRIs presents with myalgia, nausea/vomiting, impaired memory, paresthesias, shock-like sensations, irritability, anxiety, insomnia, and crying without provocation. What is the most likely diagnosis?",
    "options": [
      "Serotonin Syndrome",
      "SSRI Discontinuation Syndrome",
      "Neuroleptic Malignant Syndrome",
      "Anticholinergic toxicity"
    ],
    "correctAnswer": 1,
    "rationale": "Trauma-informed care: recognizes trauma prevalence, impact. Safety, trustworthiness, collaboration, empowerment. Avoids re-traumatization. (SAMHSA)",
    "category": "Antidepressants - Adverse Effects"
  },
  {
    "id": 184,
    "question": "What are risk factors for SSRI Discontinuation Syndrome?",
    "options": [
      "Long half-life medications and gradual taper",
      "Medications with short half-life, abrupt discontinuation, noncompliance, high dose, long-term treatment",
      "Low dose and short-term use",
      "Use of adjunct medications"
    ],
    "correctAnswer": 1,
    "rationale": "Adverse childhood experiences (ACEs): trauma, abuse, neglect. Cumulative dose-response with health outcomes. Screen, address. (CDC)",
    "category": "Antidepressants - Adverse Effects"
  },
  {
    "id": 185,
    "question": "A patient on antidepressants presents with confusion, delirium, agitation, irritability, ataxia, and incoordination. The mnemonic 'PACU PATIENTS' helps identify which syndrome?",
    "options": [
      "SSRI Discontinuation Syndrome",
      "Serotonin Syndrome",
      "Anticholinergic syndrome",
      "Lithium toxicity"
    ],
    "correctAnswer": 1,
    "rationale": "Attachment theory: early relationships shape internal working models. Secure, anxious, avoidant, disorganized styles. Impacts adult relationships. (Bowlby/Ainsworth)",
    "category": "Serotonin Syndrome"
  },
  {
    "id": 186,
    "question": "Which of the following is part of the severe manifestations of Serotonin Syndrome?",
    "options": [
      "Bradycardia and hypothermia",
      "Tremor, seizure, respiratory depression, cyanosis, and coma",
      "Constipation and urinary retention",
      "Hypothyroidism and weight loss"
    ],
    "correctAnswer": 1,
    "rationale": "Cultural competence: awareness, knowledge, skills for diverse populations. Ask about beliefs, involve family, use interpreters. (APA/CLAS Standards)",
    "category": "Serotonin Syndrome"
  },
  {
    "id": 187,
    "question": "Additional signs of Serotonin Syndrome include:",
    "options": [
      "Hyporeflexia and bradycardia",
      "Hyperreflexia, diaphoresis, nausea, vomiting, abdominal pain, and tachycardia",
      "Dry skin and constipation",
      "Hypothermia and sedation"
    ],
    "correctAnswer": 1,
    "rationale": "Health literacy: ability to understand health information. Use plain language, teach-back method. Critical for adherence. (IOM)",
    "category": "Serotonin Syndrome"
  },
  {
    "id": 188,
    "question": "Which of the following drugs is MOST likely to cause Serotonin Syndrome?",
    "options": [
      "Lithium",
      "L-Tryptophan",
      "Haloperidol",
      "Lorazepam"
    ],
    "correctAnswer": 1,
    "rationale": "Shared decision-making: collaborative process. Present options, discuss risks/benefits, incorporate preferences. Improves outcomes, satisfaction. (APA/AHRQ)",
    "category": "Serotonin Syndrome"
  },
  {
    "id": 189,
    "question": "All of the following can cause Serotonin Syndrome EXCEPT:",
    "options": [
      "Trazadone",
      "Buspirone",
      "Diphenhydramine",
      "Cocaine"
    ],
    "correctAnswer": 2,
    "rationale": "Pharmacogenomics: genetic variations affect drug metabolism. CYP450 testing can guide medication selection. Clinical utility evolving. (FDA/CPIC)",
    "category": "Serotonin Syndrome"
  },
  {
    "id": 190,
    "question": "Meperidine was noted by Sadock (2021) to be associated with:",
    "options": [
      "Anticholinergic crisis",
      "Serotonin Syndrome",
      "Neuroleptic Malignant Syndrome",
      "Lithium toxicity"
    ],
    "correctAnswer": 1,
    "rationale": "CYP2D6: metabolizes many antidepressants, antipsychotics, opioids. Poor/ultrarapid metabolizers affect dosing. Genetic testing available. (CPIC)",
    "category": "Serotonin Syndrome"
  },
  {
    "id": 191,
    "question": "A patient on lithium presents with weight gain and impaired thyroid functioning. What is the most likely thyroid condition?",
    "options": [
      "Hyperthyroidism",
      "Hypothyroidism",
      "Thyroid storm",
      "Thyroiditis"
    ],
    "correctAnswer": 1,
    "rationale": "CYP2C19: metabolizes SSRIs (escitalopram, citalopram, sertraline). Poor/rapid metabolizers affect levels. Consider testing if treatment resistance. (CPIC)",
    "category": "Lithium - Side Effects"
  },
  {
    "id": 192,
    "question": "Which of the following CNS side effects is associated with lithium?",
    "options": [
      "Seizures and hallucinations",
      "Fine hand tremors, fatigue, mental cloudiness, headaches",
      "Muscle rigidity and hyperthermia",
      "Hyperactivity and insomnia"
    ],
    "correctAnswer": 1,
    "rationale": "CYP3A4: major drug metabolizer. Induced by carbamazepine, St John's wort. Inhibited by grapefruit, azole antifungals. (FDA)",
    "category": "Lithium - Side Effects"
  },
  {
    "id": 193,
    "question": "What dermatological side effects are associated with lithium?",
    "options": [
      "Urticaria and angioedema",
      "Maculopapular rash, pruritus, and acne",
      "Stevens-Johnson syndrome",
      "Photosensitivity"
    ],
    "correctAnswer": 1,
    "rationale": "CYP1A2: metabolizes clozapine, caffeine. Induced by smoking. Clozapine dose often 2x higher in smokers. Monitor if smoking cessation. (Stahl's)",
    "category": "Lithium - Side Effects"
  },
  {
    "id": 194,
    "question": "Which gastrointestinal side effects are commonly seen with lithium?",
    "options": [
      "Constipation and bloating",
      "GI upset, diarrhea, vomiting, cramps, anorexia",
      "Gastric bleeding",
      "Hepatotoxicity"
    ],
    "correctAnswer": 1,
    "rationale": "Smoking cessation in psychiatric patients: clozapine, olanzapine levels increase significantly. Reduce dose 25-50% upon quitting. Monitor closely. (Stahl's)",
    "category": "Lithium - Side Effects"
  },
  {
    "id": 195,
    "question": "What renal side effects are associated with lithium use?",
    "options": [
      "Acute tubular necrosis",
      "Polyuria with related polydipsia, diabetes insipidus, edema, microscopic tubular changes",
      "Glomerulonephritis",
      "Renal calculi"
    ],
    "correctAnswer": 1,
    "rationale": "Grapefruit juice: potent CYP3A4 inhibitor. Increases levels of carbamazepine, buspirone, quetiapine, lurasidone, others. Avoid combination. (FDA)",
    "category": "Lithium - Side Effects"
  },
  {
    "id": 196,
    "question": "What cardiac side effects can lithium cause?",
    "options": [
      "QTc prolongation and torsades de pointes",
      "T-wave inversions and dysrhythmias",
      "Heart block and bradycardia",
      "Hypertensive crisis"
    ],
    "correctAnswer": 1,
    "rationale": "St John's wort: CYP3A4 inducer. Decreases levels many medications. Serotonergic, can cause serotonin syndrome. Avoid with antidepressants. (FDA)",
    "category": "Lithium - Side Effects"
  },
  {
    "id": 197,
    "question": "Which hematological side effect is associated with lithium?",
    "options": [
      "Thrombocytopenia",
      "Leukocytosis",
      "Anemia",
      "Neutropenia"
    ],
    "correctAnswer": 1,
    "rationale": "Omega-3 fatty acids: adjunctive depression treatment. EPA 1-2g may benefit. Well-tolerated. More research needed. (APA)",
    "category": "Lithium - Side Effects"
  },
  {
    "id": 198,
    "question": "Which class of medications can cause depression?",
    "options": [
      "Antibiotics only",
      "Beta blockers, steroids, isotretinoin (Accutane), antineoplastic drugs, benzodiazepines, progesterone",
      "Antipsychotics only",
      "SSRIs and SNRIs"
    ],
    "correctAnswer": 1,
    "rationale": "Folate augmentation: l-methylfolate adjunct to antidepressants. 15mg dose. May help with inadequate response. (Studies)",
    "category": "Medications - Psychiatric Side Effects"
  },
  {
    "id": 199,
    "question": "Interferon (BABI RAPS, Sandra Lampkin, 22) is known to cause:",
    "options": [
      "Mania",
      "Depression",
      "Anxiety disorders",
      "Psychosis"
    ],
    "correctAnswer": 1,
    "rationale": "Vitamin D: deficiency associated with depression. Screening reasonable. Supplementation if deficient. Unclear if improves mood independently. (Research)",
    "category": "Medications - Psychiatric Side Effects"
  },
  {
    "id": 200,
    "question": "A patient is taking interferon and excitalopram, and now complains of depression. As a PMHNP, which medication is the likely cause of her depression?",
    "options": [
      "Excitalopram",
      "Interferon",
      "Both medications equally",
      "Neither medication"
    ],
    "correctAnswer": 1,
    "rationale": "Exercise: moderate evidence for depression, anxiety. Comparable to medications in some studies. Recommend 150 min/week. (APA/USPSTF)",
    "category": "Medications - Psychiatric Side Effects"
  },
  {
    "id": 201,
    "question": "Which medications can cause mania?",
    "options": [
      "Beta blockers and benzodiazepines",
      "Steroids, antidepressants, INH, disulfiran, and certain antibiotics (SAID)",
      "Antipsychotics and lithium",
      "Anticholinergics and antihistamines"
    ],
    "correctAnswer": 1,
    "rationale": "Mediterranean diet: associated with lower depression risk. Anti-inflammatory. Recommend as part of holistic care. (Research)",
    "category": "Medications - Psychiatric Side Effects"
  },
  {
    "id": 202,
    "question": "An example of steroids that can cause mania includes:",
    "options": [
      "Prednisone",
      "Dexamethasone or Flonace (belonging to corticosteroids)",
      "Testosterone",
      "Estrogen"
    ],
    "correctAnswer": 1,
    "rationale": "Sleep restriction therapy: part of CBT-I. Limits time in bed to actual sleep time. Increases sleep drive. (AASM)",
    "category": "Medications - Psychiatric Side Effects"
  },
  {
    "id": 203,
    "question": "What is the therapeutic plasma level of lithium carbonate?",
    "options": [
      "0.4-0.8 mEq/L",
      "0.6-1.2 mEq/L",
      "1.5-2.0 mEq/L",
      "2.0-3.0 mEq/L"
    ],
    "correctAnswer": 1,
    "rationale": "Stimulus control: associate bed with sleep only. No screens, eating in bed. Leave if not asleep in 20 min. (AASM)",
    "category": "Mood Stabilizers - Therapeutic Levels"
  },
  {
    "id": 204,
    "question": "What are common side effects of lithium carbonate?",
    "options": [
      "Hypertension and tachycardia",
      "Nausea, fine-hand tremors, increased urination and thirst",
      "Constipation and dry mouth",
      "Weight loss and insomnia"
    ],
    "correctAnswer": 1,
    "rationale": "Mindfulness meditation: present-moment awareness. Evidence for anxiety, depression, chronic pain. MBSR and MBCT structured programs. (Research)",
    "category": "Mood Stabilizers - Side Effects"
  },
  {
    "id": 205,
    "question": "What is a toxicity symptom of lithium?",
    "options": [
      "Mild nausea",
      "Slurred speech, confusion, severe GI effect",
      "Mild hand tremor",
      "Polyuria"
    ],
    "correctAnswer": 1,
    "rationale": "Progressive muscle relaxation: tense and release muscle groups. Reduces anxiety, improves sleep. Simple, teachable skill. (Relaxation Techniques)",
    "category": "Mood Stabilizers - Toxicity"
  },
  {
    "id": 206,
    "question": "Important comments about lithium carbonate include all of the following EXCEPT:",
    "options": [
      "Established standard treatment for bipolar disorder",
      "Pregnancy Category D",
      "Lactation Category L3",
      "Safe to use in first trimester of pregnancy"
    ],
    "correctAnswer": 3,
    "rationale": "Biofeedback: monitors physiological processes (heart rate, muscle tension). Learn self-regulation. Evidence for anxiety, headaches. (AAPB)",
    "category": "Mood Stabilizers - Safety"
  },
  {
    "id": 207,
    "question": "Concurrent use of NSAIDs and angiotensin-converting enzyme inhibitors (ACEi) may do what to lithium levels?",
    "options": [
      "Decrease lithium levels",
      "Double lithium level",
      "Have no effect",
      "Cause lithium toxicity immediately"
    ],
    "correctAnswer": 1,
    "rationale": "Light therapy: 10,000 lux 30 minutes morning. First-line seasonal affective disorder. Adjunct non-seasonal depression. (APA)",
    "category": "Mood Stabilizers - Drug Interactions"
  },
  {
    "id": 208,
    "question": "What is the therapeutic plasma level of carbamazepine (Tegretol)?",
    "options": [
      "2-6 mcg/ml",
      "6-12 mcg/ml",
      "12-20 mcg/ml",
      "20-30 mcg/ml"
    ],
    "correctAnswer": 1,
    "rationale": "Seasonal affective disorder: recurrent depression with seasonal pattern (fall/winter). Light therapy, bupropion XL FDA-approved. (DSM-5-TR/FDA)",
    "category": "Mood Stabilizers - Therapeutic Levels"
  },
  {
    "id": 209,
    "question": "Common side effects of carbamazepine include all of the following EXCEPT:",
    "options": [
      "Nausea, dizziness, sedation, headache",
      "Dry mouth, constipation, skin rash",
      "Weight loss and hyperactivity",
      "Agranulocytosis/aplastic anemia (rare)"
    ],
    "correctAnswer": 2,
    "rationale": "Perimenopause depression: hormonal fluctuations increase risk. SSRIs effective. Hormone therapy may help. Address vasomotor symptoms. (NAMS)",
    "category": "Mood Stabilizers - Side Effects"
  },
  {
    "id": 210,
    "question": "What rare but serious side effects are associated with carbamazepine?",
    "options": [
      "Mild sedation",
      "Agranulocytosis/aplastic anemia and Stevens-Johnson syndrome",
      "Weight gain",
      "Mild tremor"
    ],
    "correctAnswer": 1,
    "rationale": "Postpartum depression: onset within 4 weeks-1 year postpartum. Screen all postpartum women (EPDS). SSRIs safe in breastfeeding. (ACOG/APA)",
    "category": "Mood Stabilizers - Serious Adverse Effects"
  },
  {
    "id": 211,
    "question": "Important considerations for carbamazepine include all of the following EXCEPT:",
    "options": [
      "Hepatic enzyme inducer",
      "Monitor LFTs",
      "Safe during pregnancy",
      "Alternative to lithium or valproic acid"
    ],
    "correctAnswer": 2,
    "rationale": "Postpartum psychosis: rare, medical emergency. Onset within 2 weeks postpartum. Risk of infanticide. Requires hospitalization, antipsychotics. (APA)",
    "category": "Mood Stabilizers - Safety"
  },
  {
    "id": 212,
    "question": "For Asian patients, what screening should be done before initiating carbamazepine?",
    "options": [
      "CBC with differential",
      "Screen for HLA-B 1502 allele",
      "Thyroid function tests",
      "Liver function tests only"
    ],
    "correctAnswer": 1,
    "rationale": "Brexanolone (Zulresso): IV allopregnanolone. FDA-approved postpartum depression. 60-hour infusion. Requires REMS. Rapid onset. (FDA)",
    "category": "Mood Stabilizers - Screening"
  },
  {
    "id": 213,
    "question": "Valproic acid and divalproex sodium are effective for all of the following EXCEPT:",
    "options": [
      "Rapid cycling and mixed bipolar",
      "Depakote minimizes GI effects",
      "Treatment of schizophrenia",
      "More effective than lithium for rapid cycling"
    ],
    "correctAnswer": 2,
    "rationale": "Edinburgh Postnatal Depression Scale (EPDS): 10-item screening. Score ≥10 suggests depression. Question 10 assesses self-harm. (ACOG)",
    "category": "Mood Stabilizers - Indications"
  },
  {
    "id": 214,
    "question": "What is the therapeutic plasma level of valproic acid?",
    "options": [
      "25-75 mcg/ml",
      "50-125 mcg/ml",
      "100-200 mcg/ml",
      "150-250 mcg/ml"
    ],
    "correctAnswer": 1,
    "rationale": "Premenstrual dysphoric disorder (PMDD): severe mood symptoms luteal phase. Improves with menses. SSRIs effective (continuous or luteal). (DSM-5-TR)",
    "category": "Mood Stabilizers - Therapeutic Levels"
  },
  {
    "id": 215,
    "question": "Common side effects of valproic acid include:",
    "options": [
      "Constipation and dry mouth",
      "Nausea, diarrhea, abdominal cramps, sedation, tremor",
      "Hypertension and tachycardia",
      "Weight loss and insomnia"
    ],
    "correctAnswer": 1,
    "rationale": "Gender-affirming hormone therapy: testosterone, estrogen for transgender patients. Improves mental health outcomes. Psychiatric support important. (WPATH)",
    "category": "Mood Stabilizers - Side Effects"
  },
  {
    "id": 216,
    "question": "What rare but serious side effect is associated with valproic acid?",
    "options": [
      "Mild sedation",
      "Increased liver enzymes and Stevens-Johnson syndrome",
      "Mild tremor",
      "Constipation"
    ],
    "correctAnswer": 1,
    "rationale": "Testosterone effects: voice deepening, facial hair, muscle mass. Monitor lipids, hematocrit. Mood improvements. (WPATH)",
    "category": "Mood Stabilizers - Serious Adverse Effects"
  },
  {
    "id": 217,
    "question": "What is the loading dose for valproic acid?",
    "options": [
      "10 mg/kg",
      "20 mg/kg",
      "30 mg/kg",
      "40 mg/kg"
    ],
    "correctAnswer": 1,
    "rationale": "Estrogen effects: breast development, fat redistribution, decreased libido. Monitor for thrombosis. Mood improvements. (WPATH)",
    "category": "Mood Stabilizers - Dosing"
  },
  {
    "id": 218,
    "question": "What is the SLUM score range indicating dementia?",
    "options": [
      "0-10",
      "0-20",
      "21-26",
      "27-30"
    ],
    "correctAnswer": 1,
    "rationale": "Gender dysphoria: incongruence between assigned and experienced gender. Not inherently pathological. Support transition if desired. (DSM-5-TR/WPATH)",
    "category": "Mental Status Assessment"
  },
  {
    "id": 219,
    "question": "On the MMSE (0-30), what score indicates moderate cognitive impairment?",
    "options": [
      "0-9",
      "10-20",
      "21-24",
      "25-30"
    ],
    "correctAnswer": 2,
    "rationale": "Minority stress: chronic stress from stigma, discrimination. Higher rates mental illness in LGBTQ+. Affirming care essential. (Meyer/APA)",
    "category": "Mental Status Assessment"
  },
  {
    "id": 220,
    "question": "On the Hamilton Depression Rating Scale (HAM-D 0-76), what score indicates moderate depression?",
    "options": [
      "0-7",
      "8-13",
      "14-18",
      "19+"
    ],
    "correctAnswer": 2,
    "rationale": "Geriatric depression: often atypical presentation (somatic complaints, apathy). Higher suicide risk. Start low, go slow. (APA/USPSTF)",
    "category": "Depression Assessment"
  },
  {
    "id": 221,
    "question": "Using the PHQ9 (0-27) depression scale, what score range indicates moderate depression?",
    "options": [
      "0-4",
      "5-9",
      "10-14",
      "15-19"
    ],
    "correctAnswer": 2,
    "rationale": "Beers Criteria: inappropriate medications in elderly. Avoid anticholinergics, benzodiazepines, TCAs. High risk falls, delirium, cognitive impairment. (AGS)",
    "category": "Depression Assessment"
  },
  {
    "id": 222,
    "question": "On the Beck Depression Inventory (0-63), what score indicates moderate depression?",
    "options": [
      "0-13",
      "14-19",
      "20-28",
      "29-63"
    ],
    "correctAnswer": 2,
    "rationale": "Anticholinergic burden: cumulative effects multiple medications. Delirium, falls, cognitive decline in elderly. Calculate ACB score, reduce when possible. (AGS)",
    "category": "Depression Assessment"
  },
  {
    "id": 223,
    "question": "On the Hamilton Anxiety Scale (HAM-A 0-56), what score indicates moderate anxiety?",
    "options": [
      "0-13",
      "14-17",
      "18-24",
      "25+"
    ],
    "correctAnswer": 2,
    "rationale": "Polypharmacy: 5+ medications. Common in elderly, psychiatric patients. Review regularly. Deprescribe when appropriate. (AGS)",
    "category": "Anxiety Assessment"
  },
  {
    "id": 224,
    "question": "Using the GAD-7 (0-21) anxiety scale, what score indicates moderate anxiety?",
    "options": [
      "0-4",
      "5-9",
      "10-14",
      "15-21"
    ],
    "correctAnswer": 2,
    "rationale": "Deprescribing: systematic medication reduction. Weigh risks/benefits. Taper slowly. Improve quality of life, reduce adverse effects. (Deprescribing Guidelines)",
    "category": "Anxiety Assessment"
  },
  {
    "id": 225,
    "question": "On the COWS (Clinical Opiate Withdrawal Scale) for opioid withdrawal, when should treatment be started?",
    "options": [
      "Score of 0-4",
      "Score of 5-12",
      "Score greater than 13",
      "Only when score is above 25"
    ],
    "correctAnswer": 2,
    "rationale": "QTc monitoring: baseline ECG for patients on QTc-prolonging medications. Repeat if dose change, drug interactions. Male >450ms, female >470ms concerning. (AHA)",
    "category": "Substance Use Assessment"
  },
  {
    "id": 226,
    "question": "On the CIWA (Clinical Institute Withdrawal Assessment for Alcohol), what score indicates moderate withdrawal and requires treatment initiation?",
    "options": [
      "0-9",
      "10-15",
      "16-20",
      "21+"
    ],
    "correctAnswer": 2,
    "rationale": "QTc drug interactions: multiple QTc-prolonging drugs increase risk additively. Avoid combinations when possible. Citalopram, ziprasidone, antiarrhythmics. (FDA/AHA)",
    "category": "Substance Use Assessment"
  },
  {
    "id": 227,
    "question": "A 45-year-old patient presents with red-colored urine and muscle aches after starting aggressive workouts. He also has hematuria. What is the most concerning diagnosis?",
    "options": [
      "Urinary tract infection",
      "Rhabdomyolysis with muscle breakdown",
      "Bladder cancer",
      "Kidney stones"
    ],
    "correctAnswer": 1,
    "rationale": "Hyponatremia: SIADH from SSRIs, carbamazepine. Symptoms: confusion, seizures. Check sodium, especially elderly. Discontinue if severe. (FDA)",
    "category": "Medical Complications"
  },
  {
    "id": 228,
    "question": "What medication should a patient avoid after trying 3 trials of appropriate medication without success for their condition?",
    "options": [
      "SSRIs",
      "Antipsychotics",
      "Benzodiazepines",
      "Mood stabilizers"
    ],
    "correctAnswer": 0,
    "rationale": "SIADH: syndrome inappropriate ADH secretion. Causes hyponatremia. Common with SSRIs, carbamazepine. Fluid restriction, treat underlying cause. (Medical)",
    "category": "Treatment Guidelines"
  },
  {
    "id": 229,
    "question": "When assessing the functioning of an elderly individual, what is the most important factor to evaluate?",
    "options": [
      "Ability to manage a check book",
      "Memory recall",
      "Physical strength",
      "Social interactions"
    ],
    "correctAnswer": 0,
    "rationale": "Hyperprolactinemia workup: TSH, pregnancy test, MRI if markedly elevated or symptoms. Rule out prolactinoma before attributing to medication. (Endocrine)",
    "category": "Geriatric Assessment"
  },
  {
    "id": 230,
    "question": "An autistic child is not responding to your verbal commands. What is the most likely explanation?",
    "options": [
      "The child is being defiant",
      "This is a normal and part of the disease process",
      "The child has hearing impairment",
      "The child is experiencing regression"
    ],
    "correctAnswer": 1,
    "rationale": "Metabolic syndrome monitoring: baseline and periodic weight, BMI, waist circumference, fasting glucose, lipid panel. Every 3-6 months on high-risk antipsychotics. (APA)",
    "category": "Autism Spectrum Disorder"
  },
  {
    "id": 231,
    "question": "What is the role of a Nurse Practitioner involved in politics?",
    "options": [
      "Fundraising",
      "Advocate",
      "Lobbying only",
      "Running for office"
    ],
    "correctAnswer": 1,
    "rationale": "Antipsychotic metabolic monitoring: baseline within 3 months: weight, glucose, lipids. Then quarterly weight, annually labs. More frequent if abnormal. (APA)",
    "category": "Professional Practice"
  },
  {
    "id": 232,
    "question": "An NP is working in a community health center and is also on the board of an organization that wants to put a clinic in the same area. What is the appropriate action?",
    "options": [
      "Continue in both roles",
      "Abstain from voting, conflict of interest",
      "Resign from the board",
      "Disclose but vote anyway"
    ],
    "correctAnswer": 1,
    "rationale": "Akathisia misdiagnosed as anxiety: inner restlessness from antipsychotics. Reduce dose, add propranolol or benzodiazepine. Increasing antipsychotic worsens. (Stahl's)",
    "category": "Professional Ethics"
  },
  {
    "id": 233,
    "question": "What is the first symptom of metabolic syndrome?",
    "options": [
      "Hypertension",
      "Large waist circumference",
      "Hyperglycemia",
      "Dyslipidemia"
    ],
    "correctAnswer": 1,
    "rationale": "EPS prophylaxis: not routinely recommended. Anticholinergics have side effects. Use lowest effective antipsychotic dose. Add if symptoms develop. (APA)",
    "category": "Metabolic Syndrome"
  },
  {
    "id": 234,
    "question": "Tegretol (carbamazepine) interactions with Cipro or erythromycin (inhibitors) will result in:",
    "options": [
      "Decreased tegretol levels",
      "Significantly increased plasma concentration of tegretol (inducer)",
      "No change in tegretol levels",
      "Increased antibiotic levels only"
    ],
    "correctAnswer": 1,
    "rationale": "Anticholinergic medications for EPS: benztropine, trihexyphenidyl. Effective for dystonia, parkinsonism, some akathisia. Avoid long-term if possible. (Stahl's)",
    "category": "Drug Interactions"
  },
  {
    "id": 235,
    "question": "Nuchal rigidity and involuntary muscle spasms that limit passive neck flexion are signs of:",
    "options": [
      "Tension headache",
      "Meningitis",
      "Migraine",
      "Cervical strain"
    ],
    "correctAnswer": 1,
    "rationale": "Benztropine: anticholinergic for EPS. 1-2mg BID. Can give IM for acute dystonia. Anticholinergic side effects. (FDA)",
    "category": "Neurological Signs"
  },
  {
    "id": 236,
    "question": "ACE inhibitors are primarily used for:",
    "options": [
      "Diabetes management",
      "Heart failure",
      "Hyperlipidemia",
      "Arrhythmias"
    ],
    "correctAnswer": 1,
    "rationale": "Propranolol for akathisia: 10-30mg TID. Blocks peripheral symptoms. Contraindicated in asthma, heart block. (Off-label)",
    "category": "Cardiovascular Medications"
  },
  {
    "id": 237,
    "question": "Signs of Serotonin Syndrome include all of the following EXCEPT:",
    "options": [
      "Autonomic instability, tachycardia, fever, anxiety, muscle rigidity",
      "Hyperreflexia, myoclonus, agitation and restless",
      "Bradycardia and hypothermia",
      "Risk factors include use of more than 1 SSRI, St. John's Wart with SSRI, Antidepressant with SSRI (e.g., Tramadol)"
    ],
    "correctAnswer": 2,
    "rationale": "Vitamin B12 deficiency: can cause depression, cognitive impairment, neuropathy. Screen if symptoms, vegan diet, metformin use. (Medical)",
    "category": "Serotonin Syndrome"
  },
  {
    "id": 238,
    "question": "A patient has a Grade II/V harsh systolic heart murmur. What is the most likely diagnosis?",
    "options": [
      "Mitral stenosis",
      "Aortic stenosis (MR ASS, MS ARD)",
      "Tricuspid regurgitation",
      "Pulmonary stenosis"
    ],
    "correctAnswer": 1,
    "rationale": "Thyroid function screening: baseline and periodic on lithium. Annually in depression if no other cause. Hypothyroidism mimics/worsens depression. (APA)",
    "category": "Cardiac Assessment"
  },
  {
    "id": 239,
    "question": "A woman with generalized anxiety disorder tells you she is pregnant and takes Buspar and Klonopin. What should you tell her?",
    "options": [
      "Continue both medications",
      "Stop Klonopin and continue Buspar",
      "Stop both medications immediately",
      "Increase Buspar dose"
    ],
    "correctAnswer": 1,
    "rationale": "Testosterone screening: low testosterone causes depression, fatigue, low libido in men. Screen if symptoms. Replacement improves mood. (Endocrine)",
    "category": "Pregnancy and Medications"
  },
  {
    "id": 240,
    "question": "A patient on an inpatient unit is aggressive and has tried to hit staff. Despite seclusion and Ativan 2mg IM, there is no improvement. To shorten time in seclusion, what should be given?",
    "options": [
      "Another dose of Ativan",
      "Geodon IM",
      "Haldol PO",
      "Lithium"
    ],
    "correctAnswer": 1,
    "rationale": "Anemia screening: fatigue, depression symptoms. CBC baseline reasonable. Iron deficiency common, treatable. (Medical)",
    "category": "Acute Agitation Management"
  },
  {
    "id": 241,
    "question": "What is the most concerning diagnosis for an adolescent male with substance abuse history who has been working out and now presents with muscle ache and red-colored urine with hematuria?",
    "options": [
      "Urinary tract infection",
      "Rhabdomyolysis - muscle breakdown",
      "Dehydration",
      "Kidney infection"
    ],
    "correctAnswer": 1,
    "rationale": "Hepatitis screening: before starting hepatotoxic medications (valproate). Baseline LFTs. Hepatitis B/C if risk factors. (FDA/CDC)",
    "category": "Medical Complications"
  },
  {
    "id": 242,
    "question": "What is the appropriate response when a patient confides in you that since she was born she saw herself as opposite sex?",
    "options": [
      "Refer to psychiatry immediately",
      "Patient privacy and parents right to know",
      "Tell the parents immediately",
      "Start hormone therapy"
    ],
    "correctAnswer": 1,
    "rationale": "HIV screening: recommended ages 15-65 at least once. More frequent if risk factors. Psychiatric symptoms common with HIV. (CDC)",
    "category": "Gender Identity and Ethics"
  },
  {
    "id": 243,
    "question": "A patient on lithium should be monitored for:",
    "options": [
      "Liver function only",
      "Protein in the urine",
      "Blood glucose only",
      "Cholesterol levels"
    ],
    "correctAnswer": 1,
    "rationale": "Syphilis screening: can cause neuropsychiatric symptoms. Screen if risk factors, unexplained symptoms. Treatable. (CDC)",
    "category": "Lithium Monitoring"
  },
  {
    "id": 244,
    "question": "What does Amitriptyline cause in the elderly?",
    "options": [
      "Hypertension",
      "Constipation in the elder",
      "Diarrhea",
      "Weight loss"
    ],
    "correctAnswer": 1,
    "rationale": "Lyme disease: can cause depression, anxiety, cognitive impairment. Consider if endemic area, unexplained symptoms. (CDC)",
    "category": "Geriatric Pharmacology"
  },
  {
    "id": 245,
    "question": "What medication is H2 histamine receptor antagonist?",
    "options": [
      "Omeprazole",
      "Zantac (Ranitidine)",
      "Tums",
      "Maalox"
    ],
    "correctAnswer": 1,
    "rationale": "Obstructive sleep apnea: causes fatigue, depression, cognitive impairment. Screen with STOP-BANG. Refer for sleep study. (AASM)",
    "category": "Gastrointestinal Medications"
  },
  {
    "id": 246,
    "question": "Which medication is H2 antagonist (antihistamine)?",
    "options": [
      "Loratadine",
      "Antihistamine",
      "Diphenhydramine",
      "Cetirizine"
    ],
    "correctAnswer": 1,
    "rationale": "STOP-BANG: sleep apnea screening. Snoring, Tired, Observed apnea, high blood Pressure, BMI >35, Age >50, Neck >40cm, male Gender. ≥3 high risk. (AASM)",
    "category": "Pharmacology"
  },
  {
    "id": 247,
    "question": "What is the number one therapy for Borderline Personality Disorder?",
    "options": [
      "Cognitive Behavioral Therapy",
      "Dialectical Behavior Therapy (DBT)",
      "Psychoanalysis",
      "Supportive therapy"
    ],
    "correctAnswer": 1,
    "rationale": "Restless legs syndrome: uncomfortable leg sensations, urge to move. Worse at rest/evening. Disrupts sleep. Iron deficiency common cause. (IRLSSG)",
    "category": "Psychotherapy"
  },
  {
    "id": 248,
    "question": "A child with Oppositional Defiant Disorder can be prevented from getting antisocial personality disorder by:",
    "options": [
      "Medication management",
      "Refer for Parental training and child training",
      "Hospitalization",
      "School intervention only"
    ],
    "correctAnswer": 1,
    "rationale": "Restless legs treatment: check ferritin (goal >75). Iron supplementation if low. Gabapentin, pramipexole if severe. (IRLSSG)",
    "category": "Child Psychiatry"
  },
  {
    "id": 249,
    "question": "What is the bipolar genetic link regarding children of bipolar parents?",
    "options": [
      "2 times greater risk",
      "4 times greater risk",
      "No increased risk",
      "10 times greater risk"
    ],
    "correctAnswer": 1,
    "rationale": "Akathisia vs restless legs: akathisia upper body, drug-induced, worse with movement. RLS lower body, primary, better with movement. (Differential Dx)",
    "category": "Genetics"
  },
  {
    "id": 250,
    "question": "In an elderly person with apoptosis, what laboratory tests will you assess?",
    "options": [
      "Complete blood count only",
      "Fasting glucose, thyroid panel, and calculated BMI",
      "Liver function tests only",
      "Lipid panel only"
    ],
    "correctAnswer": 1,
    "rationale": "Periodic limb movement disorder: repetitive limb movements during sleep. Disrupts sleep. Detected on sleep study. Treat like RLS. (AASM)",
    "category": "Geriatric Assessment"
  },
  {
    "id": 251,
    "question": "A man with erectile dysfunction has been prescribed a medication. What should you assess?",
    "options": [
      "Testosterone levels",
      "Cialis - slow acting (PDE5 inhibitor)",
      "Blood glucose",
      "Thyroid function"
    ],
    "correctAnswer": 1,
    "rationale": "Narcolepsy: excessive daytime sleepiness, cataplexy (sudden muscle weakness with emotion). Treat with modafinil, stimulants, sodium oxybate. (AASM)",
    "category": "Sexual Dysfunction"
  },
  {
    "id": 252,
    "question": "What cranial nerve is used for frowning?",
    "options": [
      "Cranial nerve 5 (Trigeminal)",
      "Cranial nerve 7 (Facial)",
      "Cranial nerve 9 (Glossopharyngeal)",
      "Cranial nerve 10 (Vagus)"
    ],
    "correctAnswer": 1,
    "rationale": "Hypersomnia: excessive sleepiness not explained by sleep deprivation. Screen for sleep apnea, depression. Consider modafinil. (DSM-5-TR)",
    "category": "Neurological Examination"
  },
  {
    "id": 253,
    "question": "What cranial nerve is used for temporal muscle function?",
    "options": [
      "Cranial nerve 3 (Oculomotor)",
      "Cranial nerve 5 (Trigeminal)",
      "Cranial nerve 7 (Facial)",
      "Cranial nerve 11 (Accessory)"
    ],
    "correctAnswer": 1,
    "rationale": "Circadian rhythm disorders: misalignment between internal clock and environment. Shift work, delayed/advanced sleep phase. Light therapy, melatonin. (AASM)",
    "category": "Neurological Examination"
  },
  {
    "id": 254,
    "question": "What can Accutane (isotretinoin) cause?",
    "options": [
      "Hypertension",
      "Depression",
      "Diabetes",
      "Seizures"
    ],
    "correctAnswer": 1,
    "rationale": "Nightmare disorder: recurrent disturbing dreams. Common in PTSD. Prazosin effective. Imagery rehearsal therapy evidence-based. (DSM-5-TR/VA)",
    "category": "Medication Side Effects"
  },
  {
    "id": 255,
    "question": "What reflex is expected to be present at one month of age?",
    "options": [
      "Babinski reflex",
      "Moro reflex",
      "Stepping reflex",
      "Tonic neck reflex"
    ],
    "correctAnswer": 1,
    "rationale": "Sleep-related eating disorder: eating during sleep with amnesia. Associated with zolpidem, sedatives. Discontinue offending agent. (AASM)",
    "category": "Pediatric Development"
  },
  {
    "id": 256,
    "question": "In a 1-month-old child, what motor skill do you expect?",
    "options": [
      "Rolling over",
      "Palmer grasp",
      "Sitting unsupported",
      "Walking"
    ],
    "correctAnswer": 1,
    "rationale": "Sexsomnia: sexual behaviors during sleep with amnesia. Parasomnia. Safety concerns. Treat underlying sleep disorders. (AASM)",
    "category": "Pediatric Development"
  },
  {
    "id": 257,
    "question": "For a child adopted with fetal alcohol syndrome, what would you recommend?",
    "options": [
      "Regular pediatric follow-up only",
      "Early Intervention specialty services",
      "No special services needed",
      "Speech therapy only"
    ],
    "correctAnswer": 1,
    "rationale": "REM sleep behavior disorder: acting out dreams, loss of REM atonia. Risk of injury. Associated with Parkinson's, Lewy body. Clonazepam, melatonin. (AASM)",
    "category": "Fetal Alcohol Syndrome"
  },
  {
    "id": 258,
    "question": "Signs of Fetal Alcohol Syndrome include:",
    "options": [
      "Large head, thick upper lip, and wide-set eyes",
      "Small head, thin upper lip, and smooth philtrum",
      "Macrocephaly and obesity",
      "Normal facial features"
    ],
    "correctAnswer": 1,
    "rationale": "Panic disorder: recurrent unexpected panic attacks plus persistent concern/behavioral change. SSRIs first-line. CBT highly effective. (DSM-5-TR/APA)",
    "category": "Fetal Alcohol Syndrome"
  },
  {
    "id": 259,
    "question": "Extrapyramidal symptoms (EPS) can be a precursor for:",
    "options": [
      "Neuroleptic Malignant Syndrome",
      "Tardive dyskinesia",
      "Serotonin Syndrome",
      "Malignant hyperthermia"
    ],
    "correctAnswer": 1,
    "rationale": "Panic attack symptoms: palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, derealization, fear dying/losing control. Peak within 10 min. (DSM-5-TR)",
    "category": "Antipsychotic Side Effects"
  },
  {
    "id": 260,
    "question": "EPS side effects include all of the following EXCEPT:",
    "options": [
      "Akathisia - motor restlessness, inability to remain still",
      "Akinesia - Absence of movement",
      "Hypothermia and bradycardia",
      "Dystonia (Muscle spasms) and Pseudoparkinson"
    ],
    "correctAnswer": 2,
    "rationale": "GAD: excessive worry most days 6+ months, difficult to control, physical symptoms. SSRIs, SNRIs, buspirone effective. CBT evidence-based. (DSM-5-TR/APA)",
    "category": "Antipsychotic Side Effects"
  },
  {
    "id": 261,
    "question": "What is the initial signs of HIV induced dementia?",
    "options": [
      "Seizures",
      "Low concentration and decreased memory",
      "Hallucinations",
      "Aggressive behavior"
    ],
    "correctAnswer": 1,
    "rationale": "Social anxiety disorder: fear of social/performance situations, scrutiny. Avoidance, significant distress. SSRIs, SNRIs first-line. CBT with exposure. (DSM-5-TR/APA)",
    "category": "HIV-Related Conditions"
  },
  {
    "id": 262,
    "question": "When you have a 7-year-old whose parent you are treating with off-label medication, what are you going to document?",
    "options": [
      "Only the diagnosis",
      "Document the consent",
      "Nothing special",
      "Parent's medical history"
    ],
    "correctAnswer": 1,
    "rationale": "Specific phobia: fear of specific object/situation, out of proportion, avoidance. Exposure therapy highly effective. Medication not typically needed. (DSM-5-TR)",
    "category": "Documentation and Consent"
  },
  {
    "id": 263,
    "question": "Which of the following medications should rabbits be given when working with?",
    "options": [
      "Amoxicillin",
      "Please from working effectively (context unclear - likely about contraindicated medication)",
      "Penicillin",
      "Cephalosporins"
    ],
    "correctAnswer": 1,
    "rationale": "Agoraphobia: fear of situations where escape difficult (crowds, open spaces, public transport). Avoidance, distress. SSRIs, CBT with exposure. (DSM-5-TR)",
    "category": "Medication Administration"
  },
  {
    "id": 264,
    "question": "For a patient with a congenital man and collabravist with a secret health care, what do you do as an NP?",
    "options": [
      "Ignore the situation",
      "You work with a congenial man and collabravist with a secret health care. What do you do as an NP",
      "Report immediately",
      "Consult ethics committee"
    ],
    "correctAnswer": 1,
    "rationale": "Separation anxiety disorder: excessive fear of separation from attachment figures. Not just children. SSRIs, CBT effective. (DSM-5-TR)",
    "category": "Professional Ethics"
  },
  {
    "id": 265,
    "question": "A patient with sleep apnea and oversleep stances. The APN will know that pt snores because:",
    "options": [
      "Sleep study results",
      "The APN will know that pt snores because of sleep apnea symptoms",
      "Patient self-report only",
      "Physical examination findings"
    ],
    "correctAnswer": 1,
    "rationale": "Selective mutism: consistent failure to speak in specific situations despite speaking elsewhere. Childhood onset. Behavioral interventions first-line. (DSM-5-TR)",
    "category": "Sleep Disorders"
  },
  {
    "id": 266,
    "question": "Delirium, deceive the patient, receive orders for? Phobic anxiety state, what will you discourage?",
    "options": [
      "Benzodiazepines",
      "CBT therapy",
      "Exposure therapy",
      "SSRIs"
    ],
    "correctAnswer": 0,
    "rationale": "Illness anxiety disorder: preoccupation with having serious illness despite minimal symptoms. Excessive health behaviors. CBT most effective. (DSM-5-TR)",
    "category": "Anxiety Disorders"
  },
  {
    "id": 267,
    "question": "An anorexic patient stated she feels bloated after eating meals. What do you tell her?",
    "options": [
      "This is normal and will resolve",
      "Tell her to space meals out and eat more",
      "Prescribe laxatives",
      "Recommend fasting"
    ],
    "correctAnswer": 1,
    "rationale": "Somatic symptom disorder: excessive thoughts/feelings/behaviors related to somatic symptoms. Causes distress, impairment. CBT, address comorbid depression/anxiety. (DSM-5-TR)",
    "category": "Eating Disorders"
  },
  {
    "id": 268,
    "question": "What PICOT stands for in evidence-based practice?",
    "options": [
      "Patient, Intervention, Comparison, Outcome, Time",
      "Population Intervention Comparison Outcome Time (Who is your patient, Disease or Health status, age, race, sex, etc.)",
      "Protocol, Implementation, Control, Outcome, Testing",
      "Practice, Investigation, Comparison, Observation, Treatment"
    ],
    "correctAnswer": 1,
    "rationale": "Conversion disorder (functional neurological symptom): neurological symptoms incompatible with medical condition. Not intentional. Psychotherapy, physical therapy. (DSM-5-TR)",
    "category": "Evidence-Based Practice"
  },
  {
    "id": 269,
    "question": "Know Carbamazepine (CBZ/Tegretol) drug interactions. Use during pregnancy may cause harm to the baby (Neural tube defects). Carbamazepine, as a CYP450 inducer, may:",
    "options": [
      "Increase levels of other drugs",
      "Decrease clearance of many drugs, decreasing their concentration in the blood to sub-therapeutic levels",
      "Have no effect on other medications",
      "Only affect antibiotic levels"
    ],
    "correctAnswer": 1,
    "rationale": "Factitious disorder: falsifying physical/psychological symptoms in absence of external rewards. Imposed on self or another (Munchausen by proxy). (DSM-5-TR)",
    "category": "Drug Interactions"
  },
  {
    "id": 270,
    "question": "Drugs that decrease the metabolism of carbamazepine and can raise its blood levels include:",
    "options": [
      "Phenobarbital and phenytoin",
      "Erythromycin, cimetidine, propoxyphene, and calcium channel blockers including verapamil, diltiazem, and nifedipine",
      "Rifampin and carbamazepine",
      "Warfarin and aspirin"
    ],
    "correctAnswer": 1,
    "rationale": "Malingering: intentional feigning symptoms for external gain (financial, avoiding work). Not a disorder. Consider forensic evaluation. (DSM-5-TR)",
    "category": "Drug Interactions"
  },
  {
    "id": 271,
    "question": "Carbamazepine can potentially cause all of the following serious effects EXCEPT:",
    "options": [
      "Stevens-Johnson syndrome",
      "Toxic epidermal necrolysis",
      "Hypertensive crisis",
      "Severe skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis"
    ],
    "correctAnswer": 2,
    "rationale": "Dissociative identity disorder: two or more distinct personality states. Recurrent amnesia. History of severe trauma. Trauma-focused therapy. (DSM-5-TR)",
    "category": "Serious Adverse Effects"
  },
  {
    "id": 272,
    "question": "What is the best initial action for a pregnant woman with ETOH (alcohol) issues?",
    "options": [
      "Immediate hospitalization",
      "Benzodiazepines (naltrexone) can be considered a first-line pharmacological treatment for patients who are not pregnant",
      "Methadone maintenance",
      "Disulfiram"
    ],
    "correctAnswer": 1,
    "rationale": "Depersonalization/derealization disorder: persistent feelings of detachment from self/surroundings. Intact reality testing. Associated with anxiety, depression. (DSM-5-TR)",
    "category": "Substance Use in Pregnancy"
  },
  {
    "id": 273,
    "question": "A depressed patient on Lexapro and Wellbutrin has been put on digoxin. Knowing the side effects of medications, which one is the most concern?",
    "options": [
      "Lexapro causing bleeding",
      "Lower Wellbutrin. Combo may increase risk of seizures",
      "Digoxin toxicity from Lexapro",
      "Wellbutrin causing hypertension"
    ],
    "correctAnswer": 1,
    "rationale": "Dissociative amnesia: inability to recall autobiographical information, usually traumatic. Beyond ordinary forgetting. Trauma-focused therapy. (DSM-5-TR)",
    "category": "Drug Interactions"
  },
  {
    "id": 274,
    "question": "When you are getting informed consent for research, what do you need?",
    "options": [
      "Verbal consent only",
      "You need a signed consent",
      "Witness signature only",
      "No consent needed for minimal risk studies"
    ],
    "correctAnswer": 1,
    "rationale": "Body dysmorphic disorder: preoccupation with perceived defect in appearance not observable by others. Repetitive behaviors. SSRIs, CBT effective. (DSM-5-TR)",
    "category": "Research Ethics"
  },
  {
    "id": 275,
    "question": "Which of these provides care for the whole person in ambulatory setting?",
    "options": [
      "Emergency department",
      "Not sure of correct answer: Pt8 (Provides Comprehensive Care)",
      "Specialty clinic",
      "Urgent care"
    ],
    "correctAnswer": 1,
    "rationale": "Hoarding disorder: difficulty discarding possessions, accumulation cluttering living space. Significant distress, impairment. CBT adapted for hoarding. (DSM-5-TR)",
    "category": "Healthcare Delivery"
  },
  {
    "id": 276,
    "question": "Which part of these answer. Pt8 review third party payers. A kid does not want to participate in gym class, he says it hurts every time he turns. The family is worried about the family (Tredelenburg)?",
    "options": [
      "Refer to physical therapy",
      "You might recommend to go to hip specialist. You will refer you to hip specialist",
      "Prescribe pain medication",
      "Recommend rest only"
    ],
    "correctAnswer": 1,
    "rationale": "Trichotillomania: recurrent hair pulling resulting in hair loss. Tension before, relief after. NAC, habit reversal training effective. (DSM-5-TR)",
    "category": "Pediatric Orthopedics"
  },
  {
    "id": 277,
    "question": "What is the first symptom of HIV-related dementia?",
    "options": [
      "Psychosis",
      "Memory loss (refer to ficklike symptoms, >CD4 200, Opportunistic infections)",
      "Seizures",
      "Mood changes"
    ],
    "correctAnswer": 1,
    "rationale": "Excoriation disorder: recurrent skin picking causing lesions. Attempts to stop. NAC, habit reversal training. (DSM-5-TR)",
    "category": "HIV-Related Conditions"
  },
  {
    "id": 278,
    "question": "A kid does not want to participate in gym class because it hurts every time he turns. What should you assess for?",
    "options": [
      "Knee injury",
      "Assessment needs to be done. Ask family about previous hip injury. What do you tell the family (Trendelenburg)?",
      "Ankle sprain",
      "Growing pains"
    ],
    "correctAnswer": 1,
    "rationale": "N-acetylcysteine (NAC): glutamate modulator. Evidence for trichotillomania, excoriation, OCD. 1200-2400mg daily. Well-tolerated. (Research)",
    "category": "Pediatric Assessment"
  },
  {
    "id": 279,
    "question": "A 12-year-old patient who knows they have two conflicts involved. The patient has the right to know. A patient tells you she has had sex with her 6-year-old brother (Sodomy). Mother call and reported to you. What do you do?",
    "options": [
      "Maintain confidentiality",
      "Tell her, but keep secret away from each other, call child protective service and also notify the police. This is Sodomy",
      "Talk to parents first",
      "Refer to therapy only"
    ],
    "correctAnswer": 1,
    "rationale": "Intermittent explosive disorder: recurrent behavioral outbursts (verbal/physical aggression). Out of proportion. Mood stabilizers, CBT. (DSM-5-TR)",
    "category": "Child Abuse Reporting"
  },
  {
    "id": 280,
    "question": "Brother 14 has a larger breast than 11-year-old sister. What do you tell him?",
    "options": [
      "Refer to endocrinology",
      "Normal aging",
      "Start hormone therapy",
      "Order breast imaging"
    ],
    "correctAnswer": 1,
    "rationale": "Conduct disorder: repetitive violation of rights of others, societal norms (aggression, destruction, deceitfulness, rule violations). Before age 18. Therapy, family interventions. (DSM-5-TR)",
    "category": "Adolescent Development"
  },
  {
    "id": 281,
    "question": "Asthma medication that can cause depression:",
    "options": [
      "Albuterol",
      "Qvar inhalation",
      "Salmeterol",
      "Montelukast"
    ],
    "correctAnswer": 1,
    "rationale": "Oppositional defiant disorder: angry mood, argumentative/defiant behavior, vindictiveness for 6+ months. Less severe than conduct disorder. Parent management training. (DSM-5-TR)",
    "category": "Medication Side Effects"
  },
  {
    "id": 282,
    "question": "What is the interaction of Diflucan (fluconazole) and Seroquel (quetiapine)?",
    "options": [
      "No interaction",
      "Quetiapine/Moderate-Strong CYP3A4 inhibitor. Diflucan medicine may slow down how quickly your liver processes quetiapine. The amount of quetiapine in your blood may increase and cause more side effects",
      "Decreased Seroquel levels",
      "Increased Diflucan side effects only"
    ],
    "correctAnswer": 1,
    "rationale": "Disruptive mood dysregulation disorder: severe recurrent temper outbursts, persistent irritability between outbursts. Age 6-18. Mood stabilizers, therapy. (DSM-5-TR)",
    "category": "Drug Interactions"
  },
  {
    "id": 283,
    "question": "NAMI advocates for mental health and what other issue?",
    "options": [
      "Housing only",
      "Public policy issues",
      "Research funding only",
      "Insurance coverage only"
    ],
    "correctAnswer": 1,
    "rationale": "DMDD vs bipolar: DMDD chronic irritability without distinct episodes. No mania. Consider if irritability non-episodic. (DSM-5-TR)",
    "category": "Mental Health Advocacy"
  },
  {
    "id": 284,
    "question": "In a study of education for prevention of delirium post cardiac surgery, why does the sample have bias?",
    "options": [
      "Sample size too small",
      "Ethical intervention needs to be offered to all patients",
      "Wrong population studied",
      "No control group"
    ],
    "correctAnswer": 1,
    "rationale": "Reactive attachment disorder: inhibited, emotionally withdrawn behavior toward caregivers. History of insufficient care. Minimal seeking comfort. Attachment-focused therapy. (DSM-5-TR)",
    "category": "Research Methodology"
  },
  {
    "id": 285,
    "question": "HIV dementia is often confused with:",
    "options": [
      "Alzheimer's disease",
      "Delirium",
      "Depression",
      "Anxiety"
    ],
    "correctAnswer": 1,
    "rationale": "Disinhibited social engagement disorder: overly familiar behavior with strangers, lack of boundaries. History of insufficient care. Structured caregiving. (DSM-5-TR)",
    "category": "Differential Diagnosis"
  },
  {
    "id": 286,
    "question": "A PMHNP wants to open up an outpatient clinic to determine economic viability. What financial tool is needed?",
    "options": [
      "Income statement",
      "Balanced sheet",
      "Cash flow analysis",
      "Budget forecast"
    ],
    "correctAnswer": 1,
    "rationale": "Adjustment disorder: emotional/behavioral symptoms in response to identifiable stressor within 3 months. Out of proportion or impairing. Resolve within 6 months of stressor ending. (DSM-5-TR)",
    "category": "Practice Management"
  },
  {
    "id": 287,
    "question": "When assessing an elderly patient for dementia, what is the most important differential diagnosis to rule out?",
    "options": [
      "Delirium",
      "Memory",
      "Depression",
      "Medication side effects"
    ],
    "correctAnswer": 1,
    "rationale": "Prolonged grief disorder: intense yearning/preoccupation with deceased >12 months (6 months children). Impairment. Grief-focused therapy. (DSM-5-TR)",
    "category": "Geriatric Assessment"
  },
  {
    "id": 288,
    "question": "Peplau, when doing qualitative research, recommends which method?",
    "options": [
      "Randomized controlled trial",
      "Process recording",
      "Meta-analysis",
      "Survey methodology"
    ],
    "correctAnswer": 1,
    "rationale": "Brief psychotic disorder: psychosis lasting 1 day-1 month. Full return to baseline. May follow stressor. Antipsychotic short-term. (DSM-5-TR)",
    "category": "Research Methodology"
  },
  {
    "id": 289,
    "question": "An individual with a frontal lobe tumor would have difficulty with:",
    "options": [
      "Vision",
      "Problem solving, behavioral and emotional changes and language",
      "Hearing",
      "Memory only"
    ],
    "correctAnswer": 1,
    "rationale": "Schizophreniform disorder: schizophrenia symptoms lasting 1-6 months. If persists beyond 6 months, diagnosis changes to schizophrenia. (DSM-5-TR)",
    "category": "Neuropsychiatry"
  },
  {
    "id": 290,
    "question": "For someone preparing with PTSD for mindfulness training, what is the first intervention?",
    "options": [
      "Meditation practice",
      "Guided imagery",
      "Exposure therapy",
      "Medication"
    ],
    "correctAnswer": 1,
    "rationale": "Schizoaffective disorder: schizophrenia plus mood episode. Psychosis occurs 2+ weeks without mood symptoms. Antipsychotic + mood stabilizer or antidepressant. (DSM-5-TR)",
    "category": "PTSD Treatment"
  },
  {
    "id": 291,
    "question": "Benzodiazepines (naltrexone) for pregnant women with ETOH can be considered:",
    "options": [
      "Contraindicated",
      "A first-line pharmacological treatment for patients who are not pregnant",
      "Safe in all trimesters",
      "Only in third trimester"
    ],
    "correctAnswer": 1,
    "rationale": "Delusional disorder: one or more delusions 1+ month. Functioning not markedly impaired. No schizophrenia criteria. Antipsychotics, limited evidence. (DSM-5-TR)",
    "category": "Pregnancy and Substance Use"
  },
  {
    "id": 292,
    "question": "A woman is anxious about administering medication to her child. What should you do?",
    "options": [
      "Demonstrate administration technique",
      "Stop and address her anxiety",
      "Have someone else give the medication",
      "Provide written instructions only"
    ],
    "correctAnswer": 1,
    "rationale": "Substance-induced psychotic disorder: hallucinations/delusions during/after intoxication/withdrawal. Exceeds what typically expected. Resolves with abstinence. (DSM-5-TR)",
    "category": "Patient Education"
  },
  {
    "id": 293,
    "question": "During a home visit to a woman with an overweight child, there is uncooked chicken on the counter and she is using ice cream with the child. What should the NP assess?",
    "options": [
      "Food preferences only",
      "Assess for understanding of health activities and nutrition",
      "Financial status only",
      "Cultural practices only"
    ],
    "correctAnswer": 1,
    "rationale": "Stimulant intoxication: euphoria, hypervigilance, tachycardia, pupil dilation, hypertension. Can cause psychosis with chronic use. (DSM-5-TR)",
    "category": "Health Education"
  },
  {
    "id": 294,
    "question": "What medication slows down gastric motility?",
    "options": [
      "Metoclopramide",
      "Anticholinergics",
      "Proton pump inhibitors",
      "H2 blockers"
    ],
    "correctAnswer": 1,
    "rationale": "Stimulant withdrawal: dysphoria, fatigue, hypersomnia, increased appetite. Unpleasant but not dangerous. Supportive care. (DSM-5-TR)",
    "category": "Pharmacology"
  },
  {
    "id": 295,
    "question": "A patient on Olanzapine is starting a smoking cessation class. What should the NP recommend?",
    "options": [
      "Increase Olanzapine dose",
      "NP will recommend smoking cessation class",
      "Discontinue Olanzapine",
      "Switch to different antipsychotic"
    ],
    "correctAnswer": 1,
    "rationale": "Cocaine: dopamine/norepinephrine/serotonin reuptake inhibition. Short half-life, intense craving. No FDA-approved medications. Behavioral interventions. (NIDA)",
    "category": "Smoking Cessation"
  },
  {
    "id": 296,
    "question": "An elder population taking SSRI should be concerned with:",
    "options": [
      "Weight gain",
      "Hyponatremia",
      "Hyperglycemia",
      "Hyperlipidemia"
    ],
    "correctAnswer": 1,
    "rationale": "Methamphetamine: releases dopamine. Neurotoxic. Psychosis common. No FDA-approved medications. Contingency management effective. (NIDA)",
    "category": "Geriatric Pharmacology"
  },
  {
    "id": 297,
    "question": "A teenage girl on Depakote should be tested for:",
    "options": [
      "Thyroid function",
      "Human Chorionic Gonadotropin (HCG)",
      "Vitamin D levels",
      "Cholesterol"
    ],
    "correctAnswer": 1,
    "rationale": "Cannabis intoxication: euphoria, anxiety, impaired judgment, conjunctival injection, increased appetite. Can trigger psychosis in vulnerable. (DSM-5-TR)",
    "category": "Medication Monitoring"
  },
  {
    "id": 298,
    "question": "What should you focus on in a new clinic as an NP?",
    "options": [
      "Marketing and advertising",
      "Focus on patient and family outcome",
      "Profit maximization",
      "Expansion plans"
    ],
    "correctAnswer": 1,
    "rationale": "Cannabis use disorder: increasingly recognized. Withdrawal syndrome exists. CBT, motivational enhancement therapy. No FDA-approved medications. (DSM-5-TR/NIDA)",
    "category": "Professional Practice"
  },
  {
    "id": 299,
    "question": "Rather than doing a comprehensive assessment in a neonate, what is most important to assess?",
    "options": [
      "Reflexes",
      "Family history of drug use",
      "Weight and length",
      "Hearing screening"
    ],
    "correctAnswer": 1,
    "rationale": "Cannabis and psychosis: precipitates psychosis in vulnerable individuals. Earlier onset schizophrenia. Advise avoidance in psychotic disorders, family history. (Research)",
    "category": "Neonatal Assessment"
  },
  {
    "id": 300,
    "question": "When billing Medicare, what number do you include?",
    "options": [
      "Social security number",
      "CPT code",
      "NPI number",
      "Tax ID"
    ],
    "correctAnswer": 1,
    "rationale": "Synthetic cannabinoids (K2, Spice): unpredictable effects, more dangerous than cannabis. Severe psychosis, medical complications. (CDC/NIDA)",
    "category": "Billing and Coding"
  },
  {
    "id": 301,
    "question": "What cranial nerve is assessed when 'puffing the cheek'?",
    "options": [
      "Trigeminal (CN V)",
      "Facial Nerve (CN VII)",
      "Glossopharyngeal (CN IX)",
      "Hypoglossal (CN XII)"
    ],
    "correctAnswer": 1,
    "rationale": "Alcohol intoxication: slurred speech, incoordination, unsteady gait, nystagmus, impaired attention/memory, stupor/coma. (DSM-5-TR)",
    "category": "Neurological Examination"
  },
  {
    "id": 302,
    "question": "Which two Hispanic groups are implicated in mood dx?",
    "options": [
      "Mexican and Puerto Rican",
      "Puerto Rican and Dominican",
      "Cuban and Colombian",
      "Guatemalan and Honduran"
    ],
    "correctAnswer": 1,
    "rationale": "Alcohol withdrawal: autonomic hyperactivity, tremor, insomnia, nausea, hallucinations, agitation, seizures. Can be fatal. Benzodiazepines. (DSM-5-TR)",
    "category": "Cultural Psychiatry"
  },
  {
    "id": 303,
    "question": "Gabapentin (Neurontin) is used to treat all of the following EXCEPT:",
    "options": [
      "Epilepsy",
      "Depression",
      "Neuropathic pain",
      "Hot flashes"
    ],
    "correctAnswer": 1,
    "rationale": "Alcohol withdrawal seizures: typically 12-48 hours after last drink. Generalized tonic-clonic. Prevent with benzodiazepines. (Medical)",
    "category": "Anticonvulsants"
  },
  {
    "id": 304,
    "question": "Gabapentin affects which inhibitory neurotransmitter?",
    "options": [
      "Serotonin",
      "GABA (gamma-aminobutyric acid)",
      "Dopamine",
      "Norepinephrine"
    ],
    "correctAnswer": 1,
    "rationale": "Delirium tremens: severe alcohol withdrawal. Confusion, hallucinations, autonomic instability, tremor. Onset 48-96 hours. Medical emergency. High-dose benzodiazepines. (Medical)",
    "category": "Pharmacology"
  },
  {
    "id": 305,
    "question": "Depressed Diabetic on SSRI. Why would you be interested in reticulocyte count?",
    "options": [
      "To assess for infection",
      "Aplastic anemia: A reticulocyte count with low RBCs to help evaluate conditions that affect red blood cells (RBCs)",
      "To monitor diabetes control",
      "To check liver function"
    ],
    "correctAnswer": 1,
    "rationale": "CIWA-Ar: alcohol withdrawal assessment. Scores severity. Guides benzodiazepine dosing. Repeat every 4-8 hours. (Medical)",
    "category": "Laboratory Monitoring"
  },
  {
    "id": 306,
    "question": "What interferes with Oral Iron therapy?",
    "options": [
      "Vitamin C",
      "Caffeine and Antacids",
      "Protein",
      "Folic acid"
    ],
    "correctAnswer": 1,
    "rationale": "Benzodiazepine withdrawal: anxiety, tremor, perceptual disturbances, seizures. Can be fatal. Taper slowly 10% every 1-2 weeks. (Medical)",
    "category": "Drug Interactions"
  },
  {
    "id": 307,
    "question": "What are side effects of Fluoroquinolones?",
    "options": [
      "Nausea and diarrhea only",
      "Tendon rupture",
      "Headache",
      "Insomnia"
    ],
    "correctAnswer": 1,
    "rationale": "Opioid intoxication: euphoria, apathy, pupillary constriction, drowsiness, slurred speech, respiratory depression. Overdose: respiratory arrest. (DSM-5-TR)",
    "category": "Antibiotic Side Effects"
  },
  {
    "id": 308,
    "question": "What are hypertensives and tetracycline known to cause in children?",
    "options": [
      "Growth retardation",
      "Teeth discolorations",
      "Bone deformities",
      "Liver damage"
    ],
    "correctAnswer": 1,
    "rationale": "Opioid withdrawal: dysphoria, nausea, vomiting, muscle aches, lacrimation, rhinorrhea, pupil dilation, piloerection, diarrhea. Unpleasant but not life-threatening. (DSM-5-TR)",
    "category": "Pediatric Pharmacology"
  },
  {
    "id": 309,
    "question": "What is Synthroid medication used for?",
    "options": [
      "Hyperthyroidism",
      "Osteoporosis",
      "Hypothyroidism",
      "Diabetes"
    ],
    "correctAnswer": 2,
    "rationale": "Clonidine for opioid withdrawal: alpha-2 agonist reduces noradrenergic symptoms. 0.1-0.2mg TID-QID. Hypotension risk. (Off-label)",
    "category": "Endocrine Medications"
  },
  {
    "id": 310,
    "question": "What is the sensitivity test that measures the degree to which those who have a disease screen test positive?",
    "options": [
      "Specificity",
      "Positive predictive value",
      "Sensitivity - True positive rate",
      "Negative predictive value"
    ],
    "correctAnswer": 2,
    "rationale": "Buprenorphine induction: start when mild-moderate withdrawal (COWS ≥11-12). Precipitated withdrawal if started too early. (SAMHSA)",
    "category": "Research and Statistics"
  },
  {
    "id": 311,
    "question": "What chromosomal condition affects development in females with common features like short stature and loss of ovarian function?",
    "options": [
      "Down syndrome",
      "Klinefelter syndrome",
      "Turner syndrome",
      "Triple X syndrome"
    ],
    "correctAnswer": 2,
    "rationale": "COWS: Clinical Opiate Withdrawal Scale. Assesses withdrawal severity. Guides buprenorphine induction timing. (SAMHSA)",
    "category": "Genetics"
  },
  {
    "id": 312,
    "question": "What is Neuroleptic Malignant Syndrome characterized by?",
    "options": [
      "Hypotension and bradycardia",
      "Leukocytosis, myoglobinuria, mutism, tachycardia, fever, anxiety, muscle rigidity",
      "Tremor and seizures only",
      "Confusion and hypothermia"
    ],
    "correctAnswer": 1,
    "rationale": "Buprenorphine maintenance: partial agonist reduces craving, blocks euphoria from opioids. Target dose 12-16mg daily. (SAMHSA)",
    "category": "Antipsychotic Emergencies"
  },
  {
    "id": 313,
    "question": "What is the treatment for Neuroleptic Malignant Syndrome?",
    "options": [
      "Continue antipsychotic and add benzodiazepine",
      "Discontinue antipsychotic medication. Administration of Dantriom (dantrolene) or Parlodel (bromocriptine)",
      "Increase antipsychotic dose",
      "Supportive care only"
    ],
    "correctAnswer": 1,
    "rationale": "Buprenorphine/naloxone: combination prevents IV abuse (naloxone precipitates withdrawal if injected). Preferred over monoproduct. (FDA/SAMHSA)",
    "category": "Emergency Treatment"
  },
  {
    "id": 314,
    "question": "What is Serotonin Syndrome characterized by?",
    "options": [
      "Hypothermia and bradycardia",
      "Tachycardia, fever, anxiety, muscle hyperreflexia",
      "Muscle rigidity and mutism",
      "Hypotension and sedation"
    ],
    "correctAnswer": 1,
    "rationale": "Methadone vs buprenorphine: methadone full agonist, restricted access. Buprenorphine office-based, safer ceiling effect. Both effective. (SAMHSA)",
    "category": "Serotonin Syndrome"
  },
  {
    "id": 315,
    "question": "What is the Mini Mental Status Exam score range indicating mild impairment?",
    "options": [
      "0-7",
      "8-13",
      "18-24",
      "25-30"
    ],
    "correctAnswer": 2,
    "rationale": "Naltrexone for alcohol: reduces heavy drinking days. 50mg daily or 380mg IM monthly. Opioid antagonist. Check LFTs. (FDA)",
    "category": "Cognitive Assessment"
  },
  {
    "id": 316,
    "question": "What are the Beck Depression Inventory score ranges?",
    "options": [
      "0-5 normal, 6-10 mild",
      "Not depressed 0-9, Mild-moderate depression 10-18, Moderate-severe 19-29, Severe depression 30-63",
      "0-13 minimal, 14-19 mild",
      "Different scale entirely"
    ],
    "correctAnswer": 1,
    "rationale": "Vivitrol: extended-release naltrexone IM. Once monthly. FDA-approved alcohol dependence, opioid dependence. Improves adherence. (FDA)",
    "category": "Depression Assessment"
  },
  {
    "id": 317,
    "question": "What are the Hamilton Depression Rating Scale (HAM-D) score ranges?",
    "options": [
      "0-7 normal, 8-15 mild",
      "Very severe: More than 23, Severe: 19-22, Moderate: 14-18, Mild 8-13, No depression: 0-7",
      "0-10 minimal, 11-20 moderate",
      "Different scoring system"
    ],
    "correctAnswer": 1,
    "rationale": "Sedative-hypnotic withdrawal: anxiety, tremor, seizures. Similar to alcohol withdrawal. Taper slowly. Benzodiazepines can be fatal. (Medical)",
    "category": "Depression Assessment"
  },
  {
    "id": 318,
    "question": "What statement is true regarding a patient ready for termination?",
    "options": [
      "Patient becomes more dependent",
      "Patient shows no progress",
      "Patient demonstrates progress and readiness to terminate",
      "Patient requests more frequent sessions"
    ],
    "correctAnswer": 2,
    "rationale": "Barbiturate withdrawal: more dangerous than benzodiazepines. Seizures, delirium. Taper with phenobarbital. Inpatient setting. (Medical)",
    "category": "Psychotherapy"
  },
  {
    "id": 319,
    "question": "What should a suicide risk assessment include in a school setting?",
    "options": [
      "Only asking about suicidal thoughts",
      "There has been 1 death by suicide at the ER call came that say the boy is not obeying the rules and parents say they could not take it any longer, question was ask is: Is the grade alteraticd?",
      "Family history only",
      "Peer relationships only"
    ],
    "correctAnswer": 1,
    "rationale": "GHB withdrawal: severe, rapid onset. Delirium, autonomic instability. High-dose benzodiazepines. ICU level care. (Medical)",
    "category": "Suicide Risk Assessment"
  },
  {
    "id": 320,
    "question": "When a patient becomes silent during an interview, what should you do?",
    "options": [
      "End the interview",
      "Ask to reschedule the appointment for both of them to be there. There has been 1 death by suicide, the management will identify the outcome and cause. What kind of intervention is this?",
      "Continue talking",
      "Change topics immediately"
    ],
    "correctAnswer": 1,
    "rationale": "Hallucinogen intoxication: perceptual changes, depersonalization, synesthesia. No withdrawal. Supportive care, benzodiazepines for anxiety. (DSM-5-TR)",
    "category": "Interviewing Techniques"
  },
  {
    "id": 321,
    "question": "A couple is undergoing a joint therapy session. One person came angry about the other. What will the NP do?",
    "options": [
      "Side with one partner",
      "Ask to reschedule the appointment for both of them to be there",
      "Continue with individual therapy",
      "End therapy"
    ],
    "correctAnswer": 1,
    "rationale": "LSD: serotonin 5-HT2A agonist. Prolonged effects (12 hours). Flashbacks possible. No physical dependence. (NIDA)",
    "category": "Couples Therapy"
  },
  {
    "id": 322,
    "question": "A patient who is alcoholic comes to the ED 3 times. The APN needs to coordinate care. Who will the APN consult?",
    "options": [
      "Primary care only",
      "Consult with the ID manager; the case management and discharge team",
      "Social work only",
      "Psychiatry only"
    ],
    "correctAnswer": 1,
    "rationale": "Psilocybin: classic hallucinogen. Research for treatment-resistant depression, anxiety. Not FDA-approved. Legal status evolving. (Research)",
    "category": "Case Management"
  },
  {
    "id": 323,
    "question": "As an NP, when a minor patient confides information in you about sexual orientation, what should you do?",
    "options": [
      "Tell parents immediately",
      "Increase intramural pressure",
      "Maintain confidentiality while assessing risk",
      "Discharge from care"
    ],
    "correctAnswer": 2,
    "rationale": "MDMA: entactogen, both stimulant and hallucinogenic properties. Researched for PTSD. Neurotoxicity concerns. Not FDA-approved. (NIDA/Research)",
    "category": "Adolescent Confidentiality"
  },
  {
    "id": 324,
    "question": "A baby is crying excessively. What should be assessed?",
    "options": [
      "Feeding schedule only",
      "Increase intramural pressure (ICP)",
      "Sleep patterns only",
      "Growth parameters only"
    ],
    "correctAnswer": 1,
    "rationale": "PCP/ketamine: NMDA antagonists. Dissociative anesthetics. PCP causes violent behavior, psychosis. Ketamine therapeutic uses emerging. (NIDA)",
    "category": "Pediatric Assessment"
  },
  {
    "id": 325,
    "question": "As an NP, when you prescribe opioids for pain, what legal principle is of most concern regarding privacy and confidentiality?",
    "options": [
      "FERPA",
      "Tele-psychiatry: Okem both written and privacy",
      "ADA",
      "EMTALA"
    ],
    "correctAnswer": 1,
    "rationale": "Inhalant intoxication: dizziness, nystagmus, incoordination, slurred speech, euphoria. Sudden sniffing death from cardiac arrhythmia. (DSM-5-TR)",
    "category": "Legal Issues"
  },
  {
    "id": 326,
    "question": "What does erythromycin (Inhibitor) do to Tegretol (Carbamazepine) (Inducer)?",
    "options": [
      "Decreases Tegretol levels",
      "It Increase tegretol serum level",
      "No interaction",
      "Increases erythromycin levels only"
    ],
    "correctAnswer": 1,
    "rationale": "Inhalants: brain damage, peripheral neuropathy with chronic use. Common in adolescents. No specific treatment. (NIDA)",
    "category": "Drug Interactions"
  },
  {
    "id": 327,
    "question": "Zoloft for 3 weeks, stating having side effects. What do you do?",
    "options": [
      "Discontinue immediately",
      "You see pt for Rx change. Consultation slows down the metabolism of Zoloft",
      "Increase dose",
      "Add another medication"
    ],
    "correctAnswer": 1,
    "rationale": "Anabolic steroid withdrawal: depression, fatigue, anhedonia, suicidal ideation. Mood symptoms can persist. Antidepressants if needed. (DSM-5-TR)",
    "category": "Medication Management"
  },
  {
    "id": 328,
    "question": "You have a 5-year-old who yesterday was using the clinic, and yesterday was ordered Zoloft. He was eating but not enjoying food and is paying attention to activities around him. As an NP what diagnosis will you give him?",
    "options": [
      "Major Depression",
      "Adjustment Disorder with emotional dysregulation and conduct problem",
      "ADHD",
      "Oppositional Defiant Disorder"
    ],
    "correctAnswer": 1,
    "rationale": "Caffeine intoxication: restlessness, nervousness, excitement, insomnia, GI disturbance, tachycardia, psychomotor agitation. >250mg. (DSM-5-TR)",
    "category": "Child Psychiatry Diagnosis"
  },
  {
    "id": 329,
    "question": "When a patient is having Neuroleptic Malignant Syndrome (NMS), what should you give?",
    "options": [
      "Continue antipsychotic",
      "CK, WBC monitoring, benzo and dantrolene",
      "SSRIs",
      "Lithium"
    ],
    "correctAnswer": 1,
    "rationale": "Caffeine withdrawal: headache, fatigue, dysphoria, concentration difficulty. Onset 12-24 hours, peaks 20-51 hours. (DSM-5-TR)",
    "category": "Emergency Treatment"
  },
  {
    "id": 330,
    "question": "Which statement about the staff nurse just came with a new law. This is?",
    "options": [
      "Policy change",
      "State statute",
      "Federal regulation",
      "Institutional guideline"
    ],
    "correctAnswer": 1,
    "rationale": "Nicotine withdrawal: irritability, anxiety, difficulty concentrating, increased appetite, insomnia, depressed mood. Peaks 2-3 days. (DSM-5-TR)",
    "category": "Legal and Regulatory"
  },
  {
    "id": 331,
    "question": "A Muslim patient sitting alone for hours. You finally got an interpreter to speak for him. What is this?",
    "options": [
      "Cultural assessment",
      "Patient centered care",
      "Language barrier resolution",
      "Informed consent process"
    ],
    "correctAnswer": 1,
    "rationale": "Tobacco use disorder: most common substance use disorder. High relapse rates. Combination behavioral + pharmacotherapy most effective. (NIDA)",
    "category": "Cultural Competence"
  },
  {
    "id": 332,
    "question": "ACE inhibitors are used for what indication?",
    "options": [
      "Diabetes",
      "Heart failure, Beck depression score of 12. What do you do?",
      "Hypertension only",
      "Kidney disease only"
    ],
    "correctAnswer": 1,
    "rationale": "Harm reduction: meets people where they are. Reduces consequences without requiring abstinence. Needle exchange, safer use strategies. (SAMHSA)",
    "category": "Cardiovascular Pharmacology"
  },
  {
    "id": 333,
    "question": "What intervention is motivating staff by leading by example?",
    "options": [
      "Authoritarian leadership",
      "Innovation - e.g smoking cessation (Process pros and cons)",
      "Transactional leadership",
      "Laissez-faire leadership"
    ],
    "correctAnswer": 1,
    "rationale": "Contingency management: behavioral intervention rewarding abstinence. Vouchers, prizes for negative drug screens. Evidence-based for stimulants. (NIDA)",
    "category": "Leadership"
  },
  {
    "id": 334,
    "question": "The recovery model focuses on:",
    "options": [
      "Symptom elimination only",
      "Medication adherence versus non-adherence",
      "Hospitalization prevention",
      "Cure of mental illness"
    ],
    "correctAnswer": 1,
    "rationale": "12-step facilitation: structured approach to engage with AA/NA. Evidence-based, especially with mandated populations. Emphasizes disease model, powerlessness. (Research)",
    "category": "Recovery Model"
  },
  {
    "id": 335,
    "question": "Frontal lobe dementia is characterized by deficits in:",
    "options": [
      "Memory only",
      "Social skills",
      "Visual processing",
      "Motor function only"
    ],
    "correctAnswer": 1,
    "rationale": "SMART recovery: self-empowerment approach. Cognitive-behavioral foundation. Alternative to 12-step. 4-point program. (SMART)",
    "category": "Dementia Types"
  },
  {
    "id": 336,
    "question": "When going to work in a new clinic as an NP, what is the focus?",
    "options": [
      "Revenue generation",
      "Patient and family oriented",
      "Administrative tasks",
      "Marketing"
    ],
    "correctAnswer": 1,
    "rationale": "Relapse prevention: identify high-risk situations, develop coping strategies. Relapse part of recovery process. Problem-solve, don't give up. (Marlatt)",
    "category": "Professional Practice"
  },
  {
    "id": 337,
    "question": "What is the highest level of evidence for research?",
    "options": [
      "Expert opinion",
      "Advocate for access to evidence-based articles",
      "Case studies",
      "Cohort studies"
    ],
    "correctAnswer": 1,
    "rationale": "Urine drug screening: detects recent substance use. Know detection windows. Confirms abstinence, guides treatment. (SAMHSA)",
    "category": "Evidence-Based Practice"
  },
  {
    "id": 338,
    "question": "What development skill is expected in a toddler?",
    "options": [
      "Writing letters",
      "Developing peer traditions",
      "Abstract thinking",
      "Logical reasoning"
    ],
    "correctAnswer": 1,
    "rationale": "Drug detection windows: cannabis days-weeks (chronic use), cocaine 2-4 days, amphetamines 2-4 days, opioids 2-3 days, benzodiazepines 1-6 weeks (long-acting). (Toxicology)",
    "category": "Child Development"
  },
  {
    "id": 339,
    "question": "At what age is suicide risk highest?",
    "options": [
      "Under 18 years old",
      "83-year-old white male in assisted living",
      "25-35 years old",
      "40-50 years old"
    ],
    "correctAnswer": 1,
    "rationale": "False positive drug screen: cross-reactivity. Poppy seeds (opioids), pseudoephedrine (amphetamines), quinolones (opioids). Confirm with GC/MS. (Toxicology)",
    "category": "Suicide Risk"
  },
  {
    "id": 340,
    "question": "A patient with dyscopraxia can do all of the following EXCEPT:",
    "options": [
      "Dress themselves",
      "Coordinate care with herbalist and familiy",
      "Feed themselves",
      "Walk independently"
    ],
    "correctAnswer": 1,
    "rationale": "Pain management in addiction: legitimate pain deserves treatment. Use multimodal approach. Buprenorphine treats pain and addiction. (ASAM)",
    "category": "Neurological Disorders"
  },
  {
    "id": 341,
    "question": "What level of decreased TSH do you see in patients taking lithium?",
    "options": [
      "Increased TSH",
      "Decreased TSH (actually lithium typically causes hypothyroidism with increased TSH)",
      "Normal TSH",
      "Variable TSH"
    ],
    "correctAnswer": 0,
    "rationale": "Chronic pain and mental health: bidirectional relationship. Depression, anxiety worsen pain. Pain worsens mental health. Integrated treatment. (APA)",
    "category": "Lithium Monitoring"
  },
  {
    "id": 342,
    "question": "What is a crisis intervention for the APN regarding integrated care?",
    "options": [
      "Long-term therapy",
      "Integrated Care. ANS - Do not continue it with coordinated care",
      "Medication management only",
      "Hospitalization"
    ],
    "correctAnswer": 1,
    "rationale": "Opioid risk assessment: ORT (Opioid Risk Tool), SOAPP (Screener/Opioid Assessment for Patients with Pain). Identify high-risk patients. (Pain Medicine)",
    "category": "Crisis Intervention"
  },
  {
    "id": 343,
    "question": "When asked about time spent with patient, what is the appropriate code of ethics?",
    "options": [
      "Beneficence",
      "What process is this? Direct vs. Indirect (care) process",
      "Justice",
      "Autonomy"
    ],
    "correctAnswer": 1,
    "rationale": "Prescription drug monitoring program (PDMP): state database tracks controlled substance prescriptions. Check before prescribing. Identify doctor shopping. (State Law)",
    "category": "Professional Ethics"
  },
  {
    "id": 344,
    "question": "What is a standard of care according to professional guidelines?",
    "options": [
      "Personal preference",
      "Standard of care: What is it? Standard of care",
      "Local practice patterns",
      "Insurance requirements"
    ],
    "correctAnswer": 1,
    "rationale": "Informed consent for controlled substances: discuss risks (addiction, overdose, respiratory depression), benefits, alternatives. Document. (Medical Ethics/Law)",
    "category": "Standards of Care"
  },
  {
    "id": 345,
    "question": "In discrepancy screening, what is the focus?",
    "options": [
      "Medication compliance",
      "The discrepancy in the efficacy of bipolar treatment between children and adult is attributed to what factor? Use of mood stabilizers (Bipolar treatment)",
      "Diagnosis accuracy",
      "Treatment duration"
    ],
    "correctAnswer": 1,
    "rationale": "Controlled substance agreement: written document outlining expectations. Single prescriber, random drug screens, no early refills. (Pain Medicine)",
    "category": "Bipolar Disorder Treatment"
  },
  {
    "id": 346,
    "question": "For a female patient with bipolar disorder taking lithium, what is the first lab test to order?",
    "options": [
      "Complete blood count",
      "Pregnancy Test",
      "Liver function tests",
      "Thyroid function tests"
    ],
    "correctAnswer": 1,
    "rationale": "X-waiver eliminated 2023: all DEA-licensed prescribers can prescribe buprenorphine without special training requirement. Increases access. (Federal Law)",
    "category": "Lithium Monitoring"
  },
  {
    "id": 347,
    "question": "For someone taking Depakote, what is the most important lab to order?",
    "options": [
      "Complete blood count",
      "Serum Pregnanediol",
      "Kidney function",
      "Lipid panel"
    ],
    "correctAnswer": 1,
    "rationale": "Telehealth prescribing: expanded during COVID-19. Controlled substances require video (audio-only insufficient). State-specific regulations. (DEA/State Law)",
    "category": "Valproate Monitoring"
  },
  {
    "id": 348,
    "question": "The check EKG for ADHD stimulants is done in children with:",
    "options": [
      "All children starting stimulants",
      "Family history of cardiovascular disease",
      "Obesity only",
      "Learning disabilities"
    ],
    "correctAnswer": 1,
    "rationale": "Ryan Haight Act: restricts online prescribing controlled substances. In-person visit required unless exemptions. (Federal Law)",
    "category": "ADHD Treatment"
  },
  {
    "id": 349,
    "question": "What is the purpose of the bipolar treatment in medication adherence?",
    "options": [
      "Symptom control only",
      "Highest level of evidence - Medication adherence. Systematic literature review",
      "Prevent hospitalization only",
      "Weight management"
    ],
    "correctAnswer": 1,
    "rationale": "REMS programs: Risk Evaluation and Mitigation Strategy. FDA-required for high-risk medications (clozapine, esketamine, buprenorphine transmucosal). (FDA)",
    "category": "Bipolar Treatment"
  },
  {
    "id": 350,
    "question": "What type of medication causes depression in elderly patients?",
    "options": [
      "Antibiotics",
      "Hypothyroid - decreased TSH, increased TSH (Sleepy periods, cold intolerance, thick and dry skin)",
      "Antihypertensives",
      "Analgesics"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine REMS: monitor ANC. Registry enrollment required. Dispensing based on ANC results. Protects against agranulocytosis. (FDA)",
    "category": "Geriatric Depression"
  },
  {
    "id": 351,
    "question": "Tardive Dyskinesia is characterized by which symptom?",
    "options": [
      "Tremor at rest",
      "Repeated use of random and gross body - Involuntary and repetitive body movements, uncontrolled (e.g finger closes)",
      "Muscle rigidity",
      "Bradykinesia"
    ],
    "correctAnswer": 1,
    "rationale": "Esketamine REMS: administration in certified healthcare setting. Monitor 2 hours post-dose for sedation, dissociation, blood pressure. (FDA)",
    "category": "Movement Disorders"
  },
  {
    "id": 352,
    "question": "EKG with taking Geodon (due to QT prolongation). Ziprasidone?",
    "options": [
      "No monitoring needed",
      "EKG monitoring required",
      "Only blood pressure monitoring",
      "Only weight monitoring"
    ],
    "correctAnswer": 1,
    "rationale": "Prior authorization: insurance requirement before coverage. Common for expensive medications, controlled substances. Appeals process available. (Insurance)",
    "category": "Antipsychotic Monitoring"
  },
  {
    "id": 353,
    "question": "What is the Cause of Depression (Steroids, Accutane interferon)?",
    "options": [
      "Neurotransmitter depletion",
      "Medication-induced depression",
      "Vitamin deficiency",
      "Hormonal imbalance only"
    ],
    "correctAnswer": 1,
    "rationale": "Step therapy: insurance requires trying cheaper medication first. Common for antipsychotics, brand-name drugs. (Insurance)",
    "category": "Medication-Induced Depression"
  },
  {
    "id": 354,
    "question": "For Type 2 Diabetes, what is the 1st line medication?",
    "options": [
      "Insulin",
      "Metformin",
      "Sulfonylureas",
      "DPP-4 inhibitors"
    ],
    "correctAnswer": 1,
    "rationale": "Formulary: list of medications covered by insurance. Tiers affect cost. Generic tier 1, preferred brand tier 2, non-preferred tier 3, specialty tier 4. (Insurance)",
    "category": "Diabetes Management"
  },
  {
    "id": 355,
    "question": "What is the Mania induced medication (Steroids, NH, Antidepressants with Bipolar Disorder)?",
    "options": [
      "Lithium",
      "Steroids, INH, Antidepressants (SAID)",
      "Benzodiazepines",
      "Antipsychotics"
    ],
    "correctAnswer": 1,
    "rationale": "Patient assistance programs: pharmaceutical company programs provide free/reduced-cost medications. Application required, income limits. (Pharmaceutical)",
    "category": "Medication-Induced Mania"
  },
  {
    "id": 356,
    "question": "Cluster A personality disorders are characterized as:",
    "options": [
      "Dramatic, Histrionic, Narcissistic, borderline",
      "Odd, unusual, Schizr",
      "Anxious, OCPD, avoidant, dependent",
      "Impulsive and erratic"
    ],
    "correctAnswer": 1,
    "rationale": "340B program: federal program allows eligible healthcare organizations purchase outpatient drugs at reduced prices. Serves underserved populations. (HRSA)",
    "category": "Personality Disorders"
  },
  {
    "id": 357,
    "question": "Cluster B personality disorders include:",
    "options": [
      "Schizoid and paranoid",
      "Dramatic, Histrionic, Narcissistic, borderline",
      "Avoidant and dependent",
      "Obsessive-compulsive"
    ],
    "correctAnswer": 1,
    "rationale": "Medication adherence: only 50% take medications as prescribed. Cost, side effects, forgetfulness common barriers. Motivational interviewing helps. (WHO)",
    "category": "Personality Disorders"
  },
  {
    "id": 358,
    "question": "Cluster C personality disorders are characterized as:",
    "options": [
      "Odd and eccentric",
      "Anxious, OCPD, avoidant, dependent",
      "Dramatic and emotional",
      "Antisocial behaviors"
    ],
    "correctAnswer": 1,
    "rationale": "Teach-back method: ask patient explain back instructions. Assesses understanding, improves adherence. \"What will you tell your family?\" (Health Literacy)",
    "category": "Personality Disorders"
  },
  {
    "id": 359,
    "question": "Clozapine dosing recommendation is:",
    "options": [
      "Start high and maintain",
      "ANC > 950 - D/C med",
      "No monitoring needed",
      "Weekly labs indefinitely"
    ],
    "correctAnswer": 1,
    "rationale": "Pill organizers: weekly organizers improve adherence. Especially helpful for complex regimens, cognitive impairment. (Adherence Strategies)",
    "category": "Clozapine Monitoring"
  },
  {
    "id": 360,
    "question": "What brings a daughter and mother to therapy?",
    "options": [
      "Medication management",
      "Daughter brings mother in - Subclavicular firm",
      "Crisis intervention",
      "Family conflict"
    ],
    "correctAnswer": 1,
    "rationale": "Long-acting injectable antipsychotics: improve adherence. Address needle anxiety. Reduced relapse rates vs oral. (Research)",
    "category": "Medical Assessment"
  },
  {
    "id": 361,
    "question": "At risk for suicide in an elderly patient. What intervention should you do?",
    "options": [
      "Prescribe antidepressants only",
      "Suicide sigma - Provide school-based clinic",
      "Hospitalize immediately",
      "Weekly therapy only"
    ],
    "correctAnswer": 1,
    "rationale": "Therapeutic drug monitoring: measures medication blood levels. Guides dosing for lithium, valproate, carbamazepine, clozapine. (Pharmacology)",
    "category": "Suicide Prevention"
  },
  {
    "id": 362,
    "question": "Under what legal principle makes them more mental health and older sigma SUPPORT GROUPS?",
    "options": [
      "HIPAA",
      "Support groups for mental health and reducing stigma",
      "ADA",
      "EMTALA"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine levels: trough level 350-600 ng/mL therapeutic. Draw 12 hours post-dose. Higher levels if smoking. (Stahl's)",
    "category": "Mental Health Advocacy"
  },
  {
    "id": 363,
    "question": "What is osteoporosis management recommendation?",
    "options": [
      "Calcium supplements only",
      "Educate to keep up exercise and decrease caffeine",
      "Bed rest",
      "High protein diet only"
    ],
    "correctAnswer": 1,
    "rationale": "Carbamazepine levels: 4-12 mcg/mL therapeutic. Autoinduction occurs, levels decrease over 3-5 weeks. Adjust dose accordingly. (FDA)",
    "category": "Osteoporosis Management"
  },
  {
    "id": 364,
    "question": "What patient education regarding Old lady and SSRI?",
    "options": [
      "Take with food only",
      "Also use of exercise also use decrease of caffeine (lab) - DO NOT think it is discontinuation syndrome",
      "Increase fluid intake",
      "Take at bedtime"
    ],
    "correctAnswer": 1,
    "rationale": "Carbamazepine autoinduction: induces own metabolism. Levels drop after starting despite stable dose. May need dose increase after 2-4 weeks. (Pharmacology)",
    "category": "Geriatric Pharmacology"
  },
  {
    "id": 365,
    "question": "What statement is true about adolescents and ADHD screening?",
    "options": [
      "Screen all adolescents",
      "Adolescents - ADHD, educate parents - Screen adolescents at risk for ADHD",
      "No screening needed",
      "Only screen if failing school"
    ],
    "correctAnswer": 1,
    "rationale": "HLA-B*1502: genetic marker increases Stevens-Johnson syndrome risk with carbamazepine in Asians. Screen before starting. Avoid if positive. (FDA/CPIC)",
    "category": "ADHD Screening"
  },
  {
    "id": 366,
    "question": "A patient involved in social justice, religion campaigns, legal rights, gay right activism demonstrates which ethical principle?",
    "options": [
      "A. Social justice",
      "B. Autonomy",
      "C. Beneficence",
      "D. Non-maleficence"
    ],
    "correctAnswer": 0,
    "rationale": "Stevens-Johnson syndrome: life-threatening skin reaction. Blisters, skin sloughing, mucosal involvement. Stop medication immediately, hospitalize. (Medical Emergency)",
    "category": "Ethics"
  },
  {
    "id": 367,
    "question": "Is it possible to get a random sample if you are doing research on a preoperative patient where you have a treatment group and no treatment group?",
    "options": [
      "A. Yes, it is possible",
      "B. No, it is impossible to get a random sample",
      "C. Only with consent",
      "D. Only with IRB approval"
    ],
    "correctAnswer": 1,
    "rationale": "DRESS syndrome: drug reaction with eosinophilia and systemic symptoms. Rash, fever, lymphadenopathy, organ involvement. Anticonvulsants, allopurinol. (Medical)",
    "category": "Research"
  },
  {
    "id": 368,
    "question": "What is the highest level of evidence in research?",
    "options": [
      "A. Case studies",
      "B. Cohort studies",
      "C. Systematic reviews of RCTs",
      "D. Expert opinion"
    ],
    "correctAnswer": 2,
    "rationale": "Neuroleptic malignant syndrome vs serotonin syndrome: NMS develops over days, rigid, bradykinetic. SS develops over hours, hyperreflexic, myoclonic. (Differential Dx)",
    "category": "Research"
  },
  {
    "id": 369,
    "question": "You are opening a private practice and must calculate time spent with patients versus time on risk management. This is called:",
    "options": [
      "A. Direct versus indirect processes",
      "B. Indirect versus direct processes",
      "C. Patient care ratio",
      "D. Practice metrics"
    ],
    "correctAnswer": 1,
    "rationale": "NMS treatment: stop antipsychotic, supportive care (hydration, cooling). Dantrolene or bromocriptine if severe. ECT if refractory. (Medical Emergency)",
    "category": "Professional Practice"
  },
  {
    "id": 370,
    "question": "An NP is planning reforms in her community. How will the NP disseminate it?",
    "options": [
      "A. Journal publication",
      "B. Through a community meeting involving members from various cultures",
      "C. Social media campaign",
      "D. Through a journal"
    ],
    "correctAnswer": 1,
    "rationale": "Serotonin syndrome treatment: stop serotonergic agents, supportive care. Benzodiazepines for agitation. Cyproheptadine (serotonin antagonist) if severe. (Medical Emergency)",
    "category": "Professional Practice"
  },
  {
    "id": 371,
    "question": "You are to testify under oath. Patient attorney advises you not to disclose missed appointment sessions. Which ethical concern applies?",
    "options": [
      "A. Confidentiality",
      "B. Personal or professional integrity",
      "C. Legal immunity",
      "D. Patient rights"
    ],
    "correctAnswer": 1,
    "rationale": "Cyproheptadine: antihistamine, serotonin antagonist. Used for severe serotonin syndrome. 12mg initial, then 2mg every 2 hours. (Off-label)",
    "category": "Ethics"
  },
  {
    "id": 372,
    "question": "Three questions on Kava herbs - don't remember the questions",
    "options": [
      "A. Contraindicated with benzos",
      "B. Safe with all medications",
      "C. No side effects",
      "D. Increases energy"
    ],
    "correctAnswer": 0,
    "rationale": "Lithium-induced tremor: fine, rapid, postural. Dose-related. Propranolol 20-40mg helps. Distinguish from Parkinsonian tremor (resting). (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 373,
    "question": "You work in a rural clinic where minorities are not getting access to care. As an NP what do you do?",
    "options": [
      "A. Document only",
      "B. Lobby and get awareness through the media",
      "C. Ignore the issue",
      "D. Transfer patients"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium-induced diabetes insipidus: nephrogenic. Polyuria, polydipsia. Amiloride may help. Consider alternative mood stabilizer. (Endocrine)",
    "category": "Professional Practice"
  },
  {
    "id": 374,
    "question": "A mother reports her child being mad most of the time and presenting with temper tantrums. What is the diagnosis?",
    "options": [
      "A. ODD",
      "B. DMDD - Disruptive Mood Dysregulation Disorder",
      "C. Conduct disorder",
      "D. IED"
    ],
    "correctAnswer": 1,
    "rationale": "Amiloride for lithium polyuria: potassium-sparing diuretic. Blocks lithium entry into collecting duct cells. 5-10mg daily. (Off-label)",
    "category": "Child Psychiatry"
  },
  {
    "id": 375,
    "question": "You want to start a new consulting firm. What tool would show economic viability?",
    "options": [
      "A. Business plan",
      "B. Revenue and expenses analysis",
      "C. Market survey",
      "D. SWOT analysis"
    ],
    "correctAnswer": 1,
    "rationale": "Propranolol contraindications: asthma, COPD, heart block, hypotension. Beta-blocker. Use with caution in diabetes (masks hypoglycemia). (FDA)",
    "category": "Professional Practice"
  },
  {
    "id": 376,
    "question": "An outpatient program to support patients with chronic illness uses what approach?",
    "options": [
      "A. Inpatient care",
      "B. ACT - Assertive Community Treatment",
      "C. Standard outpatient",
      "D. Group therapy only"
    ],
    "correctAnswer": 1,
    "rationale": "Asthma and beta-blockers: avoid non-selective beta-blockers (propranolol). Can cause bronchospasm. Selective beta-1 blockers safer. (Medical)",
    "category": "Treatment Modalities"
  },
  {
    "id": 377,
    "question": "A question on appreciative inquiry - it focuses on:",
    "options": [
      "A. Problems",
      "B. Strengths and competencies",
      "C. Weaknesses",
      "D. Past failures"
    ],
    "correctAnswer": 1,
    "rationale": "Weight gain strategies: dietary counseling, exercise, switch to weight-neutral medication (aripiprazole, ziprasidone, lurasidone). Consider metformin. (APA)",
    "category": "Therapy Approaches"
  },
  {
    "id": 378,
    "question": "A question on just culture - Learning from experience",
    "options": [
      "A. Punishment focused",
      "B. Learning from experience",
      "C. Blame assignment",
      "D. Disciplinary action"
    ],
    "correctAnswer": 1,
    "rationale": "Metformin for antipsychotic weight gain: off-label. 500-1000mg BID. Evidence mixed but may prevent/reduce weight gain. (Research/Off-label)",
    "category": "Professional Practice"
  },
  {
    "id": 379,
    "question": "A patient complained they didn't add her to a clinical trial because they think she can't afford the medication. Which ethical principle is violated?",
    "options": [
      "A. Autonomy",
      "B. Beneficence",
      "C. Justice",
      "D. Non-maleficence"
    ],
    "correctAnswer": 2,
    "rationale": "Sexual dysfunction from SSRIs: decreased libido, anorgasmia, delayed ejaculation. Very common. Add bupropion, switch medications, or sildenafil. (Stahl's)",
    "category": "Ethics"
  },
  {
    "id": 380,
    "question": "Child tells you he is gay and tells you not to tell parents. What applies?",
    "options": [
      "A. Break confidentiality",
      "B. Don't tell - Parents right to know VS patient's privacy",
      "C. Tell parents immediately",
      "D. Ignore the disclosure"
    ],
    "correctAnswer": 1,
    "rationale": "Bupropion augmentation for SSRI sexual dysfunction: add 150-300mg. Dopamine/norepinephrine activity. May improve sexual function and antidepressant response. (Off-label)",
    "category": "Ethics"
  },
  {
    "id": 381,
    "question": "You go to court and judge pulls your EHR documentation about accountability. How is validity proven?",
    "options": [
      "A. Verbal testimony",
      "B. Authorization signature/electronic signature",
      "C. Witness confirmation",
      "D. Hospital records"
    ],
    "correctAnswer": 1,
    "rationale": "Sildenafil for SSRI sexual dysfunction: PDE5 inhibitor. 25-100mg before sexual activity. Effective for erectile dysfunction, some evidence for women. (Off-label)",
    "category": "Legal/Documentation"
  },
  {
    "id": 382,
    "question": "Tarasoff v. Regents of University of California case established what?",
    "options": [
      "A. Confidentiality rules",
      "B. Right to treatment",
      "C. Duty to warn a person who may be in danger from combative patient",
      "D. Informed consent"
    ],
    "correctAnswer": 2,
    "rationale": "Priapism management: medical emergency if >4 hours. Painful erection. Stop trazodone. Urology consultation immediately. Aspiration, phenylephrine injection. (Medical Emergency)",
    "category": "Legal/Ethics"
  },
  {
    "id": 383,
    "question": "A clinician discussed benefits and side effects after diagnosing, sent med order to pharmacy. What did he do wrong?",
    "options": [
      "A. Nothing wrong",
      "B. Didn't document",
      "C. Should have made the patient sign a consent form",
      "D. Wrong medication"
    ],
    "correctAnswer": 2,
    "rationale": "Orthostatic hypotension: common with TCAs, trazodone, quetiapine, clozapine. Check orthostatic vitals. Slow titration. Compression stockings, salt, fluids. (Medical)",
    "category": "Legal/Ethics"
  },
  {
    "id": 384,
    "question": "Patient getting information from the internet about symptoms. What should you tell them?",
    "options": [
      "A. Stop using internet",
      "B. Use only .gov sites",
      "C. Information has to be discussed and verified with provider",
      "D. Internet is always wrong"
    ],
    "correctAnswer": 2,
    "rationale": "Orthostatic vital signs: measure BP/HR supine, then standing after 1 and 3 minutes. Drop ≥20 systolic or ≥10 diastolic or HR increase ≥30 concerning. (Medical)",
    "category": "Patient Education"
  },
  {
    "id": 385,
    "question": "What would you assess in a patient taking Risperdal?",
    "options": [
      "A. Only blood sugar",
      "B. Waist circumference, hip to waist ratio, BMI or basal metabolic rate - NMS umbrella",
      "C. Only blood pressure",
      "D. Only weight"
    ],
    "correctAnswer": 1,
    "rationale": "Falls risk: anticholinergics, benzodiazepines, sedatives increase risk. Orthostatic hypotension. Particularly dangerous in elderly. Minimize use. (AGS/Beers)",
    "category": "Pharmacology"
  },
  {
    "id": 386,
    "question": "Three questions on MMSE. For severe cognition, scores were 17 and 18 (lowest). What indicates moderate cognitive impairment?",
    "options": [
      "A. 24-27",
      "B. 18-23",
      "C. 10-17",
      "D. 0-9"
    ],
    "correctAnswer": 1,
    "rationale": "Bone density: SSRIs associated with decreased bone density, increased fracture risk. Monitor in elderly, long-term use. Calcium, vitamin D supplementation. (Research)",
    "category": "Assessment"
  },
  {
    "id": 387,
    "question": "Patient diagnosed with Alzheimer's 3 years ago (MMSE 29), now MMSE is 26. How does NP handle this?",
    "options": [
      "A. Continue treatment",
      "B. Increase medications",
      "C. Reconsider the diagnosis of Alzheimer's dementia",
      "D. Refer to neurology"
    ],
    "correctAnswer": 2,
    "rationale": "Bleeding risk SSRIs: impair platelet aggregation. Increased GI bleeding risk, especially with NSAIDs. Use caution with anticoagulants. (FDA)",
    "category": "Diagnosis"
  },
  {
    "id": 388,
    "question": "Know that ACE inhibitors treat CHF",
    "options": [
      "A. True",
      "B. False",
      "C. Only for hypertension",
      "D. Only for diabetes"
    ],
    "correctAnswer": 0,
    "rationale": "SSRIs and NSAIDs: increased GI bleeding risk when combined. Consider PPI. Avoid if possible, especially in elderly. (Medical)",
    "category": "Pharmacology"
  },
  {
    "id": 389,
    "question": "Aggressive patient given benzo without effect. Which medication next to prevent prolonged restraints?",
    "options": [
      "A. Another benzo",
      "B. IM Geodon",
      "C. Oral medication",
      "D. Sedative"
    ],
    "correctAnswer": 1,
    "rationale": "Hyponatremia from SSRIs: SIADH. More common in elderly. Symptoms: confusion, falls, seizures. Check sodium if symptoms. (FDA/Medical)",
    "category": "Pharmacology"
  },
  {
    "id": 390,
    "question": "Young female on Depakote. What test does NP order?",
    "options": [
      "A. Pregnancy test only",
      "B. LFTs only",
      "C. CBC only",
      "D. All of the above"
    ],
    "correctAnswer": 3,
    "rationale": "Syndrome of inappropriate antidiuretic hormone (SIADH): dilutional hyponatremia. Low serum osmolality, high urine osmolality. Fluid restriction. (Medical)",
    "category": "Pharmacology"
  },
  {
    "id": 391,
    "question": "Patient on Risperdal for 10 months started on metoclopramide (Reglan). What should NP teach?",
    "options": [
      "A. Weight gain only",
      "B. Renal failure, TD, akathisia, EPS",
      "C. Hyperglycemia",
      "D. Hypertension"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine and smoking cessation: smoking induces CYP1A2. Quitting increases clozapine levels 2-fold. Reduce dose 25-50% when quit. Monitor levels, sedation, seizures. (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 392,
    "question": "SSRI and pantoprazole effect?",
    "options": [
      "A. Increased SSRI levels",
      "B. Decreased SSRI levels",
      "C. No interaction",
      "D. Serotonin syndrome"
    ],
    "correctAnswer": 0,
    "rationale": "Clozapine constipation: serious side effect. Can lead to obstruction, ileus, death. Prophylactic stool softeners, stimulant laxatives. Monitor bowel movements. (FDA Warning)",
    "category": "Pharmacology"
  },
  {
    "id": 393,
    "question": "Patient on lithium. What would NP worry about?",
    "options": [
      "A. Weight loss",
      "B. 4+ protein in urine",
      "C. Hyperglycemia",
      "D. Tachycardia"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine myocarditis: rare but serious. First month risk highest. Monitor for tachycardia, chest pain, flu-like symptoms. Check troponin, CRP, ECG if suspected. (FDA Warning)",
    "category": "Pharmacology"
  },
  {
    "id": 394,
    "question": "Pregnant woman on Zoloft, Accutane and other med. Which to discontinue?",
    "options": [
      "A. Zoloft",
      "B. Accutane because it is teratogenic",
      "C. Both",
      "D. Neither"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine cardiomyopathy: dilated cardiomyopathy. Can develop months-years into treatment. Monitor for dyspnea, edema. Echocardiogram if suspected. (FDA Warning)",
    "category": "Pharmacology"
  },
  {
    "id": 395,
    "question": "Phosphodiesterase 5 inhibitors used for erectile dysfunction. NP knows it's absorbed:",
    "options": [
      "A. Slowly",
      "B. Rapidly",
      "C. Not absorbed orally",
      "D. Partially"
    ],
    "correctAnswer": 1,
    "rationale": "Clozapine rechallenge after agranulocytosis: contraindicated. Risk of rapid severe agranulocytosis. Do not rechallenge. (FDA Black Box)",
    "category": "Pharmacology"
  },
  {
    "id": 396,
    "question": "Desmopressin (DDAVP) effect:",
    "options": [
      "A. Increases urine",
      "B. Makes less urine",
      "C. No effect",
      "D. Causes frequency"
    ],
    "correctAnswer": 1,
    "rationale": "ANC monitoring schedule clozapine: weekly 6 months, biweekly 6 months, then monthly. If ANC <1500, increase frequency. (FDA REMS)",
    "category": "Pharmacology"
  },
  {
    "id": 397,
    "question": "NP notices teenager with DKA leave without psych eval. What does NP do?",
    "options": [
      "A. Let them go",
      "B. Call security",
      "C. Collaborate with ER staff to provide psych history",
      "D. Document only"
    ],
    "correctAnswer": 2,
    "rationale": "ANC thresholds clozapine: green (≥1500), yellow (1000-1499), red (<1000). Red requires stop, do not rechallenge. (FDA REMS)",
    "category": "Professional Practice"
  },
  {
    "id": 398,
    "question": "There was a question on giving off-label med to a 10-year-old child. What should NP do?",
    "options": [
      "A. Don't prescribe",
      "B. NP gave full disclosure to the child's guardian",
      "C. Get second opinion",
      "D. Prescribe anyway"
    ],
    "correctAnswer": 1,
    "rationale": "Benign ethnic neutropenia: lower baseline ANC in some populations (African, Middle Eastern). Adjusted thresholds allow clozapine use. (FDA REMS)",
    "category": "Ethics/Legal"
  },
  {
    "id": 399,
    "question": "Know serotonin syndrome symptoms, treatment, and NMS labs",
    "options": [
      "A. Bradycardia, hypothermia",
      "B. Muscle rigidity, fever, altered mental status",
      "C. Hypotension",
      "D. Decreased reflexes"
    ],
    "correctAnswer": 1,
    "rationale": "Lurasidone food requirement: take with ≥350 calories. Absorption significantly reduced without food. Efficacy depends on adequate levels. (FDA)",
    "category": "Medical Emergencies"
  },
  {
    "id": 400,
    "question": "Person with EPS will most likely experience:",
    "options": [
      "A. Weight gain",
      "B. TD (Tardive Dyskinesia)",
      "C. Hyperglycemia",
      "D. Sedation"
    ],
    "correctAnswer": 1,
    "rationale": "Ziprasidone food requirement: take with food (500 calories). Doubles absorption. Reduced efficacy if not taken with meals. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 401,
    "question": "Native American patient adamant about keeping healing stick but staff disagreed, patient in restraints. What does PMHNP do?",
    "options": [
      "A. Support staff",
      "B. Remove restraints only",
      "C. Teaches cultural competency to staff",
      "D. Discharge patient"
    ],
    "correctAnswer": 2,
    "rationale": "Paliperidone renal dosing: renally eliminated. Reduce dose if CrCl <50. Extended-release formulation not for severe impairment. (FDA)",
    "category": "Cultural Competence"
  },
  {
    "id": 402,
    "question": "Hispanic patient lost parent, has depression and stomach ache PCP couldn't fix. What do you do?",
    "options": [
      "A. Refer to GI",
      "B. Order tests",
      "C. Validate experience and provide culturally specific care",
      "D. Prescribe antacid"
    ],
    "correctAnswer": 2,
    "rationale": "Lithium and ACE inhibitors: ACE inhibitors increase lithium levels. ARBs also increase. Monitor levels closely. May need lithium dose reduction. (Drug Interaction)",
    "category": "Cultural Competence"
  },
  {
    "id": 403,
    "question": "Know the part of brain responsible for impulsivity in ADHD:",
    "options": [
      "A. Hippocampus",
      "B. Prefrontal cortex/Orbitofrontal",
      "C. Amygdala",
      "D. Cerebellum"
    ],
    "correctAnswer": 1,
    "rationale": "Lithium and thiazide diuretics: thiazides increase lithium levels significantly. Avoid combination. Loop diuretics safer alternative. (Drug Interaction)",
    "category": "Neurobiology"
  },
  {
    "id": 404,
    "question": "Review eating disorders - anorexia, bulimia, binge eating. Know the weight needed for hospitalization.",
    "options": [
      "A. BMI <15",
      "B. BMI <17.5",
      "C. BMI <18.5",
      "D. Any weight with medical instability"
    ],
    "correctAnswer": 3,
    "rationale": "Lithium and NSAIDs: NSAIDs (except aspirin) increase lithium levels by reducing renal clearance. Monitor. Acetaminophen safer alternative. (Drug Interaction)",
    "category": "Eating Disorders"
  },
  {
    "id": 405,
    "question": "Question on autistic child not following instruction. What brain part affected?",
    "options": [
      "A. Frontal lobe",
      "B. Mirror neuron - brain parts: Amygdala, hippocampus, basal ganglia, parietal",
      "C. Temporal lobe",
      "D. Occipital lobe"
    ],
    "correctAnswer": 1,
    "rationale": "Fluoxetine and tamoxifen: fluoxetine inhibits CYP2D6, reduces tamoxifen efficacy. Tamoxifen is prodrug. Avoid combination in breast cancer. (Drug Interaction/FDA)",
    "category": "Neurobiology"
  },
  {
    "id": 406,
    "question": "Question about osteoporosis prevention:",
    "options": [
      "A. Calcium only",
      "B. Weight bearing exercise and decrease smoking",
      "C. Medication only",
      "D. Vitamin D only"
    ],
    "correctAnswer": 1,
    "rationale": "SSRIs and tamoxifen: paroxetine and fluoxetine strong CYP2D6 inhibitors, avoid with tamoxifen. Citalopram, escitalopram, sertraline safer alternatives. (Drug Interaction)",
    "category": "Health Promotion"
  },
  {
    "id": 407,
    "question": "What part of brain controls clock drawing:",
    "options": [
      "A. Left hemisphere",
      "B. Dorsolateral, Right hemisphere",
      "C. Frontal only",
      "D. Parietal only"
    ],
    "correctAnswer": 1,
    "rationale": "Carbamazepine and oral contraceptives: carbamazepine reduces contraceptive efficacy. Use barrier method or alternative contraception. (Drug Interaction)",
    "category": "Neurobiology"
  },
  {
    "id": 408,
    "question": "Question on dissemination - options like peer review, newspaper research:",
    "options": [
      "A. Social media",
      "B. Peer review journals",
      "C. Newspaper",
      "D. Conference only"
    ],
    "correctAnswer": 1,
    "rationale": "Enzyme inducers and contraceptives: carbamazepine, oxcarbazepine, topiramate reduce contraceptive efficacy. Use higher dose or alternative method. (Drug Interaction)",
    "category": "Research"
  },
  {
    "id": 409,
    "question": "Know meta-analyses and levels of evidence-based articles",
    "options": [
      "A. Case reports highest",
      "B. Meta-analyses/systematic reviews highest",
      "C. Expert opinion highest",
      "D. All equal"
    ],
    "correctAnswer": 1,
    "rationale": "Warfarin drug interactions: many psychiatric medications interact. SSRIs increase bleeding risk. Monitor INR closely with any changes. (Drug Interaction)",
    "category": "Research"
  },
  {
    "id": 410,
    "question": "Question about pregnant patient - which medication can cause birth defect:",
    "options": [
      "A. Acetaminophen",
      "B. Accutane",
      "C. Prenatal vitamins",
      "D. Folic acid"
    ],
    "correctAnswer": 1,
    "rationale": "Lamotrigine and valproate: valproate doubles lamotrigine levels. Reduce lamotrigine dose 50% when combined. Titrate even slower. (Drug Interaction/FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 411,
    "question": "Child on amphetamine develops tics - which medication to switch to:",
    "options": [
      "A. Different stimulant",
      "B. Options: Adderall, Ritalin, Methamphetamine, Guanfacine",
      "C. Antipsychotic",
      "D. SSRI"
    ],
    "correctAnswer": 1,
    "rationale": "Lamotrigine and oral contraceptives: contraceptives reduce lamotrigine levels 50%. May need higher lamotrigine dose. Levels fluctuate with pill-free week. (Drug Interaction)",
    "category": "Pharmacology"
  },
  {
    "id": 412,
    "question": "Depressed lady with marital conflicts wants therapy for 3-4 or 4-6 months. What therapy?",
    "options": [
      "A. Psychoanalysis",
      "B. Options: exposure, interpersonal, psychodynamic therapy",
      "C. CBT only",
      "D. Medication only"
    ],
    "correctAnswer": 1,
    "rationale": "Lamotrigine rash: 10% develop benign rash, 0.1% serious (SJS/TEN). Slow titration reduces risk. Stop if fever, lymphadenopathy, mucosal involvement. (FDA)",
    "category": "Therapy Approaches"
  },
  {
    "id": 413,
    "question": "Child on amphetamine develops tics. Which medication will you switch to?",
    "options": [
      "A. Adderall",
      "B. Ritalin",
      "C. Methamphetamine",
      "D. Guanfacine"
    ],
    "correctAnswer": 3,
    "rationale": "Lamotrigine titration: start 25mg daily, increase slowly. Faster with valproate (12.5mg). Slower with enzyme inducers. Follow titration schedule strictly. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 414,
    "question": "Young lady concerned about weight, doesn't want weight-gain medication. Which to prescribe:",
    "options": [
      "A. Trileptal",
      "B. Lithium",
      "C. Zyprexa",
      "D. Lamictal"
    ],
    "correctAnswer": 3,
    "rationale": "Quetiapine and CYP3A4 inhibitors: inhibitors increase quetiapine levels significantly. Reduce quetiapine dose to 1/6 with strong inhibitors. (Drug Interaction/FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 415,
    "question": "Which therapy for PTSD:",
    "options": [
      "A. Psychodynamic only",
      "B. EMDR, exposure therapy, image rehearsal",
      "C. CBT only",
      "D. Medication only"
    ],
    "correctAnswer": 1,
    "rationale": "Lurasidone and CYP3A4: strong 3A4 inhibitors contraindicated (ketoconazole, clarithromycin). Moderate inhibitors require dose reduction. Strong inducers contraindicated. (FDA)",
    "category": "Therapy Approaches"
  },
  {
    "id": 416,
    "question": "Patient withdrawing from alcohol with hepatic problem. Know signs/symptoms:",
    "options": [
      "A. Bradycardia",
      "B. Give IM Ativan",
      "C. Tremors, sweating, seizures",
      "D. Hypotension"
    ],
    "correctAnswer": 2,
    "rationale": "Pimozide drug interactions: contraindicated with CYP3A4 inhibitors, QTc-prolonging drugs. Narrow therapeutic index. (FDA Black Box)",
    "category": "Substance Use"
  },
  {
    "id": 417,
    "question": "What score on CIWA do you give Benzo:",
    "options": [
      "A. Score 5",
      "B. Score 8 start PRN, 15 scheduled with 2-hour assessment",
      "C. Any score",
      "D. Score 20"
    ],
    "correctAnswer": 1,
    "rationale": "Thioridazine QTc prolongation: dose-related QTc prolongation. Torsades risk. Reserved for treatment-resistant schizophrenia. ECG monitoring required. (FDA Black Box)",
    "category": "Substance Use"
  },
  {
    "id": 418,
    "question": "20-year-old says 'I cannot make friend, nobody likes me.' What Erickson stage:",
    "options": [
      "A. Identity vs role confusion (12-20: 6-12 Industry vs inferiority)",
      "B. Intimacy vs isolation",
      "C. Generativity vs stagnation",
      "D. Trust vs mistrust"
    ],
    "correctAnswer": 0,
    "rationale": "Citalopram dose limit: 40mg maximum (20mg if >60 years, CYP2C19 poor metabolizers, CYP2C19 inhibitors). QTc prolongation. (FDA)",
    "category": "Developmental Psychology"
  },
  {
    "id": 419,
    "question": "8-year-old plays with two toys having sex. What does NP do:",
    "options": [
      "A. Ignore",
      "B. Call CPS",
      "C. Observe more",
      "D. Talk to parents first"
    ],
    "correctAnswer": 1,
    "rationale": "Citalopram vs escitalopram: escitalopram no dose limit. S-enantiomer of citalopram. Often preferred due to citalopram restrictions. (FDA/Pharmacology)",
    "category": "Child Protection"
  },
  {
    "id": 420,
    "question": "Lamictal is ideal for preventing weight gain (mood stabilizer):",
    "options": [
      "A. True",
      "B. False",
      "C. Only short-term",
      "D. Depends on dose"
    ],
    "correctAnswer": 0,
    "rationale": "Aripiprazole partial agonism: stabilizes dopamine. Reduces activity when high, increases when low. Lower side effects. (Stahl's)",
    "category": "Pharmacology"
  },
  {
    "id": 421,
    "question": "Giving patient Tegretol and erythromycin. You will:",
    "options": [
      "A. Increase Tegretol",
      "B. Decrease Tegretol",
      "C. No change",
      "D. Stop erythromycin"
    ],
    "correctAnswer": 1,
    "rationale": "Brexpiprazole: partial dopamine agonist similar to aripiprazole. Approved schizophrenia, adjunct depression. Lower akathisia than aripiprazole. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 422,
    "question": "PMHNP doing medication reconciliation should know ACE inhibitors used for:",
    "options": [
      "A. Diabetes only",
      "B. Cardiac/heart failure",
      "C. Depression",
      "D. Hypertension only"
    ],
    "correctAnswer": 1,
    "rationale": "Cariprazine: dopamine partial agonist, D3 preferring. FDA-approved schizophrenia, bipolar mania, bipolar depression. Long half-life (weeks). (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 423,
    "question": "Question on Desmopressin - how NP assesses mother's understanding:",
    "options": [
      "A. Increases urination",
      "B. Mom will say it decreases urine production",
      "C. Improves sleep",
      "D. Increases appetite"
    ],
    "correctAnswer": 1,
    "rationale": "Cariprazine long half-life: active metabolite half-life 1-3 weeks. Takes 8 weeks steady state. Effects persist after discontinuation. (Pharmacology)",
    "category": "Patient Education"
  },
  {
    "id": 424,
    "question": "Appreciative inquiry - focuses on strength and hope, doesn't blame:",
    "options": [
      "A. True",
      "B. False",
      "C. Focuses on problems",
      "D. Blames systems"
    ],
    "correctAnswer": 0,
    "rationale": "Lumateperone (Caplyta): serotonin, dopamine, glutamate modulator. FDA-approved schizophrenia, bipolar depression. Low side effects. (FDA)",
    "category": "Professional Practice"
  },
  {
    "id": 425,
    "question": "Recovery model - gives hope to patient:",
    "options": [
      "A. True",
      "B. False",
      "C. Cure-focused only",
      "D. Medical model"
    ],
    "correctAnswer": 0,
    "rationale": "Pimavanserin: selective 5-HT2A inverse agonist. FDA-approved Parkinson's disease psychosis. No worsening motor symptoms. (FDA)",
    "category": "Treatment Philosophy"
  },
  {
    "id": 426,
    "question": "Family therapy question - Triangulation/Self-differentiation:",
    "options": [
      "A. Individual therapy",
      "B. Bowen family systems concepts",
      "C. Behavioral therapy",
      "D. Medication focus"
    ],
    "correctAnswer": 1,
    "rationale": "Parkinson's disease psychosis: dopamine replacement causes psychosis. Typical antipsychotics worsen parkinsonism. Pimavanserin, quetiapine, clozapine options. (APA/FDA)",
    "category": "Therapy Approaches"
  },
  {
    "id": 427,
    "question": "Know brain parts - Executive function:",
    "options": [
      "A. Hippocampus",
      "B. Dorsolateral prefrontal cortex",
      "C. Amygdala",
      "D. Cerebellum"
    ],
    "correctAnswer": 1,
    "rationale": "Antipsychotics in Parkinson's: most worsen motor symptoms (dopamine blockade). Pimavanserin first-line. Quetiapine weak D2 blockade. Clozapine effective but monitoring. (APA)",
    "category": "Neurobiology"
  },
  {
    "id": 428,
    "question": "Know what part of brain controls aggression:",
    "options": [
      "A. Frontal lobe",
      "B. Amygdala (anxiety by hippocampus)",
      "C. Parietal lobe",
      "D. Occipital lobe"
    ],
    "correctAnswer": 1,
    "rationale": "Valbenazine: VMAT2 inhibitor. FDA-approved tardive dyskinesia. Reduces abnormal movements. Once daily dosing. (FDA)",
    "category": "Neurobiology"
  },
  {
    "id": 429,
    "question": "What medication for acute dystonia (stiff neck):",
    "options": [
      "A. Anticholinergic",
      "B. Benztropine (Cogentin)",
      "C. Benadryl",
      "D. All of the above"
    ],
    "correctAnswer": 3,
    "rationale": "Deutetrabenazine: VMAT2 inhibitor. FDA-approved tardive dyskinesia, Huntington's chorea. Twice daily dosing. Depression risk. (FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 430,
    "question": "Kava Kava - which medication contraindicated:",
    "options": [
      "A. Aspirin",
      "B. No Benzo",
      "C. Antidepressants",
      "D. Antibiotics"
    ],
    "correctAnswer": 1,
    "rationale": "Tardive dyskinesia treatment: stop offending agent if possible. Switch to clozapine (lower TD risk). VMAT2 inhibitors (valbenazine, deutetrabenazine). (APA/FDA)",
    "category": "Pharmacology"
  },
  {
    "id": 431,
    "question": "Patient taking Kava Kava. What to educate about:",
    "options": [
      "A. Weight gain",
      "B. Hepatotoxicity",
      "C. Renal failure",
      "D. Cardiac effects"
    ],
    "correctAnswer": 1,
    "rationale": "VMAT2 inhibitors mechanism: reduce dopamine release. Effective for hyperkinetic movement disorders. Don't treat underlying psychosis. (Pharmacology)",
    "category": "Patient Education"
  },
  {
    "id": 432,
    "question": "How do you treat fibromyalgia:",
    "options": [
      "A. NSAIDs only",
      "B. Give Benzo",
      "C. TCAs, SNRIs",
      "D. Steroids"
    ],
    "correctAnswer": 2,
    "rationale": "Huntington's disease: genetic neurodegenerative disorder. Chorea, psychiatric symptoms, dementia. Tetrabenazine for chorea. Supportive psych treatment. (Neurology)",
    "category": "Pharmacology"
  },
  {
    "id": 433,
    "question": "Man says wife died and uses which defense mechanism:",
    "options": [
      "A. Denial",
      "B. Idealization",
      "C. Projection",
      "D. Regression"
    ],
    "correctAnswer": 1,
    "rationale": "Wilson's disease: copper accumulation. Psychiatric symptoms common (mood, psychosis, personality change). Kayser-Fleischer rings. Chelation therapy. (Neurology)",
    "category": "Psychology"
  },
  {
    "id": 434,
    "question": "Patient on Risperdal - how assess for metabolic syndrome:",
    "options": [
      "A. Weight only",
      "B. Measure hip to waist circumference",
      "C. Blood pressure only",
      "D. Blood sugar only"
    ],
    "correctAnswer": 1,
    "rationale": "Neuropsychiatric lupus: CNS involvement in SLE. Psychosis, depression, cognitive impairment. Immunosuppression treats underlying disease. (Rheumatology)",
    "category": "Assessment"
  },
  {
    "id": 435,
    "question": "Patient on lithium taking Indocin/Mobic (Meloxicam) for back pain. What is NP concerned about:",
    "options": [
      "A. No interaction",
      "B. Decrease lithium dose (Indocin is NSAID which increases lithium level)",
      "C. Increase lithium",
      "D. Stop Indocin only"
    ],
    "correctAnswer": 1,
    "rationale": "Multiple sclerosis: demyelinating disease. Depression, cognitive impairment, fatigue common. Treat psychiatric symptoms. DMTs for MS. (Neurology)",
    "category": "Pharmacology"
  },
  {
    "id": 436,
    "question": "Know MMSE - Difference between thought process and thought content:",
    "options": [
      "A. Same thing",
      "B. Process is how thoughts flow, content is what thoughts are about",
      "C. No difference",
      "D. Only content matters"
    ],
    "correctAnswer": 1,
    "rationale": "Traumatic brain injury: depression, anxiety, cognitive impairment, personality changes common. Avoid medications lowering seizure threshold. (Neurology/Rehab)",
    "category": "Assessment"
  },
  {
    "id": 437,
    "question": "Know where to document on MMSE patient wanting to commit suicide:",
    "options": [
      "A. Mood section",
      "B. Thought content",
      "C. Thought process",
      "D. Behavior section"
    ],
    "correctAnswer": 1,
    "rationale": "Postconcussion syndrome: persistent symptoms after mild TBI. Headache, dizziness, concentration problems, mood changes. Reassurance, gradual return to activity. (Neurology)",
    "category": "Documentation"
  },
  {
    "id": 438,
    "question": "Reglan can cause:",
    "options": [
      "A. Weight loss",
      "B. Tardive dyskinesia",
      "C. Hyperglycemia",
      "D. Hypertension"
    ],
    "correctAnswer": 1,
    "rationale": "Seizure disorder and psychiatry: higher rates depression, anxiety. Some psych medications lower seizure threshold. Bupropion, clozapine avoid in uncontrolled seizures. (Neurology)",
    "category": "Pharmacology"
  },
  {
    "id": 439,
    "question": "Serial 7 counting down from 100. What assessing:",
    "options": [
      "A. Memory",
      "B. Concentration and attention",
      "C. Language",
      "D. Mood"
    ],
    "correctAnswer": 1,
    "rationale": "Seizure threshold: bupropion, clozapine, TCAs lower threshold. Use cautiously. Start low, titrate slow. Avoid in seizure disorder. (Neurology)",
    "category": "Assessment"
  },
  {
    "id": 440,
    "question": "Child with weight loss, irritability, increased energy. What to assess:",
    "options": [
      "A. Depression",
      "B. Check lead level",
      "C. ADHD",
      "D. Anxiety"
    ],
    "correctAnswer": 1,
    "rationale": "Brain tumors: personality changes, mood symptoms, cognitive decline. Consider neuroimaging for atypical presentations, focal findings. (Neurology)",
    "category": "Pediatric Assessment"
  },
  {
    "id": 441,
    "question": "How assess patient with thought disorder:",
    "options": [
      "A. Yes/no questions",
      "B. Have patient do proverb interpretation/abstract thinking",
      "C. MMSE",
      "D. Depression scale"
    ],
    "correctAnswer": 1,
    "rationale": "CNS infections: HSV encephalitis, neurosyphilis, HIV can present with psychiatric symptoms. Fever, focal findings, rapid onset warrant workup. (Infectious Disease)",
    "category": "Assessment"
  },
  {
    "id": 442,
    "question": "How prevent ODD from becoming conduct disorder:",
    "options": [
      "A. Medication",
      "B. Teach parenting skills/behavior therapy",
      "C. Punishment",
      "D. Ignoring behaviors"
    ],
    "correctAnswer": 1,
    "rationale": "Autoimmune encephalitis: anti-NMDA receptor most common. Psychosis, seizures, movement disorder, autonomic instability. Young women, may follow ovarian teratoma. (Neurology)",
    "category": "Prevention"
  },
  {
    "id": 443,
    "question": "What medication for patient with acute dystonia (stiff neck):",
    "options": [
      "A. Antipsychotic",
      "B. Benztropine (Cogentin)",
      "C. SSRI",
      "D. Mood stabilizer"
    ],
    "correctAnswer": 1,
    "rationale": "Anti-NMDA receptor encephalitis: psychiatric symptoms often first. Psychosis, catatonia. CSF antibodies. Immunotherapy effective. (Neurology)",
    "category": "Pharmacology"
  },
  {
    "id": 444,
    "question": "Patient taking Kava - educate about:",
    "options": [
      "A. Weight changes",
      "B. Hepatotoxicity",
      "C. Renal effects",
      "D. Cardiac effects"
    ],
    "correctAnswer": 1,
    "rationale": "Cushing's syndrome: hypercortisolism. Depression, anxiety, psychosis, mania. Central obesity, striae, hypertension. Treat underlying cause. (Endocrinology)",
    "category": "Patient Education"
  },
  {
    "id": 445,
    "question": "Patient on Kava - what medication to avoid:",
    "options": [
      "A. Antibiotics",
      "B. Benzodiazepine",
      "C. Antihypertensives",
      "D. Antihistamines"
    ],
    "correctAnswer": 1,
    "rationale": "Addison's disease: adrenal insufficiency. Fatigue, depression, cognitive impairment. Hypotension, hyperpigmentation, hyponatremia. Hormone replacement. (Endocrinology)",
    "category": "Pharmacology"
  },
  {
    "id": 446,
    "question": "Child is an inpatient and parents have concerns of behavioral problem after discharge. What should the NP do?",
    "options": [
      "A. Discharge as planned",
      "B. Start teaching parents on behavior technique upon admission",
      "C. Wait until discharge",
      "D. Refer to outpatient"
    ],
    "correctAnswer": 1,
    "rationale": "Hyperthyroidism: anxiety, agitation, tremor, insomnia, mania-like presentation. Weight loss, tachycardia, heat intolerance. Treat thyroid. (Endocrinology)",
    "category": "Professional Practice"
  },
  {
    "id": 447,
    "question": "Antisocial personality disorder - what risk?",
    "options": [
      "A. Depression",
      "B. High risk for homicide",
      "C. Anxiety",
      "D. Psychosis"
    ],
    "correctAnswer": 1,
    "rationale": "Hypothyroidism: depression, fatigue, cognitive slowing, weight gain. Cold intolerance, constipation. Thyroid replacement. Adjunct in refractory depression. (Endocrinology)",
    "category": "Risk Assessment"
  },
  {
    "id": 448,
    "question": "Subtracting 7 from 100 until asked to stop - testing for:",
    "options": [
      "A. Memory",
      "B. Concentration",
      "C. Language",
      "D. Judgment"
    ],
    "correctAnswer": 1,
    "rationale": "T3 augmentation: liothyronine 25-50mcg adjunct to antidepressant. May enhance response in refractory depression. Monitor thyroid function. (APA/Endocrinology)",
    "category": "Assessment"
  },
  {
    "id": 449,
    "question": "HIV dementia early signs:",
    "options": [
      "A. Memory loss",
      "B. Problem with concentration - no option as cognitive impairment",
      "C. Hallucinations",
      "D. Delusions"
    ],
    "correctAnswer": 1,
    "rationale": "Hyperparathyroidism: elevated calcium. Depression, fatigue, cognitive impairment. \"Stones, bones, abdominal groans, psychiatric overtones.\" Parathyroidectomy. (Endocrinology)",
    "category": "Medical Conditions"
  },
  {
    "id": 450,
    "question": "Question about pseudo dementia:",
    "options": [
      "A. Progressive decline",
      "B. Reversible with treatment of depression",
      "C. Irreversible",
      "D. No cognitive changes"
    ],
    "correctAnswer": 1,
    "rationale": "Hypercalcemia: confusion, depression, psychosis. Check calcium if psychiatric symptoms, kidney stones, osteoporosis. (Endocrinology)",
    "category": "Diagnosis"
  },
  {
    "id": 451,
    "question": "Person at risk for suicide:",
    "options": [
      "A. Young female",
      "B. 65-year-old white man, single",
      "C. Married middle-aged man",
      "D. Adolescent female"
    ],
    "correctAnswer": 1,
    "rationale": "Vitamin B12 deficiency: depression, psychosis, cognitive impairment, neuropathy. Macrocytic anemia. Supplement. Irreversible damage if prolonged. (Hematology)",
    "category": "Risk Assessment"
  },
  {
    "id": 452,
    "question": "New onset bipolar in adolescent. What to do?",
    "options": [
      "A. Start medication immediately",
      "B. Educate patient and parents",
      "C. Hospitalize",
      "D. Psychotherapy only"
    ],
    "correctAnswer": 1,
    "rationale": "Folate deficiency: similar to B12 deficiency. Depression, cognitive impairment, macrocytic anemia. Supplement. Check B12 simultaneously. (Hematology)",
    "category": "Patient Education"
  },
  {
    "id": 453,
    "question": "Patient shouts that she was raped. What does NP do?",
    "options": [
      "A. Call police immediately",
      "B. Reassure her that she is in a safe environment",
      "C. Continue appointment",
      "D. Refer to ER"
    ],
    "correctAnswer": 1,
    "rationale": "Thiamine deficiency: Wernicke-Korsakoff syndrome in alcoholics. Confusion, ataxia, ophthalmoplegia, anterograde amnesia. Thiamine urgently before glucose. (Neurology)",
    "category": "Crisis Intervention"
  },
  {
    "id": 454,
    "question": "Discrepancy of clinical trials of depressive meds between children and adults - children with depression have:",
    "options": [
      "A. Better response than adults",
      "B. Reduced placebo rate when compared to adults",
      "C. Same response as adults",
      "D. Worse response than adults"
    ],
    "correctAnswer": 1,
    "rationale": "Wernicke encephalopathy: acute thiamine deficiency. Confusion, ataxia, ophthalmoplegia. Medical emergency. Thiamine 500mg IV TID 3 days, then 250mg daily. (Medical Emergency)",
    "category": "Research/Pharmacology"
  },
  {
    "id": 455,
    "question": "EPS:",
    "options": [
      "A. Only with first-generation antipsychotics",
      "B. Nigrostriatal pathway",
      "C. Only with clozapine",
      "D. No pathway involvement"
    ],
    "correctAnswer": 1,
    "rationale": "Korsakoff syndrome: chronic sequela of Wernicke. Anterograde amnesia, confabulation. Partially reversible with thiamine, most have residual deficits. (Neurology)",
    "category": "Neurobiology"
  },
  {
    "id": 456,
    "question": "Thought disorder in patient with schizophrenia. What to do?",
    "options": [
      "A. Increase medication",
      "B. Ask meaning of a proverb",
      "C. Start new medication",
      "D. Hospitalize"
    ],
    "correctAnswer": 1,
    "rationale": "Pernicious anemia: B12 deficiency from lack intrinsic factor. Autoimmune. Neuropsychiatric symptoms. Requires B12 injections. (Hematology)",
    "category": "Assessment"
  },
  {
    "id": 457,
    "question": "Child fearful and worried about dying after shooting incident in area:",
    "options": [
      "A. PTSD",
      "B. GAD - Acute stress disorder was also answer choice",
      "C. Social anxiety",
      "D. Specific phobia"
    ],
    "correctAnswer": 1,
    "rationale": "Hepatic encephalopathy: confusion, personality changes, asterixis. Liver disease. Elevated ammonia. Lactulose, rifaximin. Avoid hepatotoxic medications. (Hepatology)",
    "category": "Diagnosis"
  },
  {
    "id": 458,
    "question": "Child see monsters in dreams:",
    "options": [
      "A. Psychosis",
      "B. Normal for 4-year-old child",
      "C. PTSD",
      "D. Anxiety disorder"
    ],
    "correctAnswer": 1,
    "rationale": "Cirrhosis and medications: reduced hepatic metabolism. Avoid valproate, TCAs. Start low, increase cautiously. Benzos with no active metabolites (lorazepam, oxazepam, temazepam). (Hepatology)",
    "category": "Development"
  },
  {
    "id": 459,
    "question": "Patient wakes up screaming at night and consoled before going back to sleep:",
    "options": [
      "A. Nightmares",
      "B. Ask family if anyone else in family has sleep problem",
      "C. Sleep terror disorder",
      "D. Insomnia"
    ],
    "correctAnswer": 1,
    "rationale": "Renal failure and medications: adjust for GFR. Lithium eliminated renally, avoid in severe renal impairment. Gabapentin, duloxetine need adjustment. (Nephrology)",
    "category": "Assessment"
  },
  {
    "id": 460,
    "question": "Veteran came home from Afghanistan, friend died in war. Not distressed but gets sad remembering event:",
    "options": [
      "A. PTSD",
      "B. Should seek supportive therapy and go back to pre-war activities",
      "C. Major depression",
      "D. Adjustment disorder"
    ],
    "correctAnswer": 1,
    "rationale": "Dialysis and medications: variable removal. Lithium removed by dialysis, dose after dialysis. Most psychotropics protein-bound, not removed. (Nephrology)",
    "category": "Treatment"
  },
  {
    "id": 461,
    "question": "Patient diagnosed with herpes within 3 weeks:",
    "options": [
      "A. PTSD",
      "B. Adjustment disorder",
      "C. Acute stress disorder",
      "D. GAD"
    ],
    "correctAnswer": 1,
    "rationale": "Pregnancy categories outdated: FDA changed to narrative system 2015. Weigh risks/benefits individually. Untreated illness poses risks. (FDA/ACOG)",
    "category": "Diagnosis"
  },
  {
    "id": 462,
    "question": "Nurse attacked at work by patient 3 weeks ago, now scared to go back to work. What does she have?",
    "options": [
      "A. PTSD",
      "B. Acute stress disorder",
      "C. GAD",
      "D. Phobia"
    ],
    "correctAnswer": 1,
    "rationale": "Pregnancy and bipolar: high relapse risk if stop medications. Lithium safest mood stabilizer (small risk Ebstein). Avoid valproate. Lamotrigine alternative. (APA/ACOG)",
    "category": "Diagnosis"
  },
  {
    "id": 463,
    "question": "When to admit an anorexic patient:",
    "options": [
      "A. Any weight loss",
      "B. BMI 14.5",
      "C. Patient request",
      "D. Family request"
    ],
    "correctAnswer": 1,
    "rationale": "Antipsychotics pregnancy: second-generation preferred. Quetiapine, olanzapine most data. Continue if mother stabilized. Gestational diabetes risk with metabolic agents. (ACOG)",
    "category": "Treatment"
  },
  {
    "id": 464,
    "question": "Patient on 2000-calorie diet but staff giving him food:",
    "options": [
      "A. Ignore",
      "B. Consult staff/educate",
      "C. Change diet order",
      "D. Report staff"
    ],
    "correctAnswer": 1,
    "rationale": "Antidepressants pregnancy: SSRIs generally safe. Paroxetine higher cardiac malformations. Sertraline extensive data. Weigh against untreated depression risks. (ACOG/APA)",
    "category": "Professional Practice"
  },
  {
    "id": 465,
    "question": "What medication will you give a patient with Acute dystonia (Stiff neck)",
    "options": [
      "Lorazepam (Ativan)",
      "Diphenhydramine (Benadryl)",
      "Benztropine",
      "Haloperidol (Haldol)"
    ],
    "correctAnswer": 2,
    "rationale": "Lamotrigine pregnancy: safe mood stabilizer. Pregnancy reduces levels, monitor closely. Increase dose in pregnancy, reduce postpartum. (APA/ACOG)",
    "category": "Pharmacology"
  },
  {
    "id": 466,
    "question": "Kava Kava which medication is contradicting and not to give",
    "options": [
      "SSRIs",
      "Antipsychotics",
      "Mood stabilizers",
      "No Benzo"
    ],
    "correctAnswer": 3,
    "rationale": "Lithium pregnancy: Ebstein anomaly risk 0.05-0.1% (general population 0.01%). Screen with fetal echo 16-18 weeks. Monitor levels more frequently. (ACOG)",
    "category": "Pharmacology"
  },
  {
    "id": 467,
    "question": "Pt while taking Kava Kava, what will you educate pt. on",
    "options": [
      "Action B",
      "Hepatoxicity",
      "Action A",
      "Action C"
    ],
    "correctAnswer": 1,
    "rationale": "ECT pregnancy: safe, effective for severe depression, psychosis, catatonia in pregnancy. Consider if medication-refractory. Coordinate with obstetrics. (APA/ACOG)",
    "category": "Pharmacology"
  },
  {
    "id": 468,
    "question": "How do you treat fibromyalgia",
    "options": [
      "Option B",
      "Option A",
      "? Give Benzo",
      "Option C"
    ],
    "correctAnswer": 2,
    "rationale": "Postpartum psychosis: onset within 2 weeks postpartum. Risk of infanticide (4%). Psychiatric emergency. Hospitalize, antipsychotics, mood stabilizers. High bipolar association. (APA)",
    "category": "Pharmacology"
  },
  {
    "id": 469,
    "question": "A man whose wife dies and say good about her what kind of defense mechanism is the patient using",
    "options": [
      "Projection",
      "Idealization",
      "Displacement",
      "Denial"
    ],
    "correctAnswer": 1,
    "rationale": "Postpartum blues: 50-80% women. Mild mood lability, tearfulness. Onset 2-3 days, resolves 2 weeks. Reassurance, support. Differentiate from postpartum depression. (ACOG)",
    "category": "Pharmacology"
  },
  {
    "id": 470,
    "question": "Pt is on Risperdal how you assess for metabolic syndrome",
    "options": [
      "Blood glucose monitoring",
      "BMI calculation",
      "-Measure hip to waist circumference",
      "Lipid panel"
    ],
    "correctAnswer": 2,
    "rationale": "Infanticide risk: postpartum psychosis, severe depression with psychosis. Delusional beliefs about infant. Assess explicitly. Hospitalize if risk. (Forensic)",
    "category": "Pharmacology"
  },
  {
    "id": 471,
    "question": "Pt on lithium and taking Indocin/Mobic (Meloxicam) for back pain what is contradicting or what should the np do something like that",
    "options": [
      "Switch to different mood stabilizer",
      "Decrease lithium dose",
      "Increase lithium dose",
      "Discontinue NSAID"
    ],
    "correctAnswer": 1,
    "rationale": "Perinatal anxiety: common, often co-occurs with depression. Screen for both. Intrusive thoughts about harm to baby (common, non-delusional). (ACOG/APA)",
    "category": "Pharmacology"
  },
  {
    "id": 472,
    "question": "Reglan can cause",
    "options": [
      "Neuroleptic malignant syndrome",
      "Akathisia",
      "Tardive dyskinesia",
      "Serotonin syndrome"
    ],
    "correctAnswer": 2,
    "rationale": "Breastfeeding and medications: most psychotropics enter breast milk. Risks generally low. Weigh against benefits breastfeeding, risks untreated illness. (AAP)",
    "category": "Pharmacology"
  },
  {
    "id": 473,
    "question": "Serial 7 counting down from 100. What are you assessing?",
    "options": [
      "Memory",
      "Concentration and attention",
      "Orientation",
      "Language"
    ],
    "correctAnswer": 1,
    "rationale": "Breastfeeding antipsychotics: quetiapine, olanzapine lower infant exposure. Avoid clozapine (agranulocytosis risk). Monitor infant sedation, feeding. (AAP)",
    "category": "Pharmacology"
  },
  {
    "id": 474,
    "question": "How do you assess a Pt with thought disorder",
    "options": [
      "Memory testing",
      "Calculation tasks",
      "- Have the patient do proverb interpretation/ abstract thinking.",
      "Orientation assessment"
    ],
    "correctAnswer": 2,
    "rationale": "Breastfeeding mood stabilizers: lamotrigine accumulates in infant, monitor. Lithium enters milk significantly, avoid if possible. Valproate relatively safe. (AAP)",
    "category": "Pharmacology"
  },
  {
    "id": 475,
    "question": "How to prevent ODD to become conduct disorder",
    "options": [
      "Prevention method A",
      "Prevention method B",
      "teach parenting skills/behavior therapy",
      "Prevention method C"
    ],
    "correctAnswer": 2,
    "rationale": "Infant monitoring breastfeeding: assess sedation, feeding, developmental milestones. Check infant drug levels if concerns (lithium, lamotrigine). (AAP/Pediatrics)",
    "category": "Pharmacology"
  },
  {
    "id": 476,
    "question": "Question about which therapy to use for PTSD",
    "options": [
      "CBT",
      "Psychodynamic therapy",
      "there was nothing like EMDR, EXPOSURE THERAPY, OR any other therapy we know. CAN'T remember the options",
      "DBT"
    ],
    "correctAnswer": 2,
    "rationale": "Menopausal depression: hormonal changes increase risk. SSRIs effective. Hormone therapy may help vasomotor symptoms, mood. (NAMS)",
    "category": "Psychotherapy & Treatment"
  },
  {
    "id": 477,
    "question": "Pt withdrawing from alcohol with hepatic problem (Know sign and symptoms of AW)",
    "options": [
      "Option C",
      "Option A",
      "Option B",
      "give IM Ativan"
    ],
    "correctAnswer": 3,
    "rationale": "Testosterone deficiency: causes depression, fatigue, low libido. Screen if symptoms. Replacement improves mood in men with low levels. (Endocrinology)",
    "category": "Pharmacology"
  },
  {
    "id": 478,
    "question": "20 years old came to see the PMHNP and says \"I CANNOT MAKE FRIEND. NOBODY LIKES ME\" What Erickson stage is this patient",
    "options": [
      "Intimacy vs Isolation",
      "identity vs role confusion",
      "Trust vs Mistrust",
      "Generativity vs Stagnation"
    ],
    "correctAnswer": 1,
    "rationale": "Polycystic ovary syndrome: androgen excess. Higher depression, anxiety rates. Valproate worsens (weight gain, PCOS). Avoid valproate in women with PCOS. (Endocrinology)",
    "category": "Developmental Theory & Lifespan"
  },
  {
    "id": 479,
    "question": "8 years old came in and play with two toys (the child play as if the two toys are having sex with each other). The PMHNP ask the child what you are doing, and the child said this is how dad/ grandpa play with me. What will the NP DO?",
    "options": [
      "-call CPS",
      "Consult with supervisor",
      "Refer to therapy",
      "Schedule follow-up appointment"
    ],
    "correctAnswer": 0,
    "rationale": "Antipsychotics and prolactin: hyperprolactinemia causes amenorrhea, infertility. May be used for contraception unintentionally. Discuss reproductive planning. (Endocrinology)",
    "category": "Pharmacology"
  },
  {
    "id": 480,
    "question": "Know you",
    "options": [
      "Option C",
      "Option B",
      "Option A",
      "MMSE… Difference between thought process and thought content"
    ],
    "correctAnswer": 3,
    "rationale": "Amenorrhea and contraception: amenorrhea from hyperprolactinemia doesn't guarantee inability to conceive. Use contraception if sexually active, avoiding pregnancy. (Reproductive)",
    "category": "Pharmacology"
  },
  {
    "id": 481,
    "question": "You are giving a patient Tegretol and erythromycin",
    "options": [
      "You will decrease Tegretol",
      "Monitor Tegretol levels only",
      "Increase Tegretol",
      "Discontinue Tegretol"
    ],
    "correctAnswer": 0,
    "rationale": "Long-term injectable contraception: depot medroxyprogesterone (Depo-Provera) good option psychiatric patients. Every 3 months. No drug interactions. (Reproductive)",
    "category": "Pharmacology"
  },
  {
    "id": 482,
    "question": "Know Appreciative inquiry.",
    "options": [
      "Emphasizes medication compliance",
      "Targets symptom reduction",
      "Focuses on deficits and problems",
      "It focuses on strength and Hope, does not blame people"
    ],
    "correctAnswer": 3,
    "rationale": "IUD: intrauterine device highly effective contraception. Long-acting (3-10 years). No adherence issues. No drug interactions. Good option. (Reproductive)",
    "category": "Pharmacology"
  },
  {
    "id": 483,
    "question": "Know Recovery model.",
    "options": [
      "Targets symptom reduction",
      "It gives hope to patient",
      "Emphasizes medication compliance",
      "Focuses on deficits and problems"
    ],
    "correctAnswer": 1,
    "rationale": "Emergency contraception: levonorgestrel or ulipristal. Effective 72-120 hours after intercourse. CYP3A4 inducers reduce efficacy. (Reproductive)",
    "category": "Pharmacology"
  },
  {
    "id": 484,
    "question": "Know what different parts of the brain does",
    "options": [
      "Executive function- Dorsolateral",
      "Anterior cingulate cortex",
      "Posterior parietal cortex",
      "Ventromedial prefrontal cortex"
    ],
    "correctAnswer": 0,
    "rationale": "HIV and mental health: higher rates depression, anxiety, psychosis. Antiretrovirals can cause psychiatric side effects. Screen for depression. (HIV Medicine)",
    "category": "Neuroscience & Neuroanatomy"
  },
  {
    "id": 485,
    "question": "Therapy that uses movement",
    "options": [
      "CBT",
      "DBT",
      "EMDR",
      "Psychodynamic therapy"
    ],
    "correctAnswer": 2,
    "rationale": "Efavirenz neuropsychiatric effects: antiretroviral causes vivid dreams, dizziness, depression, suicidal ideation. Consider switching if severe psychiatric symptoms. (HIV Medicine)",
    "category": "Psychotherapy & Treatment"
  },
  {
    "id": 486,
    "question": "Lamictal is the ideal medication to give when a patient wants to prevent weight gain",
    "options": [
      "Alternative medication A",
      "Alternative medication C",
      "Mood stabilizer",
      "Alternative medication B"
    ],
    "correctAnswer": 2,
    "rationale": "Hepatitis C and interferon: interferon causes depression (30%), suicidality. Screen, monitor, treat proactively with antidepressants. Newer DAA regimens no interferon. (Hepatology)",
    "category": "Pharmacology"
  },
  {
    "id": 487,
    "question": "Question on family therapy",
    "options": [
      "Therapy approach A",
      "Triangulation/ Self differentiation",
      "Therapy approach B",
      "Therapy approach C"
    ],
    "correctAnswer": 1,
    "rationale": "Corticosteroids psychiatric effects: mania, psychosis, depression, agitation. Dose-related. Taper when possible. Antipsychotics for psychotic symptoms. (Endocrinology/Psychiatry)",
    "category": "Psychotherapy & Treatment"
  },
  {
    "id": 488,
    "question": "Question about how to prevent osteoporosis",
    "options": [
      "Bed rest",
      "Increase calcium intake only",
      "Avoid all exercise",
      "Weight bearing exercise and decrease smoking"
    ],
    "correctAnswer": 3,
    "rationale": "Prednisone and mood: hypomania, mania, psychosis, depression, agitation common. Higher doses increase risk. Usually resolves with taper. (Endocrinology)",
    "category": "Pharmacology"
  },
  {
    "id": 489,
    "question": "What part of the brain controls clock drawing",
    "options": [
      "Brain region B",
      "Brain region A",
      "Brain region C",
      "Dorso lateral, Right hemisphere."
    ],
    "correctAnswer": 3,
    "rationale": "Isotretinoin and depression: acne medication. Black box warning depression, suicidal ideation. Controversial if causal. Monitor mood. (Dermatology/FDA)",
    "category": "Neuroscience & Neuroanatomy"
  },
  {
    "id": 490,
    "question": "Question on dissemination there are options like peer review, newspaper",
    "options": [
      "Method C",
      "Method A",
      "Method B",
      "Research those"
    ],
    "correctAnswer": 3,
    "rationale": "Statins and cognitive effects: questionable association cognitive impairment. Benefits outweigh unclear risks. Continue unless temporal relationship. (Cardiology)",
    "category": "Pharmacology"
  },
  {
    "id": 491,
    "question": "Question about a pregnant patient which medication can cause birth defect",
    "options": [
      "Alternative medication C",
      "Alternative medication A",
      "Accutane",
      "Alternative medication B"
    ],
    "correctAnswer": 2,
    "rationale": "Anticholinergic cognitive burden scale: rates medications anticholinergic effects 0-3. Cumulative score predicts cognitive decline, delirium. Minimize in elderly. (Geriatrics)",
    "category": "Pharmacology"
  },
  {
    "id": 492,
    "question": "Question on a child who is on amphetamine and develops tics which medication will you be switching to",
    "options": [
      "Ritalin",
      "Adderall",
      "Strattera",
      "Methamphetamine and Guanfacine"
    ],
    "correctAnswer": 3,
    "rationale": "Anticholinergic alternatives: SSRI instead TCA, memantine instead anticholinergic, quetiapine instead high-potency antipsychotic with anticholinergic. (Geriatrics)",
    "category": "Pharmacology"
  },
  {
    "id": 493,
    "question": "Question about a depressed lady who has marital conflicts comes to you that she is interested in therapy however she would like to engage for a 3 to 4 months or 4 to 6 months what therapy would you suggest",
    "options": [
      "CBT",
      "interpersonal and psychodynamic therapy",
      "Exposure therapy",
      "Psychodynamic therapy"
    ],
    "correctAnswer": 1,
    "rationale": "Psychotropics and driving: sedating medications impair driving. Benzodiazepines, z-drugs, sedating antidepressants, antipsychotics. Counsel patients. (Safety)",
    "category": "Psychotherapy & Treatment"
  },
  {
    "id": 494,
    "question": "A PMHNP is doing a medication reconciliation, NP should know that",
    "options": [
      "ace inhibitors are used for cardiac/ heart failure",
      "Alternative medication A",
      "Alternative medication C",
      "Alternative medication B"
    ],
    "correctAnswer": 0,
    "rationale": "Cannabis and driving: impairs coordination, judgment, reaction time. Advise against driving under influence. (Traffic Safety)",
    "category": "Pharmacology"
  },
  {
    "id": 495,
    "question": "Question on Desmopressin, how will the NP assess that the mother of the patient understands how the medication works",
    "options": [
      "it decreases urine production",
      "Alternative medication B",
      "Alternative medication A",
      "Alternative medication C"
    ],
    "correctAnswer": 0,
    "rationale": "Workplace accommodations: reasonable accommodations under ADA. Flexible schedule, quiet workspace, time off for appointments. Document functional limitations. (ADA/Employment)",
    "category": "Pharmacology"
  },
  {
    "id": 496,
    "question": "A patient taking an MAOI presents with severe headache, hypertension, and diaphoresis after eating aged cheese. What is the priority intervention?",
    "options": [
      "Administer IV phentolamine or nifedipine",
      "Give activated charcoal",
      "Discontinue the MAOI immediately",
      "Provide supportive care only"
    ],
    "correctAnswer": 0,
    "rationale": "Disability documentation: functional limitations, not just diagnosis. How symptoms impair work, activities of daily living. Specific examples. (Disability)",
    "category": "Pharmacology"
  },
  {
    "id": 497,
    "question": "What is the first-line pharmacological treatment for social anxiety disorder according to evidence-based guidelines?",
    "options": [
      "Benzodiazepines",
      "SSRIs or SNRIs",
      "Beta-blockers",
      "Buspirone"
    ],
    "correctAnswer": 1,
    "rationale": "Return to work: gradual, supported return improves success. Address work stressors, accommodations. Maintain treatment. (Occupational Health)",
    "category": "Pharmacology"
  },
  {
    "id": 498,
    "question": "A patient reports their antidepressant is no longer working after 2 years of effective treatment. What phenomenon is this called?",
    "options": [
      "Tachyphylaxis (poop-out syndrome)",
      "Tolerance",
      "Pseudodementia",
      "Treatment-resistant depression"
    ],
    "correctAnswer": 0,
    "rationale": "Collaborative care: integrated behavioral health in primary care. Improves access, outcomes. Psychiatric consultation, care management. (IMPACT Model)",
    "category": "Pharmacology"
  },
  {
    "id": 499,
    "question": "During a mental status exam, a patient states: 'I went to the store, the door, the floor, explore.' This is an example of which thought process disturbance?",
    "options": [
      "Flight of ideas",
      "Clanging",
      "Tangentiality",
      "Perseveration"
    ],
    "correctAnswer": 1,
    "rationale": "Measurement-based care: use rating scales (PHQ-9, GAD-7) track symptoms, guide treatment. Improves outcomes. Document scores. (APA)",
    "category": "Assessment"
  },
  {
    "id": 500,
    "question": "What is the minimum duration of symptoms required to diagnose Persistent Depressive Disorder (Dysthymia) in adults?",
    "options": [
      "6 months",
      "1 year",
      "2 years",
      "5 years"
    ],
    "correctAnswer": 2,
    "rationale": "Recovery-oriented care: person-centered, strengths-based. Hope, empowerment, meaningful life beyond symptoms. Shared decision-making. (SAMHSA)",
    "category": "Diagnostic Criteria (DSM-5)"
  }
]